Document:

Exhibit 10.1

 

AULT GLOBAL HOLDINGS, INC.

 

Common Stock

(par value $0.001 per share)

 

At-The-Market Issuance Sales Agreement

 

January 22, 2021

 

Ascendiant Capital Markets, LLC

4 Park Plaza, Suite 1950

Irvine, CA 92614

 

Ladies and Gentlemen:

 

Ault Global Holdings,
Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with
Ascendiant Capital Markets, LLC (“Ascendiant”), as follows:

 

1.             Issuance
and Sale of Shares. The Company agrees to issue and sell through Ascendiant, shares (the “Placement Shares”)
of the Company’s Class A common stock, par value $0.001 per share (the “Common Stock”), from time to time
during the term of this Agreement and on the terms set forth in this Agreement; provided however, that in no event will
the Company issue or sell through Ascendiant such number of Placement Shares that would exceed $50,000,000 (the “Maximum
Amount”). Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the
limitations set forth in this Section 1 on the amount of Placement Shares issued and sold under this Agreement will be the sole
responsibility of the Company and that Ascendiant will have no obligation in connection with such compliance, provided that Ascendiant
follows the lawful trading instructions provided by the Company pursuant to any Placement Notice in all material respects. The
issuance and sale of Placement Shares through Ascendiant will be effected pursuant to the Registration Statement (as defined below)
filed by the Company and declared effective by the U.S. Securities and Exchange Commission (the “SEC”), although
nothing in this Agreement will be construed as requiring the Company to use the Registration Statement to issue Common Stock.

 

The Company has filed
with the SEC, in accordance with the provisions of the Securities Act of 1933, as amended (the “Securities Act”),
and the rules and regulations thereunder (the “Securities Act Regulations”), a registration statement on Form
S-3 (File No. 333-251995), including a base prospectus, relating to certain securities, including the Placement Shares, to be issued
from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance
with the provisions of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and
regulations thereunder. The Company has prepared a prospectus supplement specifically relating to the Placement Shares (the “Prospectus
Supplement”) to the base prospectus included as part of the registration statement. The Company will furnish to Ascendiant,
for use by it, copies of the prospectus included as part of the registration statement, as supplemented by the Prospectus Supplement,
relating to the Placement Shares. Except when the context otherwise requires, such registration statement, including all documents
filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined
below) subsequently filed with the SEC pursuant to Rule 424(b) under the Securities Act Regulations or deemed to be a part
of the registration statement pursuant to Rule 430B of the Securities Act Regulations, is herein called the “Registration
Statement.” The base prospectus, including all documents incorporated therein by reference, included in the Registration
Statement, as it may be supplemented by the Prospectus Supplement, in the form in which the prospectus and/or Prospectus Supplement
have most recently been filed by the Company with the SEC pursuant to Rule 424(b) under the Securities Act Regulations is
herein called the “Prospectus.” Any reference herein to the Registration Statement, the Prospectus, or any amendment
or supplement thereto will be deemed to refer to and include the documents incorporated by reference therein, and any reference
herein to the terms “amend,” “amendment,” or “supplement” respecting the Registration Statement
or the Prospectus will be deemed to refer to and include the filing after the execution hereof of any document with the SEC deemed
to be incorporated by reference therein (the “Incorporated Documents”).

 

    	 	 	 

    	 

    

 

For purposes of this
Agreement, all references to the Registration Statement, the Prospectus, or to any amendment or supplement thereto will be deemed
to include the most recent copy filed with the SEC pursuant to its Electronic Data Gathering Analysis and Retrieval System, or
if applicable, the Interactive Data Electronic Application system when used by the SEC (collectively, “EDGAR”).

 

2.             Placements.
Each time that the Company wishes to issue and sell Placement Shares hereunder (each, a “Placement”), it will
notify Ascendiant by email notice (or other method mutually agreed to in writing by the parties) of the number of Placement Shares,
the period during which sales are requested to be made, any limitation on the number of Placement Shares that may be sold in any
one day, and any minimum price below which sales may not be made (a “Placement Notice”), the form of which is
attached hereto as Schedule 1. The Placement Notice will originate from any of the individuals from the Company set forth
on Schedule 3 (with a copy to each of the other individuals from the Company listed on the schedule) and will be addressed
to each of the individuals from Ascendiant set forth on Schedule 3, as Schedule 3 may be amended from time to time.
The Placement Notice will be effective unless and until: (a) Ascendiant declines to accept the terms contained therein for
any reason, in its sole discretion, by notice to the Company within two (2) Business Days after the receipt of such Placement Notice;
(b) the entire amount of the Placement Shares thereunder have been sold; (c) the Company suspends or terminates the Placement
Notice; or (d) the Agreement has been terminated under the provisions of Section 13. The amount of any discount, commission,
or other compensation to be paid by the Company to Ascendiant in connection with the sale of the Placement Shares will be calculated
in accordance with the terms set forth in Schedule 2. Neither the Company nor Ascendiant will have any obligation whatsoever
respecting a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to Ascendiant and Ascendiant
does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and
herein. In the event of a conflict between the terms of Sections 2, 3, and 4 of this Agreement and the terms of a Placement Notice,
the terms of the Placement Notice will control.

 

3.             Sale
of Placement Shares by Ascendiant. Subject to the terms and conditions of this Agreement, Ascendiant, for the period specified
in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and
applicable state and federal laws, rules, and regulations and the rules of the NYSE American LLC (the “Exchange”),
to sell the Placement Shares up to the amount specified, and otherwise in accordance with the terms of such Placement Notice. Ascendiant
will provide written confirmation to the Company no later than the opening of the Trading Day (as defined below) immediately following
the Trading Day on which it has sold Placement Shares hereunder, setting forth the number of Placement Shares sold on such day,
the compensation payable by the Company to Ascendiant pursuant to Section 2 for such sales, and the Net Proceeds (as
defined below) payable to the Company, with an itemization of the deductions made by Ascendiant (as set forth in Section 5(b))
from the gross proceeds that it receives from such sales. Subject to the terms of the Placement Notice, Ascendiant may sell Placement
Shares by any method permitted by law deemed to be an “at the market” offering as defined in Rule 415(a)(1)(x)
and 415(a)(4) of the Securities Act Regulations, including sales made directly on the Exchange or on any other existing trading
market for the Common Stock or to or through a market maker. Subject to the terms of a Placement Notice, Ascendiant may also sell
Placement Shares by any other method permitted by law, including in privately negotiated transactions, with the Company’s
consent. “Trading Day” means any day on which Common Stock is purchased and sold on the Exchange.

 

4.             Suspension
of Sales. The Company or Ascendiant may, upon notice to the other party in writing (including by email correspondence to each
of the individuals of the other party set forth on Schedule 3, if receipt of such correspondence is actually acknowledged
by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable
email correspondence to each of the individuals of the other party set forth on Schedule 3), suspend any sale of Placement
Shares; provided, however, that such suspension will not affect or impair any party’s obligations respecting any Placement
Shares sold hereunder prior to the receipt of such notice. While a suspension is in effect, any obligation under Section 7(l),
7(m), and 7(n) with respect to delivery of certificates, opinions and comfort letters to Ascendiant shall be waived. Each of the
parties agrees that no such notice under this Section 4 will be effective against any other party unless it is made to one
of the individuals named on Schedule 3 hereto, as such schedule may be amended from time to time.

 

    	 	2	 

    	 

    

 

5.             Sale
and Delivery to Ascendiant; Settlement.

 

(a)             Sale
of Placement Shares. On the basis of the representations and warranties herein contained and subject to the terms and
conditions herein set forth, upon Ascendiant’s acceptance of the terms of a Placement Notice, and unless the sale of the
Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement,
Ascendiant, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its
normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Exchange to
sell such Placement Shares up to the amount specified, and otherwise in accordance with the terms of such Placement Notice. The
Company acknowledges and agrees that: (i) there can be no assurance that Ascendiant will be successful in selling Placement
Shares; (ii) Ascendiant will incur no liability or obligation to the Company or any other Person (as defined herein) if it
does not sell Placement Shares for any reason other than a failure by Ascendiant to use its commercially reasonable efforts consistent
with its normal trading and sales practices and applicable law and regulations to sell such Placement Shares as required under
this Agreement; and (iii) Ascendiant will be under no obligation to purchase Placement Shares on a principal basis pursuant
to this Agreement, except as otherwise agreed by Ascendiant and the Company.

 

(b)             Settlement
of Placement Shares. Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement
Shares will occur on the second Trading Day (or such earlier day as is industry practice for regular-way trading) following the
date on which such sales are made (each, a “Settlement Date”). The Agent shall notify the Company of each sale
of Placement Shares no later than opening day following the Trading Day that the Agent sold Placement Shares. The amount of proceeds
to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the “Net Proceeds”)
will be equal to the aggregate sales price received by Ascendiant, after deduction for: (i) Ascendiant’s commission,
discount, or other compensation for such sales payable by the Company pursuant to Section 2 hereof, and (ii) any transaction
fees imposed by any governmental or self-regulatory organization for such sales.

 

(c)             Delivery
of Placement Shares. On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically
transfer the Placement Shares being sold by crediting Ascendiant’s or its designee’s account (provided Ascendiant
will have given the Company written notice of such designee at least one (1) Business Day prior to the Settlement Date) at The
Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually
agreed upon by the parties hereto, which in all cases will be freely tradable, transferable, registered shares in good deliverable
form. On each Settlement Date, Ascendiant will deliver the related Net Proceeds in same-day funds to an account designated by the
Company on, or prior to, the Settlement Date. The Company agrees that if the Company, or its transfer agent (if applicable), defaults
in its obligation to deliver Placement Shares on a Settlement Date through no fault of Ascendiant, that in addition to and in no
way limiting the rights and obligations set forth in Section 11(a) hereto, it will: (i) hold Ascendiant harmless
against any loss, claim, damage, or expense (including reasonable and documented legal fees and expenses), as incurred, arising
out of or in connection with such default by the Company or its transfer agent (if applicable); and (ii) pay to Ascendiant
(without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such
default.

 

(d)             Limitations
on Offering Size. Under no circumstances will the Company cause or request the offer or sale of any Placement Shares
if, after giving effect to the sale of such Placement Shares, the aggregate gross sales proceeds of Placement Shares sold pursuant
to this Agreement would exceed the lesser of: (i) together with all sales of Placement Shares under this Agreement, the Maximum
Amount; or (ii) the amount authorized from time to time to be issued and sold under this Agreement by the Company’s
board of directors, a duly authorized committee thereof, or a duly authorized executive committee, and notified to Ascendiant in
writing. Under no circumstances will the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement
at a price lower than the minimum price authorized from time to time by the Company’s board of directors, a duly authorized
committee thereof, or a duly authorized executive committee, and notified to Ascendiant in writing.

 

    	 	3	 

    	 

    

 

6.             Representations
and Warranties of the Company. The Company represents and warrants to, and agrees with, Ascendiant that as of the date of this
Agreement and as of each Applicable Time (as defined below), unless such representation, warranty or agreement specifies a different
date or time:

 

(a)             Registration
Statement and Prospectus. The Company and, assuming no act or omission on the part of Ascendiant that would make such statement
untrue, the transactions contemplated by this Agreement meet the requirements for and comply with the conditions for the use of
Form S-3 under the Securities Act. The Registration Statement has been filed with the SEC and has been declared effective under
the Securities Act. The Prospectus Supplement will name Ascendiant as the agent in the section entitled “Plan of Distribution.”
The Company has not received, and has no notice of, any order of the SEC preventing or suspending the use of the Registration Statement
or threatening or instituting proceedings for that purpose. The Registration Statement and the offer and sale of Placement Shares
as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with
said Rule. Any statutes, regulations, contracts, or other documents that are required to be described in the Registration Statement
or the Prospectus or to be filed as exhibits to the Registration Statement have been so described or filed. Copies of the Registration
Statement, the Prospectus, and any such amendments or supplements and all documents incorporated by reference therein that were
filed with the SEC on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to Ascendiant
and its counsel. The Company has not distributed and, prior to the later to occur of each Settlement Date and completion of the
distribution of the Placement Shares, will not distribute any offering material in connection with the offering or sale of the
Placement Shares other than the Registration Statement and the Prospectus and any Issuer Free Writing Prospectus (as defined below)
to which Ascendiant has consented, which consent shall not be unreasonably withheld or delayed. The Common Stock is currently listed
on the Exchange under the trading symbol “DPW.” Except as disclosed in the Registration Statement, including the Incorporated
Documents, the Company has not, in the 12 months preceding the date hereof, received notice from the Exchange to the effect that
the Company is not in compliance with the Exchange’s listing or maintenance requirements. Except as disclosed on Schedule
6(a), in the Registration Statement, including the Incorporated Documents, or the Prospectus, the Company has no reason to
believe that it will not in the foreseeable future continue to be in compliance with all such listing and maintenance requirements.

 

(b)             No
Misstatement or Omission. The Registration Statement, when it became effective, and the Prospectus, and any amendment or supplement
thereto, on the date of such Prospectus or amendment or supplement, conformed and will conform in all material respects with the
requirements of the Securities Act. At each Settlement Date, the Registration Statement and the Prospectus, as of such date, will
conform in all material respects with the requirements of the Securities Act. The Registration Statement, when it became or becomes
effective, did not, and will not, contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendment and supplement thereto,
on the date thereof and at each Applicable Time (defined below), did not or will not include an untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading. The documents incorporated by reference in the Prospectus or any Prospectus Supplement did not, and
any further documents filed and incorporated by reference therein will not, when filed with the SEC, contain an untrue statement
of a material fact or omit to state a material fact required to be stated in such document or necessary to make the statements
in such document, in light of the circumstances under which they were made, not misleading. The foregoing will not apply to statements
in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished to the Company by
Ascendiant specifically for use in the preparation thereof.

 

(c)             Conformity
with Securities Act and Exchange Act. The documents incorporated by reference in the Registration Statement, the Prospectus,
or any amendment or supplement thereto, when such documents were or are filed with the SEC under the Securities Act or the Exchange
Act or became or become effective under the Securities Act, as the case may be, conformed or will conform in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable.

 

    	 	4	 

    	 

    

 

(d)             Financial
Information. The consolidated financial statements of the Company included or incorporated by reference in the Registration
Statement, the Prospectus, and the Issuer Free Writing Prospectuses, if any, together with the related notes and schedules, complied
as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC
with respect thereto as in effect as of the time of filing. Such financial statements have been prepared in accordance with generally
accepted accounting principles, consistently applied, during the periods involved (except: (i) as may be otherwise indicated
in such financial statements or the notes thereto; or (ii) in the case of unaudited interim statements, to the extent they
may exclude footnotes or may be condensed or summary statements) and fairly present in all material respects the consolidated financial
position of the Company and the Subsidiaries as of the dates indicated and the consolidated results of operations and cash flows
of the Company for the periods specified (subject, in the case of unaudited statements, to normal year-end audit adjustments that
will not be material, either individually or in the aggregate); the other financial and statistical data respecting the Company
and the Subsidiaries contained or incorporated by reference in the Registration Statement, the Prospectus, and the Issuer Free
Writing Prospectuses, if any, are accurately and fairly presented and prepared on a basis consistent with the financial statements
and books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included
or incorporated by reference in the Registration Statement or the Prospectus that are not included or incorporated by reference
as required; the Company and the Subsidiaries (as defined below) do not have any material liabilities or obligations, direct or
contingent (including any off-balance sheet obligations), not described in the Registration Statement (including the exhibits thereto)
and the Prospectus that are required to be described in the Registration Statement or the Prospectus (including exhibits thereto
and Incorporated Documents); and all disclosures contained or incorporated by reference in the Registration Statement, the Prospectus,
and the Issuer Free Writing Prospectuses, if any, regarding “non-GAAP financial measures” (as such term is defined
by the rules and regulations of the SEC) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation
S-K under the Securities Act, to the extent applicable.

 

(e)             Conformity
with EDGAR Filing. The Prospectus delivered to Ascendiant for use in connection with the sale of the Placement Shares pursuant
to this Agreement will be identical to the versions of the Prospectus created to be transmitted to the SEC for filing via EDGAR,
except to the extent permitted by Regulation S-T.

 

(f)              Organization.
Except as set forth on Schedule 6(f), the Company and each of its Subsidiaries are, and will be, duly organized, validly
existing as a corporation, limited partnership, limited liability company, or other legal entity, and in good standing under the
laws of their respective jurisdictions of organization. The Company and each of its Subsidiaries are, and will be, duly qualified
as a foreign corporation for transaction of business and in good standing under the laws of each other jurisdiction in which their
respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all
corporate power and authority necessary to own or hold their respective properties and to conduct their respective businesses as
described in the Registration Statement and the Prospectus, except where the failure to be so qualified or in good standing or
have such power or authority would not, individually or in the aggregate, have a material adverse effect or would reasonably be
expected to have a material adverse effect on the assets, business, operations, earnings, properties, condition (financial or otherwise),
prospects, stockholders’ equity, or results of operations of the Company and the Subsidiaries (as defined below) taken as
a whole, or prevent or materially interfere with consummation of the transactions contemplated hereby (a “Material Adverse
Effect”).

 

(g)             Subsidiaries.
The subsidiaries set forth on Schedule 4 (collectively, the “Subsidiaries”), are the Company’s
only subsidiaries. Except as set forth on Schedule (g), the Company owns, directly or indirectly, all of the equity interests
of the Subsidiaries free and clear of any material lien, charge, security interest, encumbrance, right of first refusal, or other
restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable, and free of
preemptive and similar rights.

 

(h)             No
Violation or Default. Neither the Company nor any of its Subsidiaries is: (i) in violation of its charter or bylaws or
similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would
constitute such a default, in the due performance or observance of any term, covenant, or condition contained in any indenture,
mortgage, deed of trust, loan agreement, or other similar agreement or instrument to which the Company or any of its Subsidiaries
is a party, by which the Company or any of its Subsidiaries is bound, or to which any of the property or assets of the Company
or any of its Subsidiaries are subject; or (iii) in violation of any law or statute or any judgment, order, rule, or regulation
of any court, arbitrator, or governmental or regulatory authority, except, in the case of each of clauses (ii) and (iii) above,
for any such violation or default that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. Except as described in the Prospectus, the Prospectus Supplement, or the Incorporated Documents, to the Company’s
knowledge, no other party under any material contract or other agreement to which it or any of its Subsidiaries is a party is in
default in any respect thereunder where such default would reasonably be expected to have a Material Adverse Effect.

 

    	 	5	 

    	 

    

 

(i)              No
Material Adverse Change. Subsequent to the respective dates as of which information is given in the Registration Statement,
the Prospectus, and the Free Writing Prospectuses, if any (including any document deemed incorporated by reference therein), there
has not been: (i) any Material Adverse Effect, or the occurrence of any development that is reasonably likely to result in
a prospective Material Adverse Effect, in or affecting the business, properties, management, financial, condition (financial or
otherwise), results of operations, or prospects of the Company and the Subsidiaries taken as a whole; (ii) any transaction
that is material to the Company and the Subsidiaries taken as a whole; (iii) any obligation or liability, direct or contingent
(including any off-balance sheet obligations), incurred by the Company or any Subsidiary, that is material to the Company and the
Subsidiaries taken as a whole; (iv) except as disclosed on Schedule 6(i), any material change in the capital stock
(other than as a result of the sale of Placement Shares or other than as described in a proxy statement filed on Schedule 14A or
a Registration Statement on Form S-4 and otherwise publicly announced) or outstanding long-term indebtedness of the Company or
any of its Subsidiaries; or (v) any dividend or distribution of any kind declared, paid, or made on the capital stock of the
Company or any Subsidiary, other than in each case above, in the ordinary course of business or as otherwise disclosed in the Registration
Statement or Prospectus (including any document deemed incorporated by reference therein).

 

(j)              Capitalization.
The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid, and nonassessable.
The Company has an authorized, issued, and outstanding capitalization as set forth in the Registration Statement and the Prospectus
as of the dates referred to therein (other than the grant of additional options under the Company’s existing stock option
plans or changes in the number of outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion
of securities exercisable for, or convertible into, Common Stock outstanding on the date hereof or as a result of the issuance
of Placement Shares), and such authorized capital stock conforms to the description thereof set forth in the Registration Statement
and the Prospectus. The description of the Common Stock in the Registration Statement and the Prospectus is complete and accurate
in all material respects. Except as disclosed in or contemplated by the Registration Statement or the Prospectus, as of the date
referred to therein, the Company did not have reserved or available for issuance any shares of Common Stock in respect of options,
any rights or warrants to subscribe for, any securities or obligations convertible into or exchangeable for, or any contracts or
commitments to issue or sell, any shares of capital stock or other securities.

 

(k)             Authorization;
Enforceability. The Company has full legal right, power, and authority to enter into this Agreement and perform the transactions
contemplated hereby. This Agreement has been duly authorized, executed, and delivered by the Company and is a legal, valid, and
binding agreement of the Company enforceable against the Company in accordance with its terms, except to the extent that: (i) enforceability
may be limited by bankruptcy, insolvency, reorganization, moratorium, or similar laws affecting creditors’ rights generally
and by general equitable principles; and (ii) the indemnification and contribution provisions of Section 11 hereof
may be limited by federal or state securities laws and public policy considerations in respect thereof.

 

(l)              Authorization
of Placement Shares. The Placement Shares, when issued and delivered pursuant to the terms approved by the board of directors
of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided
herein, will be duly and validly authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance,
security interest, or other claim (other than any pledge, lien, encumbrance, security interest, or other claim arising from an
act or omission of Ascendiant or a purchaser), including any statutory or contractual preemptive rights, resale rights, rights
of first refusal, or other similar rights, and will be registered pursuant to Section 12 of the Exchange Act. The Placement Shares,
when issued, will conform in all material respects to the description thereof set forth in or incorporated into the Prospectus.

 

    	 	6	 

    	 

    

 

(m)            No
Consents Required. No consent, approval, authorization, order, registration, or qualification of or with any court or arbitrator
or any governmental or regulatory authority is required for the execution, delivery, and performance by the Company of this Agreement,
and the issuance and sale by the Company of the Placement Shares as contemplated hereby, except for such consents, approvals, authorizations,
orders, and registrations or qualifications as may be required under applicable state securities laws or by the bylaws and rules
of the Financial Industry Regulatory Authority (“FINRA”) or the Exchange in connection with the sale of the
Placement Shares by Ascendiant.

 

(n)            No
Preferential Rights. Except as set forth in the Registration Statement and the Prospectus: (i) no person, as such term
is defined in Rule 1-02 of Regulation S-X promulgated under the Securities Act (each, a “Person”), has the right,
contractual or otherwise, to cause the Company to issue or sell to such Person any Common Stock or shares of any other capital
stock or other securities of the Company (other than upon the exercise of options or warrants to purchase Common Stock or upon
the exercise of options that may be granted from time to time under the Company’s stock option plans); (ii) no Person
has any preemptive rights, rights of first refusal, or any other rights (whether pursuant to a “poison pill” provision
or otherwise) to purchase any Common Stock or shares of any other capital stock or other securities of the Company from the Company
that have not been duly waived respecting the offering contemplated hereby; (iii) no Person has the right to act as an underwriter
or as a financial advisor to the Company in connection with the offer and sale of the Placement Shares; and (iv) no Person
has the right, contractual or otherwise, to require the Company to register under the Securities Act any Common Stock or shares
of any other capital stock or other securities of the Company, or to include any such shares or other securities in the Registration
Statement or the offering contemplated thereby, whether as a result of the filing or effectiveness of the Registration Statement
or the sale of the Placement Shares as contemplated thereby or otherwise, except for such rights as have been waived on or prior
to the date hereof.

 

(o)            Independent
Public Accountant. Marcum LLP (the “Accountants”), whose reports on the consolidated financial statements
of the Company are filed with the SEC as part of the Company’s most recent Annual Report on Form 10-K and incorporated by
reference into the Registration Statement, are and, during the periods covered by its report, were an independent registered public
accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To
the Company’s knowledge, after due inquiry, the Accountants are not in violation of the auditor independence requirements
of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) respecting the Company.

 

(p)            Enforceability
of Agreements. To the Company’s knowledge, all agreements between the Company and third parties expressly referenced
in the Prospectus, other than such agreements that have expired by their terms or whose termination is disclosed in documents filed
by the Company on EDGAR, are legal, valid, and binding obligations of the Company enforceable against the Company in accordance
with their respective terms, except to the extent that: (i) enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium, or similar laws affecting creditors’ rights generally and by general equitable principles; and (ii) the
indemnification provisions of certain agreements may be limited be federal or state securities laws or public policy considerations
in respect thereof, except for any unenforceability that, individually or in the aggregate, would not unreasonably be expected
to have a Material Adverse Effect.

 

(q)            No
Litigation. Except as set forth in the Registration Statement, the Prospectus or on Schedule 6(q): (i) there are
no legal, governmental, or regulatory actions, suits, or proceedings pending or, to the Company’s knowledge, any legal, governmental,
or regulatory investigations to which the Company or a Subsidiary is a party or to which any property of the Company or any of
its Subsidiaries is the subject that, individually or in the aggregate, if determined adversely to the Company or any of its Subsidiaries,
would reasonably be expected to have a Material Adverse Effect or materially and adversely affect the ability of the Company to
perform its obligations under this Agreement; (ii) to the Company’s knowledge, no actions, suits, or proceedings are
threatened or contemplated by any governmental or regulatory authority or threatened by others that, individually or in the aggregate,
if determined adversely to the Company or any of its Subsidiaries, would reasonably be expected to have a Material Adverse Effect;
(iii) there are no current or pending legal, governmental, or regulatory, actions, suits, proceedings or, to the Company’s
knowledge, investigations that are required under the Securities Act to be described in the Prospectus that are not described in
the Prospectus; and (iv) there are no contracts or other documents that are required under the Securities Act to be filed
as exhibits to the Registration Statement that are not so filed.

 

    	 	7	 

    	 

    

 

(r)             Licenses
and Permits. Except as set forth in the Registration Statement or the Prospectus, the Company and each of its Subsidiaries
possess or have obtained all licenses, certificates, consents, orders, approvals, permits, and other authorizations issued by,
and have made all declarations and filings with, the appropriate federal, state, local, or foreign governmental or regulatory authorities
that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described
in the Registration Statement and the Prospectus (the “Permits”), except where the failure to possess, obtain,
or make the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except
as disclosed in the Registration Statement or the Prospectus, neither the Company nor its Subsidiaries have received written notice
of any proceeding relating to revocation or modification of any such Permit or have any reason to believe that such Permit will
not be renewed in the ordinary course, except when the failure to obtain any such renewal would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.

 

(s)             S-3
Eligibility. (i) At the time of filing the Registration Statement;
and (ii) if applicable, at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3)
of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section 13
or 15(d) of the Exchange Act, or form of prospectus), the Company met the requirements for use of Form S-3 under the Securities
Act, up to the Maximum Amount. As of the close of trading on the Exchange on January 21, 2021, the aggregate market value of the
outstanding voting and non-voting common equity (as defined in Rule 405 under the Securities Act) of the Company held by persons
other than affiliates of the Company (pursuant to Rule 144 under the Securities Act, those that directly, or indirectly through
one or more intermediaries, control, or are controlled by, or are under common control with, the Company) (the “Non-Affiliate
Shares”), was approximately $161,614,419 (calculated by multiplying (x) the highest price at which the common equity
of the Company closed on the Exchange within sixty (60) days prior to the date of this Agreement, times (y) the number of Non-Affiliate
Shares).  The Company is not a shell company (as defined in Rule 405 under the Securities Act) and has not been a shell
company for at least 12 calendar months previously and if it has been a shell company at any time previously, has filed current
Form 10 information (as defined in General Instruction I.B.6. of Form S-3) with the Commission at least 12 calendar months previously
reflecting its status as an entity that is not a shell company.

 

(t)             No
Material Defaults. Except as set forth in the Registration Statement and Prospectus or on Schedule 6.6(t), neither the
Company nor any of the Subsidiaries has defaulted on any installment on indebtedness for borrowed money or on any rental on one
or more long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have a Material Adverse
Effect. Except as set forth in the Registration Statement and Prospectus, the Company has not filed a report pursuant to Section
13(a) or 15(d) of the Exchange Act since the filing of its last Annual Report on Form 10-K, indicating that it: (i) has failed
to pay any dividend or sinking fund installment on preferred stock; or (ii) has defaulted on any installment on indebtedness
for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably
be expected to have a Material Adverse Effect.

 

(u)            Certain
Market Activities. Neither the Company or any of the Subsidiaries, nor any of their respective directors, officers, or controlling
Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause
or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company
to facilitate the sale or resale of the Placement Shares.

 

    	 	8	 

    	 

    

 

(v)            Broker-Dealer
Relationships. Neither the Company nor any of the Subsidiaries or any related entities: (i) are required to register as
a “broker” or “dealer” in accordance with the provisions of the Exchange Act; or (ii) directly or
indirectly through one or more intermediaries, control or are a “person associated with a member” or “associated
person of a member” (within the meaning set forth in the FINRA rules). To the Company’s knowledge, there are no affiliations
or associations between any member of FINRA and any of the Company’s officers, directors or 5% or greater security holders,
except as set forth in the Registration Statement. All of the information (including, but not limited to, information regarding
affiliations, security ownership and trading activity) provided to Ascendiant or its counsel by the Company, its officers and directors
and the holders of any securities (debt or equity) or warrants, options or rights to acquire any securities of the Company in connection
with the filing to be made and other supplemental information to be provided to FINRA pursuant to Rule 5110 of FINRA in connection
with the transactions contemplated by this Agreement is true, complete and correct, and copies of any Company filings required
to be filed with FINRA have been filed with the Commission or delivered to the Sales Agent for filing with FINRA.

 

(w)            No
Reliance. The Company has not relied upon Ascendiant or legal counsel for Ascendiant for any legal, tax, or accounting advice
in connection with the offering and sale of the Placement Shares.

 

(x)             Taxes.
The Company and each of its Subsidiaries have filed all federal, state, local, and foreign tax returns that have been required
to be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not
being contested in good faith, except when the failure to do so would not reasonably be expected to have a Material Adverse Effect.
Except as otherwise disclosed in or contemplated by the Registration Statement or the Prospectus, no tax deficiency has been determined
adversely to the Company or any of its Subsidiaries that has had, or would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state, or other governmental tax deficiency,
penalty, or assessment that has been or might be asserted or threatened against it that could have a Material Adverse Effect.

 

(y)            Title
to Real and Personal Property. The Company and each of its Subsidiaries have good and defensible title to all of their real
and personal property owned by them that are material to the business of the Company or such Subsidiary, or to the Company’s
financial condition, in each case, free and clear of all liens, encumbrances, and defects, except as described in the Registration
Statement and Prospectus or that do not materially affect the value of the properties of the Company and its Subsidiaries, considered
as one enterprise, and do not interfere in any material respect with the use made and proposed to be made of such properties by
the Company and its Subsidiaries, considered as one enterprise; and all of the leases, subleases, and other rights under which
the Company or any of its Subsidiaries holds or uses properties described in the Registration Statement and Prospectus are in full
force and effect, with such exceptions as would not reasonably be expected to have a Material Adverse Effect, and neither the Company
nor any of its Subsidiaries has any notice of any material claim of any sort that has been asserted by anyone adverse to the rights
of the Company or its Subsidiaries under any of the leases, subleases, and other rights mentioned above, or affecting or questioning
the rights of the Company or any Subsidiary thereof to the continued possession or use of the leased or subleased premises or the
premises granted by leases, subleases, and other rights. The Company and each of its Subsidiaries have the consents, easements,
rights-of-way, or licenses from any Person as are necessary to enable them to conduct their business in the manner described in
the Registration Statement and the Prospectus, subject to such qualifications as may be set forth in the Registration Statement
and the Prospectus, and except for the consents, easements, rights-of-way, or licenses the lack of which would not have, individually
or in the aggregate, a Material Adverse Effect.

 

(z)             Intellectual
Property. Except as set forth in the Registration Statement or the Prospectus, to the Company’s knowledge, the Company
and its Subsidiaries own or possess adequate enforceable rights to use all patents, patent applications, trademarks (both registered
and unregistered), service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, and know-how
(including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems, or procedures)
(collectively, the “Intellectual Property”), necessary for the conduct of their respective businesses as conducted
as of the date hereof, except to the extent that the failure to own or possess adequate rights to use such Intellectual Property
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; except as disclosed in writing
to Ascendiant, the Company and any of its Subsidiaries have not received any written notice of any claim of infringement or conflict
that asserted Intellectual Property rights of others, which infringement or conflict, if the subject of an unfavorable decision,
would result in a Material Adverse Effect; there are no pending, or to the Company’s knowledge, threatened judicial proceedings
or interference proceedings against the Company or its Subsidiaries challenging the Company’s or its Subsidiaries’
rights in or to or the validity of the scope of any of the Company’s or its Subsidiaries’ material patents, patent
applications, or proprietary information; to the Company’s knowledge, no other entity or individual has any right or claim
in any of the Company’s or its Subsidiaries’ owned, material patents, patent applications, or any patent to be issued
therefrom by virtue of any contract, license, or other agreement entered into between such entity or individual and the Company
or a Subsidiary or by any non-contractual obligation of the Company or a Subsidiary, other than by written licenses granted by
the Company or a Subsidiary; the Company and its Subsidiaries have not received any written notice of any claim challenging the
rights of the Company or a Subsidiary in or to any Intellectual Property owned, licensed, or optioned by the Company or such Subsidiary
that, if the subject of an unfavorable decision, would result in a Material Adverse Effect.

 

    	 	9	 

    	 

    

 

(aa)           Environmental
Laws. Except as set forth in the Registration Statement or the Prospectus, the Company and its Subsidiaries: (i) are in
compliance with any and all applicable federal, state, local, and foreign laws, rules, regulations, decisions, and orders relating
to the protection of human health and safety, the environment, hazardous or toxic substances or wastes, pollutants, or contaminants
(collectively, “Environmental Laws”); (ii) have received and are in compliance with all permits, licenses,
or other approvals required of them under applicable Environmental Laws to conduct their respective businesses as described in
the Registration Statement and the Prospectus; (iii) have not received notice of any actual or potential liability for the
investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants, or contaminants,
except, in the case of any of clauses (i), (ii), or (iii) above, for any such failure to comply or failure to receive required
permits, licenses, other approvals or liability as would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect; and (iv) there are no costs or liabilities arising under Environmental Laws respecting the operation
of the Company’s and each of its Subsidiaries’ properties (including any capital or operating expenditures required
for clean-up or closure of the properties, compliance with Environmental Laws, any permit, license, or approval or any related
legal constraints or operating activities, and any potential liabilities of third parties assumed under contract by the Company
or any of its Subsidiaries) that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(bb)          Disclosure
Controls. The Company and each of its Subsidiaries maintain systems of internal accounting controls designed to provide reasonable
assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles
and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general
or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken respecting any differences. The Company is not aware of any material weaknesses in its
internal control over financial reporting (other than as set forth in the Prospectus). Since the date of the latest audited financial
statements of the Company included in the Prospectus, there has been no change in the Company’s internal control over financial
reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over
financial reporting (other than as set forth in the Prospectus). The Company has established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15 and 15d-15) for the Company and designed such disclosure controls and procedures to provide
reasonable assurance that material information relating to the Company and each of its Subsidiaries is made known to the certifying
officers by others within those entities, particularly during the period in which the Company’s Annual Report on Form 10-K
or Quarterly Report on Form 10-Q, as the case may be, is being prepared. The Company’s certifying officers have evaluated
the effectiveness of the Company’s controls and procedures as of a date within 90 days prior to the filing date of the Form
10-K for the fiscal year most recently ended (such date, the “Evaluation Date”). The Company presented in its
Form 10-K for the fiscal year most recently ended the conclusions of the certifying officers about the effectiveness of the disclosure
controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no significant
changes in the Company’s internal controls (as such term is defined in Item 307(b) of Regulation S-K under the Securities
Act). To the knowledge of the Company, the Company’s “internal controls over financial reporting” and “disclosure
controls and procedures” are effective.

 

    	 	10	 

    	 

    

 

(cc)          Sarbanes-Oxley.
There is and has been no failure on the part of the Company or, to the knowledge of the Company, any of the Company’s directors
or officers, in their capacities as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley
Act and the rules and regulations promulgated thereunder. Each of the principal executive officer and the principal financial officer
of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company
as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act respecting all reports, schedules,
forms, statements, and other documents required to be filed by it or furnished by it to the SEC. For purposes of the preceding
sentence, “principal executive officer” and “principal financial officer” will have the meanings given
to such terms in the Sarbanes-Oxley Act.

 

(dd)         Finder’s
Fees. Neither the Company nor any of the Subsidiaries has incurred any liability for any finder’s fees, brokerage commissions,
or similar payments in connection with the transactions herein contemplated, except as may otherwise exist respecting Ascendiant
pursuant to this Agreement.

 

(ee)          Labor
Disputes. No labor disturbance by or dispute with employees of the Company or any of its Subsidiaries exists or, to the knowledge
of the Company, is threatened that would reasonably be expected to result in a Material Adverse Effect.

 

(ff)           Investment
Company Act. Neither the Company nor any of the Subsidiaries is or, after giving effect to the offering and sale of the Placement
Shares, will be an “investment company” or an entity “controlled” by an “investment company,”
as such terms are defined in the Investment Company Act of 1940, as amended (the “Investment Company Act”),
and the Company and its Subsidiaries and will conduct its business in a manner so that it will not become subject to the Investment
Company Act.

 

(gg)         Operations.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money
laundering statutes of all jurisdictions to which the Company or its Subsidiaries are subject, the rules and regulations thereunder,
and any related or similar rules, regulations, or guidelines, issued, administered, or enforced by any governmental agency having
jurisdiction over the Company (collectively, the “Money Laundering Laws”), except as would not reasonably be
expected to result in a Material Adverse Effect; and no action, suit, or proceeding by or before any court or governmental agency,
authority, or body or any arbitrator involving the Company or any of its Subsidiaries respecting the Money Laundering Laws is pending
or, to the knowledge of the Company, threatened.

 

(hh)         Off-Balance
Sheet Arrangements. There are no transactions, arrangements, and other relationships between and/or among the Company, and/or,
to the knowledge of the Company, any of its affiliates and any unconsolidated entity, including any structural finance, special
purpose, or limited purpose entity (each, an “Off Balance Sheet Transaction”) that could reasonably be expected
to affect materially the Company’s liquidity or the availability of or requirements for its capital resources, including
those Off Balance Sheet Transactions described in the SEC’s Statement about Management’s Discussion and Analysis of
Financial Conditions and Results of Operations (Release Nos. 33-8056; 34-45321; FR-61), required to be described in the Prospectus
that have not been described as required.

 

(jj)           Underwriter
Agreements. The Company is not a party to any agreement with an agent or underwriter for any other “at-the-market”
or continuous equity transaction.

 

(jj)            ERISA.
To the knowledge of the Company: (i) each material employee benefit plan, within the meaning of Section 3(3) of the Employee
Retirement Income Security Act of 1974, as amended (“ERISA”), that is maintained, administered, or contributed
to by the Company or any of its Subsidiaries (other than a Multiemployer Plan, within the meaning of Section 3(37) of ERISA) for
employees or former employees of the Company and any of its Subsidiaries has been maintained in material compliance with its terms
and the requirements of any applicable statutes, orders, rules, and regulations, including ERISA and the Internal Revenue Code
of 1986, as amended (the “Code”); (ii) no prohibited transaction, within the meaning of Section 406 of
ERISA or Section 4975 of the Code, has occurred respecting any such plan (excluding transactions effected pursuant to a statutory
or administrative exemption); and (iii) for each such plan that is subject to the funding rules of Section 412 of the Code
or Section 302 of ERISA, no “accumulated funding deficiency” as defined in Section 412 of the Code has been incurred,
whether or not waived, and the fair market value of the assets of each such plan (excluding for these purposes accrued but unpaid
contributions) equals or exceeds the present value of all benefits accrued under such plan determined using reasonable actuarial
assumptions, other than, in the case of (i), (ii), and (iii) above, as would reasonably be expected to not have a Material Adverse
Effect.

 

    	 	11	 

    	 

    

 

(kk)          Margin
Rules. Neither the issuance, sale, and delivery of the Placement Shares nor the application of the proceeds thereof by the
Company as described in the Registration Statement and the Prospectus will violate Regulation T, U, or X of the Board of Governors
of the Federal Reserve System or any other regulation of such Board of Governors.

 

(ll)            Insurance.
The Company and each of its Subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as the Company
and each of its Subsidiaries reasonably believe are adequate for the conduct of their properties and as is customary for companies
of similar size engaged in similar businesses in similar industries.

 

(mm)        No
Improper Practices. (i) Neither the Company nor, to the Company’s knowledge, the Subsidiaries or any of their respective
executive officers has, in the past five years, made any unlawful contributions to any candidate for any political office (or failed
fully to disclose any contribution in violation of law) or made any contribution or other payment to any official of, or candidate
for, any federal, state, municipal, or foreign office or other Person charged with similar public or quasi-public duty in violation
of any law or of the character required to be disclosed in the Prospectus; (ii) no relationship, direct or indirect, exists
between or among the Company or, to the Company’s knowledge, any Subsidiary or any affiliate of any of them, on the one hand,
and the directors, officers and stockholders of the Company or, to the Company’s knowledge, any Subsidiary, on the other
hand, that is required by the Securities Act to be described in the Registration Statement and the Prospectus that is not so described;
(iii) no relationship, direct or indirect, exists between or among the Company or any Subsidiary or any affiliate of them,
on the one hand, and the directors, officers, stockholders, or directors of the Company or, to the Company’s knowledge, any
Subsidiary, on the other hand, that is required by the rules of FINRA to be described in the Registration Statement and the Prospectus
that is not so described; (iv) except as described in the Prospectus, there are no material outstanding loans or advances
or material guarantees of indebtedness by the Company or, to the Company’s knowledge, any Subsidiary to or for the benefit
of any of their respective officers or directors or any of the members of the families of any of them; and (v) the Company
has not offered, or caused any placement agent to offer, Common Stock to any Person with the intent to influence unlawfully: (1) a
customer or supplier of the Company or any Subsidiary to alter the customer’s or supplier’s level or type of business
with the Company or any Subsidiary; or (2) a trade journalist or publication to write or publish favorable information about
the Company or any Subsidiary or any of their respective products or services; and (vi) neither the Company nor any Subsidiary
nor, to the Company’s knowledge, any employee or agent of the Company or any Subsidiary has made any payment of funds of
the Company or any Subsidiary or received or retained any funds in violation of any law, rule, or regulation (including the Foreign
Corrupt Practices Act of 1977), which payment, receipt, or retention of funds is of a character required to be disclosed in the
Registration Statement or the Prospectus.

 

(nn)         Status
under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act
at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.

 

(oo)         No
Misstatement or Omission in an Issuer Free Writing Prospectus. Each Issuer Free Writing Prospectus, as of its issue date and
as of each Applicable Time (as defined in Section 25 below), did not, does not and will not include any information that
conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including
any incorporated document deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not
apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information
furnished to the Company by Ascendiant specifically for use therein.

 

    	 	12	 

    	 

    

 

(pp)         No
Conflicts. None of the execution of this Agreement; the issuance, offering, or sale of the Placement Shares; the consummation
of any of the transactions contemplated herein; or the compliance by the Company with the terms and provisions hereof will conflict
with or result in a breach of any of the terms and provisions of; constitute or will constitute a default under; or has resulted
in or will result in the creation or imposition of any lien, charge, or encumbrance upon any property or assets of the Company
pursuant to the terms of any contract or other agreement to which the Company may be bound or to which any of the property or assets
of the Company is subject, except: (i) such conflicts, breaches, or defaults as may have been waived; and (ii) such conflicts,
breaches, and defaults that would not reasonably be expected to have a Material Adverse Effect; nor will such action result in
any violation of the provisions of the organizational or governing documents of the Company or in any material violation of the
provisions of any statute or any order, rule, or regulation applicable to the Company or of any court or of any federal, state,
or other regulatory authority or other government body having jurisdiction over the Company, except where such violation would
not reasonably be expected to have a Material Adverse Effect.

 

(qq)         Regulatory
Compliance.

 

(i)            Neither
the Company nor any of its Subsidiaries (each, an “Entity”) nor any director, officer, employee, agent, affiliate,
or representative of the Entity, is a government, individual, or entity that is owned or controlled by any director, officer, employee,
agent, affiliate, or representative of the Entity that is:

 

(1)       the
subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Assets Control,
the United Nations Security Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively,
“Sanctions”); or

 

(2)       located,
organized, or resident in a country or territory that is the subject of Sanctions (including Burma/Myanmar, Cuba, Iran, North Korea,
Sudan and Syria).

 

(ii)           The
Company, on behalf of each Entity, represents and covenants that it will not, directly or indirectly, use, lend, contribute, or
otherwise make available the proceeds of the offering governed by this Agreement to any subsidiary, joint venture partner, or other
director, officer, employee, agent, affiliate, or representative of the Entity:

 

(1)       to
fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding
or facilitation, is the subject of Sanctions; or

 

(2)       in
any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering,
whether as underwriter, advisor, investor, or otherwise).

 

(iii)          Except
as detailed in the Prospectus, for the past five years, the Entity has not knowingly engaged in, is not now knowingly engaged in,
and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing
or transaction is or was the subject of Sanctions.

 

(rr)           Stock
Transfer Taxes. On each Settlement Date, all stock transfer or other taxes (other than income taxes) that are required to be
paid in connection with the sale and transfer of the Placement Shares to be sold hereunder will be, or will have been, fully paid
or provided for by the Company and all laws imposing such taxes will be or will have been fully complied with in all material respects.

 

Any certificate signed
by an officer of the Company and delivered to Ascendiant or to counsel for Ascendiant pursuant to or in connection with this Agreement
will be deemed to be a representation and warranty by the Company, as applicable, to Ascendiant as to the matters set forth therein.
The Company acknowledges that Ascendiant and, for purposes of the opinions to be delivered pursuant to Section 7 hereof, counsel
to the Company and counsel to Ascendiant, will rely upon the accuracy and truthfulness of the foregoing representations and hereby
consents to such reliance.

 

    	 	13	 

    	 

    

 

7.             Covenants
of the Company. The Company covenants and agrees with Ascendiant that:

 

(a)            Registration
Statement Amendments. After the date of this Agreement and during any period in which a Prospectus relating to any Placement
Shares is required to be delivered by Ascendiant under the Securities Act (including in circumstances when such requirement may
be satisfied pursuant to Rule 172 under the Securities Act): (i) the Company will notify Ascendiant promptly of the time when
any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the
SEC and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the SEC for
any amendment or supplement to the Registration Statement or Prospectus or for additional information; (ii) the Company will
prepare and file with the SEC, promptly upon Ascendiant’s reasonable request, any amendments or supplements to the Registration
Statement or Prospectus that, in Ascendiant’s reasonable opinion, may be necessary or advisable in connection with the distribution
of the Placement Shares by Ascendiant (provided, however, that the failure of Ascendiant to make such request will not relieve
the Company of any obligation or liability hereunder, or affect Ascendiant’s right to rely on the representations and warranties
made by the Company in this Agreement and provided, further, that the only remedy Ascendiant will have respecting the failure to
make such filing will be to cease making sales under this Agreement until such amendment or supplement is filed); (iii) the
Company will not file any amendment or supplement to the Registration Statement or Prospectus relating to the Placement Shares
unless a copy thereof has been submitted to Ascendiant within a reasonable period of time before the filing and Ascendiant has
not reasonably objected thereto within two (2 Business Days (provided, however, that the failure of Ascendiant to
make such objection will not relieve the Company of any obligation or liability hereunder, or affect Ascendiant’s right to
rely on the representations and warranties made by the Company in this Agreement and provided, further, that the only remedy Ascendiant
will have respecting the failure by the Company to provide Ascendiant with such copy will be to cease making sales under this Agreement)
and the Company will furnish to Ascendiant at the time of filing thereof a copy of any document that upon filing is deemed to be
incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR; and (iv) the
Company will cause each amendment or supplement to the Prospectus to be filed with the SEC as required pursuant to the applicable
paragraph of Rule 424(b) of the Securities Act or, in the case of any document to be incorporated therein by reference, to be filed
with the SEC as required pursuant to the Exchange Act, within the period prescribed (the determination to file or not file any
amendment or supplement with the SEC under this Section 7(a), based on the Company’s reasonable opinion or reasonable
objections, will be made exclusively by the Company).

 

(b)            Notice
of SEC Stop Orders. The Company will advise Ascendiant, promptly after it receives notice or obtains knowledge thereof, of
the issuance or threatened issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement, of
the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction, or of the initiation or threatening
of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of
any stop order or to obtain its withdrawal if such a stop order should be issued. The Company will advise Ascendiant promptly after
it receives any request by the SEC for any amendments to the Registration Statement or any amendment or supplements to the Prospectus
or any Issuer Free Writing Prospectus or for additional information related to the offering of the Placement Shares or for additional
information related to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus.

 

    	 	14	 

    	 

    

 

(c)            Delivery
of Prospectus; Subsequent Changes. During any period in which a Prospectus relating to the Placement Shares is required to
be delivered by Ascendiant under the Securities Act respecting the offer and sale of the Placement Shares (including in circumstances
where such requirement may be satisfied pursuant to Rule 172 under the Securities Act) (the “Prospectus Delivery Period”),
the Company will comply with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file
on or before their respective due dates all reports and any definitive proxy or information statements required to be filed by
the Company with the SEC pursuant to Sections 13(a), 13(c), 14, 15(d), or any other provision of or under the Exchange Act. If
the Company has omitted any information from the Registration Statement pursuant to Rule 430A under the Securities Act, it will
use its commercially reasonable efforts to comply with the provisions of and make all requisite filings with the SEC pursuant to
said Rule 430A and to notify Ascendiant promptly of all such filings. If during the Prospectus Delivery Period any event occurs
as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit
to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading,
or if during the Prospectus Delivery Period it is necessary to amend or supplement the Registration Statement or Prospectus to
comply with the Securities Act, the Company will promptly notify Ascendiant to suspend the offering of Placement Shares during
such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company)
so as to correct such statement or omission or effect such compliance; provided, however, that the Company may delay any amendment
or supplement, if in the sole discretion of the Company, it is in the Company’s best interest to do so.

 

(d)            Listing
of Placement Shares. During the Prospectus Delivery Period, the Company will use its commercially reasonable best efforts to
cause the Placement Shares to be listed on the Exchange.

 

(e)            Delivery
of Registration Statement and Prospectus. The Company will furnish to Ascendiant and its counsel (at the expense of the Company)
copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments
and supplements to the Registration Statement or Prospectus that are filed with the SEC during the Prospectus Delivery Period (including
all documents filed with the SEC during such period that are deemed to be incorporated by reference therein), in each case as soon
as reasonably practicable and in such quantities as Ascendiant may from time to time reasonably request and, at Ascendiant’s
request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Placement Shares may be made;
provided, however, that the Company will not be required to furnish any document (other than the Prospectus) to Ascendiant to the
extent such document is available on EDGAR.

 

(f)             Earnings
Statement. The Company will make generally available to its security holders as soon as practicable, but in any event not later
than 15 months after the end of the Company’s current fiscal quarter, an earnings statement covering a 12-month period that
satisfies the provisions of Section 11(a) and Rule 158 of the Securities Act. The Company’s compliance with the reporting
requirements of the Exchange Act shall be deemed to satisfy this Section 7(f).

 

(g)            Use
of Proceeds. The Company will use the Net Proceeds substantially as described in the Prospectus in the section entitled “Use
of Proceeds.”

 

(h)            Notice
of Other Sales. Without the prior written notice to Ascendiant, the Company will not, directly or indirectly, offer to sell,
sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered
pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase
or acquire, Common Stock during the period beginning on the second Trading Day immediately prior to the date on which any Placement
Notice is delivered to Ascendiant hereunder and ending on the second Trading Day immediately following the final Settlement Date
respecting Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended
prior to the sale of all Placement Shares covered by a Placement Notice, the date of such suspension or termination); and will
not directly or indirectly in any other “at-the-market” offering sell, contract to sell, grant any option to sell or
otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible
into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock prior to the later of the termination
of this Agreement and the earliest to occur of: (i) the date on which this Agreement is terminated by the Company pursuant
to Section 13(b)(ii); (ii) the date on which Ascendiant terminates this Agreement pursuant to Section 13(c) or (iii) the thirtieth
day immediately following the final Settlement Date respecting Placement Shares sold pursuant to such Placement Notice; provided,
however, that such restrictions will not be required in connection with the Company’s issuance or sale of: (1) Common
Stock, options to purchase Common Stock or Common Stock issuable upon the exercise of options, pursuant to any employee or director
stock option or benefits plan, stock ownership plan or dividend reinvestment plan (but not Common Stock subject to a waiver to
exceed plan limits in its dividend reinvestment plan) of the Company whether now in effect or hereafter implemented; (2) Common
Stock issuable upon conversion of securities or the exercise of warrants, options or other rights in effect or outstanding, and
disclosed in filings by the Company available on EDGAR or otherwise in writing to Ascendiant; and (3) Common Stock or securities
convertible into or exercisable for Common Stock as consideration for mergers, acquisitions, other business combinations, licensing
agreements or strategic alliances, or offered and sold in a privately negotiated transaction to vendors, customers, strategic partners
or potential strategic partners who are qualified institutional buyers and not more than three Persons that are “accredited
investors” within the meaning of such term under paragraph (a)(1), (a)(2), (a)(3), (a)(7), or (a)(8) of Rule 501 under the
Securities Act and otherwise conducted in a manner so as not to be integrated with the offering of Common Stock hereby.

 

    	 	15	 

    	 

    

 

(i)            Change
of Circumstances. The Company will, at any time during the pendency of a Placement Notice, advise Ascendiant promptly after
it will have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material
respect any opinion, certificate, letter or other document required to be provided to Ascendiant pursuant to this Agreement.

 

(j)            Due
Diligence Cooperation. The Company will cooperate with any reasonable due diligence review conducted by Ascendiant or its representatives
in connection with the transactions contemplated hereby, including providing information and making available documents and senior
corporate officers, during regular business hours and at the Company’s principal offices or such other location mutually
agreed to by the parties, as Ascendiant may reasonably request.

 

(k)           Required
Filings Relating to Placement of Placement Shares. The Company agrees that on such dates as the Securities Act requires, the
Company will: (i) file a prospectus supplement with the SEC under the applicable paragraph of Rule 424(b) under the Securities
Act (each and every filing under Rule 424(b), a “Filing Date”), which prospectus supplement will set forth,
within the relevant period, the amount of Placement Shares sold through Ascendiant, the Net Proceeds to the Company and the compensation
payable by the Company to Ascendiant respecting such Placement Shares; and (ii) deliver such number of copies of each such
prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations
of such exchange or market.

 

(l)            Representation
Dates; Certificate. On the date of this Agreement and each time the Company:

 

(i)            files
the Prospectus relating to the Placement Shares or amends or supplements (other than a prospectus supplement relating solely to
an offering of securities other than the Placement Shares) the Registration Statement or the Prospectus relating to the Placement
Shares by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents by reference
into the Registration Statement or the Prospectus relating to the Placement Shares;

 

(ii)           files
an annual report on Form 10-K under the Exchange Act (including any Form 10-K/A that contains restated financial statements);

 

(iii)          files
a quarterly report on Form 10-Q under the Exchange Act; or

 

(iv)          files
a current report on Form 8-K containing amended audited financial information (other than information “furnished” pursuant
to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification
of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under
the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) will be a “Representation
Date”);

 

    	 	16	 

    	 

    

 

the Company
will furnish Ascendiant (but in the case of clause (iv) above only if Ascendiant reasonably determines that the information contained
in such Form 8-K is material) with a certificate, in the form attached hereto as Exhibit A. The requirement to provide a
certificate under this Section 7(l) will be waived for any Representation Date occurring at a time at which no Placement Notice
is pending, which waiver will continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder
(which for such calendar quarter will be considered a Representation Date) and the next occurring Representation Date; provided,
however, that such waiver will not apply for any Representation Date on which the Company files its annual report on Form
10-K. Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following a Representation Date
when the Company relied on such waiver and did not provide Ascendiant with a certificate under this Section 7(l), then before the
Company delivers the Placement Notice or Ascendiant sells any Placement Shares, the Company will provide Ascendiant with a certificate,
in the form attached hereto as Exhibit A, dated the date of the Placement Notice.

 

(m)          Legal
Opinion. On the date of this Agreement and within five Trading Days after each Representation Date for which the Company is
obligated to deliver a certificate in the form attached hereto as Exhibit A for which no waiver is applicable, the Company
will cause to be furnished to Ascendiant written opinions of Olshan Frome Wolosky LLP (“Company Counsel”), or
other counsel reasonably satisfactory to Ascendiant, in form and substance reasonably satisfactory to Ascendiant and its counsel;
provided, however, the Company will be required to furnish to Ascendiant no more than one opinion hereunder per calendar
quarter; provided, further, that in lieu of such opinions for subsequent periodic filings under the Exchange Act, Company
Counsel may furnish Ascendiant with a letter (a “Reliance Letter”) to the effect that Ascendiant may rely on
a prior opinion delivered under this Section 7(m) to the same extent as if it were dated the date of such letter (except
that statements in such prior opinion will be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented
as of the date of the Reliance Letter).

 

(n)           Comfort
Letters. Prior to the issuance of the first Placement Notice and within five Trading Days after each Representation Date, other
than pursuant to Section 7(l)(iii), for which the Company is obligated to deliver a certificate in the form attached hereto
as Exhibit A for which no waiver is applicable, the Company will cause its Accountants to furnish Ascendiant letters (the
“Comfort Letters”), dated the date the Comfort Letters are delivered, which will meet the requirements set forth
in this Section 7(n). The Comfort Letter from each of the Accountants will be in a form and substance reasonably satisfactory
to Ascendiant: (i) confirming that they are an independent public accounting firm within the meaning of the Securities Act
and the PCAOB; (ii) stating, as of such date, the conclusions and findings of such firm respecting the financial information
and other matters ordinarily covered by accountants’ “comfort letters” to underwriters in connection with registered
public offerings (the first such letter, the “Initial Comfort Letter”); and (iii) updating the Initial
Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date
and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of
such letter.

 

(o)           Secretary’s
Certificate. On the date of this Agreement, Ascendiant shall have received a certificate, signed on behalf of the Company by
its corporate Secretary, certifying as to (i) the Certificate of Incorporation of the Company, (ii) the Bylaws of the
Company, (iii) the resolutions of the Board of Directors of the Company (or a committee thereof) authorizing the execution,
delivery and performance of this Agreement and the issuance of the Placement Shares and (iv) the incumbency of the officers
duly authorized to execute this Agreement and the other documents contemplated by this Agreement..

 

(p)           Market
Activities. The Company will not, directly or indirectly: (i) take any action designed to cause or result in, or that
constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of Common Stock; or (ii) sell, bid for, or purchase Common Stock in violation of
Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than Ascendiant.

 

(q)           Investment
Company Act. The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor any of its
Subsidiaries will be or become, at any time prior to the termination of this Agreement, required to be registered as an “investment
company,” as such term is defined in the Investment Company Act.

 

    	 	17	 

    	 

    

 

(r)            No
Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and Ascendiant in its capacity
as agent hereunder, neither Ascendiant nor the Company (including its agents and representatives, other than Ascendiant in its
capacity as such) will make, use, prepare, authorize, approve, or refer to any written communication (as defined in Rule 405 under
the Securities Act), required to be filed with the SEC, that constitutes an offer to sell or solicitation of an offer to buy Placement
Shares hereunder.

 

(s)           Sarbanes-Oxley
Act. The Company and the Subsidiaries will maintain and keep accurate books and records reflecting their assets and maintain
internal accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and
including those policies and procedures that: (i) pertain to the maintenance of records that in reasonable detail accurately
and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that
transactions are recorded as necessary to permit the preparation of the Company’s consolidated financial statements in accordance
with generally accepted accounting principles; (iii) that receipts and expenditures of the Company are being made only in
accordance with management’s and the Company’s directors’ authorization; and (iv) provide reasonable assurance
regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could
have a material effect on its financial statements. The Company and the Subsidiaries will maintain such controls and other procedures,
including those required by Sections 302 and 906 of the Sarbanes-Oxley Act, and the applicable regulations thereunder that are
designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the periods specified in the SEC’s rules and forms, including
controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files
or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive
officer and principal financial officer, or individuals performing similar functions, as appropriate to allow timely decisions
regarding required disclosure and to ensure that material information relating to the Company or the Subsidiaries is made known
to them by others within those entities, particularly during the period in which such periodic reports are being prepared.

 

8.             Representations
and Covenants of Ascendiant. Ascendiant represents and warrants that it is duly registered as a broker-dealer under FINRA,
the Exchange Act, and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold,
except such states in which Ascendiant is exempt from registration or such registration is not otherwise required. Ascendiant will
continue, for the term of this Agreement, to be duly registered as a broker-dealer under FINRA, the Exchange Act, and the applicable
statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which Ascendiant
is exempt from registration or such registration is not otherwise required, during the term of this Agreement. Ascendiant will
comply with all applicable law and regulations in connection with the Placement Shares, including Regulation M.

 

9.             Payment
of Expenses. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including:
(i) the preparation, filing, including any fees required by the SEC, and printing of the Registration Statement (including
financial statements and exhibits) as originally filed and of each amendment and supplement thereto and each Free Writing Prospectus,
in such number as Ascendiant will reasonably deem necessary; (ii) the printing and delivery to Ascendiant of this Agreement and
such other documents as may be required in connection with the offering, purchase, sale, issuance, or delivery of the Placement
Shares; (iii) the preparation, issuance, and delivery of the certificates, if any, for the Placement Shares to Ascendiant,
including any stock or other transfer taxes and any capital duties, stamp duties, or other duties or taxes payable upon the sale,
issuance, or delivery of the Placement Shares to Ascendiant; (iv) the fees and disbursements of the counsel, accountants,
and other advisors to the Company; (v) the fees and expenses of the transfer agent and registrar for the Common Stock; (vi) the
filing fees incident to any review by FINRA of the terms of the sale of the Placement Shares; (vii) the fees and expenses
incurred in connection with the listing of the Placement Shares on the Exchange; (viii) usual and customary transaction, ticket,
and similar charges; (ix) $25,000 of the fees and expenses of Ascendiant’s legal counsel initially and, thereafter, the reasonable
fees and expenses of Ascendiant’s legal counsel over $25,000 incurred in connection with quarterly and annual bring-downs
required hereunder; the Company shall pay retainers to Ascendiant’s counsel at the reasonable request of Ascendiant to cover
future fees and expenses.

 

    	 	18	 

    	 

    

 

10.           Conditions
to Ascendiant’s Obligations. The obligations of Ascendiant hereunder respecting a Placement will be subject to the continuing
accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company
in all material respects of its obligations hereunder, to the completion by Ascendiant of a due diligence review satisfactory to
it in its reasonable judgment, and to the continuing satisfaction (or waiver by Ascendiant in its sole discretion) of the following
additional conditions:

 

(a)            Registration
Statement Effective. The Company shall at all times maintain in effect the Registration Statement, which will be available
for the sale of all Placement Shares contemplated to be issued by any Placement Notice.

 

(b)            No
Material Notices. None of the following events will have occurred and be continuing: (i) receipt by the Company of any
request for additional information from the SEC or any other federal or state governmental authority during the period of effectiveness
of the Registration Statement the response to which would require any post-effective amendments or supplements to the Registration
Statement or the Prospectus; (ii) the issuance by the SEC or any other federal or state governmental authority of any stop
order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt
by the Company of any notification respecting the suspension of the qualification or exemption from qualification of any of the
Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) the
occurrence of any event that requires the making of any changes in the Registration Statement, the Prospectus or documents so that,
in the case of the Registration Statement, it will not contain any materially untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case
of the Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading.

 

(c)            No
Misstatement or Material Omission. Ascendiant will not have advised the Company that the Registration Statement or Prospectus,
or any amendment or supplement thereto, contains an untrue statement of fact that in Ascendiant’s reasonable opinion is material,
or omits to state a fact that in Ascendiant’s opinion is material and is required to be stated therein or is necessary to
make the statements therein not misleading.

 

(d)           Material
Changes. Except as contemplated in the Prospectus, or disclosed in the Company’s reports filed with the SEC, there will
not have been any material adverse change, on a consolidated basis, in the authorized capital stock of the Company or any Material
Adverse Effect, or any development that would reasonably be expected to cause a Material Adverse Effect.

 

(e)            Legal
Opinion. Ascendiant will have received the opinions of Company Counsel required to be delivered pursuant Section 7(m)
on or before the date on which such delivery of such opinions is required pursuant to Section 7(m).

 

(f)             Comfort
Letters. Ascendiant will have received the Comfort Letters required to be delivered pursuant Section 7(n) on or before
the date on which such delivery of such letter is required pursuant to Section 7(n).

 

(g)            Representation
Certificate. Ascendiant will have received the certificate required to be delivered pursuant to Section 7(l) on or before
the date on which delivery of such certificate is required pursuant to Section 7(l).

 

(h)            Secretary’s
Certificate. Ascendiant will have received the Secretary’s certificate required to be delivered pursuant to Section
7(o) on or before the date on which delivery of such certificate is required pursuant to Section 7(o).

 

(i)             No
Suspension. Trading in the Common Stock will not have been suspended on the Exchange and the Common Stock will not have been
delisted from the Exchange.

 

    	 	19	 

    	 

    

 

(j)            Other
Materials. On each date on which the Company is required to deliver a certificate pursuant to Section 7(l), the Company
will have furnished to Ascendiant such appropriate further information, certificates, and documents as Ascendiant may reasonably
request and that are usually and customarily furnished by an issuer of securities in connection with a securities offering. All
such opinions, certificates, letters, and other documents will be in compliance with the provisions hereof. The Company will furnish
Ascendiant with such conformed copies of such opinions, certificates, letters, and other documents as Ascendiant will reasonably
request.

 

(k)           Securities
Act Filings Made. All filings with the SEC required by Rule 424 with respect to the Placement Shares under the Securities Act
to have been filed prior to the issuance of any Placement Notice hereunder will have been made within the applicable period prescribed
for such filing by Rule 424.

 

(l)            Approval
for Listing. The Placement Shares will either have been approved for listing on the Exchange, subject only to notice of issuance,
or the Company will have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance
of any Placement Notice.

 

(m)          No
Termination Event. No event will have occurred that would permit Ascendiant to terminate this Agreement pursuant to Section
13(a).

 

11.           Indemnification
and Contribution.

 

(a)           Company
Indemnification. The Company agrees to indemnify and hold harmless Ascendiant, its partners, members, directors, officers,
employees, and agents and each Person, if any, who controls Ascendiant within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act as follows:

 

(i)            against
any and all third party loss, liability, claim, damage, and expense whatsoever, as incurred, joint or several, arising out of or
based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any
amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary
to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material
fact included in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), or the
omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading;

 

(ii)            against
any and all third party loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of
the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body,
commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue
statement or omission; provided that any such settlement is effected with the written consent of the Company, which consent will
not unreasonably be delayed or withheld; and

 

(iii)           against
any and all expense whatsoever, as incurred (including the reasonable fees and disbursements of counsel), reasonably incurred in
investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or
body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue
statement or omission, to the extent that any such expense is not paid under (i) or (ii) above;

 

provided,
however, that this indemnity agreement will not apply to any loss, liability, claim, damage, or expense to the extent
arising out of Ascendiant’s gross negligence or willful misconduct or any untrue statement or omission or alleged untrue
statement or omission made solely in reliance upon and in conformity with written information furnished to the Company by Ascendiant
expressly for use in the Registration Statement (or any amendment thereto), or in any related Issuer Free Writing Prospectus or
the Prospectus (or any amendment or supplement thereto).

 

    	 	20	 

    	 

    

 

(b)           Ascendiant
Indemnification. Ascendiant agrees to indemnify and hold harmless the Company and its directors and each officer of the Company
who signed the Registration Statement, and each Person, if any, that: (i) controls the Company within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act; or (ii) is controlled by or is under common control with the Company
against any and all loss, liability, claim, damage, and expense described in the indemnity contained in Section 11(c), as
incurred, but only respecting untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration
Statement (or any amendments thereto), the Prospectus (or any amendment or supplement thereto) or any Free Writing Prospectus in
reliance upon and in conformity with information furnished to the Company in writing by Ascendiant expressly for use therein.

 

(c)           Procedure.

 

(i)            Any
party that proposes to assert the right to be indemnified under this Section 11 will, promptly after receipt of notice of
commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties
under this Section 11, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers
served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from: (1) any liability
that it might have to any indemnified party otherwise than under this Section 11; and (2) any liability that it may
have to any indemnified party under the foregoing provision of this Section 11 unless, and only to the extent that, such
omission results in the forfeiture or material impairment of substantive rights or defenses by the indemnifying party.

 

(ii)            If
any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying
party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party
promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying
party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and
after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party
will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable
costs of investigation subsequently incurred by the indemnified party in connection with the defense.

 

(iii)           The
indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of
such counsel will be at the expense of such indemnified party unless: (1) the employment of counsel by the indemnified party
has been authorized in writing by the indemnifying party; (2) the indemnified party has reasonably concluded (based on advice
of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition
to those available to the indemnifying party; (3) a conflict or potential conflict exists (based on advice of counsel to the
indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have
the right to direct the defense of such action on behalf of the indemnified party); or (4) the indemnifying party has not
in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement
of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of
the indemnifying party or parties.

 

(iv)           It
is understood that the indemnifying party or parties will not, in connection with any proceeding or related proceedings in the
same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to
practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements, and other
charges will be reimbursed by the indemnifying party promptly after the indemnifying party receives a written invoice relating
to fees, disbursements and other charges in reasonable detail.

 

    	 	21	 

    	 

    

 

(v)            An
indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent.
No indemnifying party will, without the prior written consent of each indemnified party, settle or compromise or consent to the
entry of any judgment in any pending or threatened claim, action, or proceeding relating to the matters contemplated by this Section
11 (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent: (i) includes
an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding,
or claim; and (ii) does not include a statement as to or an admission of fault, culpability, or a failure to act by or on
behalf of any indemnified party.

 

(d)           Contribution.
In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing
paragraphs of this Section 11 is applicable in accordance with its terms but for any reason is held to be unavailable from
the Company or Ascendiant, the Company and Ascendiant will contribute to the total losses, claims, liabilities, expenses, and damages
(including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement
of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from Persons
other than Ascendiant, such as Persons that control the Company within the meaning of the Securities Act, officers of the Company
who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company
and Ascendiant may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company, on
the one hand, and Ascendiant, on the other hand. The relative benefits received by the Company, on the one hand, and Ascendiant,
on the other hand, will be deemed to be in the same proportion as the total net proceeds from the sale of the Placement Shares
(before deducting expenses) received by the Company bear to the total compensation received by Ascendiant (before deducting expenses)
from the sale of Placement Shares on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence
is not permitted by applicable law, the allocation of contribution will be made in such proportion as is appropriate to reflect
not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand,
and Ascendiant, on the other hand, respecting the statements or omission that resulted in such loss, claim, liability, expense
or damage, or action in respect thereof, as well as any other relevant equitable considerations respecting such offering. Such
relative fault will be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material
fact or omission or alleged omission to state a material fact relates to information supplied by the Company or Ascendiant, the
intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement
or omission. The Company and Ascendiant agree that it would not be just and equitable if contributions pursuant to this Section
11(d) were to be determined by pro rata allocation or by any other method of allocation that does not take into account the
equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim,
liability, expense, or damage, or action in respect thereof, referred to above in this Section 11(d) will be deemed to include,
for the purpose of this Section 11(d), any legal or other expenses reasonably incurred by such indemnified party in connection
with investigating or defending any such action or claim to the extent consistent with Section 11(c) hereof. Notwithstanding the
foregoing provisions of this Section 11(d), Ascendiant will not be required to contribute any amount in excess of the commissions
received by it under this Agreement and no Person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
For purposes of this Section 11(d), any Person who controls a party to this Agreement within the meaning of the Securities
Act, and any officers, directors, partners, employees or agents of Ascendiant, will have the same rights to contribution as that
party, and each officer and director of the Company who signed the Registration Statement will have the same rights to contribution
as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice
of commencement of any action against such party in respect of which a claim for contribution may be made under this Section
11(d), will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve
that party or parties from whom contribution may be sought from any other obligation it or they may have under this Section
11(d) except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses
of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of Section
11(c) hereof, no party will be liable for contribution respecting any action or claim settled without its written consent if
such consent is required pursuant to Section 11(c) hereof.

 

    	 	22	 

    	 

    

 

12.           Representations
and Agreements to Survive Delivery. The indemnity and contribution agreements contained in Section 11 of this Agreement
and all representations and warranties of the Company herein or in certificates delivered pursuant hereto will survive, as of their
respective dates, regardless of: (a) any investigation made by or on behalf of Ascendiant, any controlling Persons, or the
Company (or any of their respective officers, directors, or controlling Persons); (b) delivery and acceptance of the Placement
Shares and payment therefor; or (c) any termination of this Agreement.

 

13.           Termination.

 

(a)           Ascendiant
may terminate this Agreement, by notice to the Company, as hereinafter specified at any time: (i) if there has been, since
the time of execution of this Agreement or since the date as of which information is given in the Prospectus, any Material Adverse
Effect, or any development has occurred that is reasonably likely to have a Material Adverse Effect or in the sole judgment of
Ascendiant makes it impractical or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement
Shares; (ii) if there has occurred any material adverse change in the financial markets in the United States or the international
financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving
a prospective change in national or international political, financial or economic conditions, in each case the effect of which
is such as to make it, in the judgment of Ascendiant, impracticable or inadvisable to market the Placement Shares or to enforce
contracts for the sale of the Placement Shares; (iii) if trading in the Common Stock has been suspended or limited by the
SEC or the Exchange, or if trading generally on the Exchange has been suspended or limited, or minimum prices for trading have
been fixed on the Exchange; (iv) if any suspension of trading of any securities of the Company on any exchange or in the over-the-counter
market will have occurred and be continuing; (v) if a major disruption of securities settlements or clearance services in
the United States will have occurred and be continuing; or (vi) if a banking moratorium has been declared by either U.S. Federal
or New York authorities. Any such termination will be without liability of any party to any other party except that the provisions
of Section 9 (Expenses), Section 11 (Indemnification), Section 12 (Survival of Representations), Section
18 (Applicable Law; Waiver of Jury Trial), and Section 19 (Consent to Jurisdiction) hereof will remain in full force
and effect notwithstanding such termination. If Ascendiant elects to terminate this Agreement as provided in this Section 13(a),
Ascendiant will provide the required notice as specified in Section 14 (Notices).

 

(b)          (i)             The
Company will have the right, by giving five (5) days’ notice as hereinafter specified to terminate this Agreement in its
sole discretion at any time after the date of this Agreement.

 

(ii)           If
Ascendiant declines any commercially reasonable placement notice pursuant to Section 2(a) of this Agreement, then the Company
will have the right to terminate this Agreement by giving written notice of termination to Ascendiant. Any such termination will
be effective immediately upon a delivery of a termination notice by the Company to Ascendiant.

 

(iii)           Ascendiant
shall have the right, by giving ten (10) days’ notice, to terminate this Agreement in its sole discretion at any time after
the date of this Agreement.

 

Any termination
pursuant to Section 13(b) will be without liability of any party to any other party except that the provisions of Section
9, Section 11, Section 12, Section 18, and Section 19 hereof will remain in full force and effect
notwithstanding such termination.

 

(c)           Ascendiant
will have the right, by giving 10 days’ notice as hereinafter specified to terminate this Agreement in its sole discretion
at any time after the date of this Agreement. Any such termination will be without liability of any party to any other party except
that the provisions of Section 9, Section 11, Section 12, Section 18, and Section 19 hereof
will remain in full force and effect notwithstanding such termination.

 

    	 	23	 

    	 

    

 

(d)           Unless
earlier terminated pursuant to this Section 13, this Agreement will automatically terminate upon the earlier to occur of:
(i) the one-year anniversary of the date hereof; or (ii) the issuance and sale of all of the Placement Shares through Ascendiant
on the terms and subject to the conditions set forth herein, except that, in either such case, the provisions of Section 9,
Section 11, Section 12, Section 18 and Section 19 hereof will remain in full force and effect notwithstanding
such termination.

 

(e)           This
Agreement will remain in full force and effect unless terminated pursuant to Sections 13(a), (b), (c), or
(d) above or otherwise by mutual agreement of the parties. Upon termination of this Agreement, the Company will not have
any liability to Ascendiant for any discount, commission, or other compensation respecting any Placement Shares not otherwise sold
by Ascendiant under this Agreement.

 

(f)            Any
termination of this Agreement will be effective on the date specified in such notice of termination; provided, however,
that such termination will not be effective until the close of business on the date of receipt of such notice by Ascendiant or
the Company, as the case may be. If such termination will occur prior to the Settlement Date for any sale of Placement Shares,
such Placement Shares will settle in accordance with the provisions of this Agreement.

 

14.           Notices.

 

(a)           All
notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this
Agreement will be in writing, unless otherwise specified, and if sent to Ascendiant, will be delivered to:

 

Ascendiant Capital
Markets, LLC

Attention: Managing
Partner

4 Park Plaza,
Suite 1950

Irvine, CA 92614

 

with a copy
to:

 

Michael Best
& Friedrich LLP

Attention: James
R. Kruse

170 South Main
Street, Suite 1000

Salt Lake City,
UT 84101

 

and if to
the Company, will be delivered to:

 

Ault Global Holdings,
Inc.

Attention: Milton
Ault, III, Executive Chairman

11411 Southern
Highlands Parkway, Suite 240

Las Vegas, NV
89141

 

with a copy
to:

 

Olshan Frome
Wolosky LLP

Attention: Kenneth
A. Schlesinger, Esq.

1325 Avenue of
the Americas, 15th Floor

New York, NY
10019

 

(b)           Each
such notice or other communication will be deemed given: (i) when delivered personally on or before 4:30 p.m., New York
City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day; or (ii) on the next
Business Day after timely delivery to a nationally recognized overnight courier. For purposes of this Agreement, “Business
Day” will mean any day on which the Exchange and commercial banks in the City of New York are open for business.

 

    	 	24	 

    	 

    

 

(c)           An
electronic communication (“Electronic Notice”) will be deemed written notice for purposes of this Section
14 if sent to the electronic mail address specified by the receiving party under separate cover. Electronic Notice will be
deemed received at the time the party sending Electronic Notice receives confirmation of receipt by the receiving party. Any party
receiving Electronic Notice may request and will be entitled to receive the notice on paper, in a nonelectronic form (“Nonelectronic
Notice”), which will be sent to the requesting party within 10 days of receipt of the written request for Nonelectronic
Notice.

 

(d)           Each
party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new
address for such purpose.

 

15.           Successors
and Assigns. This Agreement will inure to the benefit of and be binding upon the Company and Ascendiant and their respective
successors and the affiliates, controlling persons, partners, members, officers, directors, employees, and agents referred to in
Section 11 hereof. References to any of the parties contained in this Agreement will be deemed to include the successors
and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other
than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under
or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations
under this Agreement without the prior written consent of the other party.

 

16.           Adjustments
for Stock Splits. The parties acknowledge and agree that all share-related numbers contained in this Agreement will be adjusted
to take into account any share consolidation, stock split, stock dividend, corporate domestication or similar event effected respecting
the Placement Shares.

 

17.           Entire
Agreement; Amendment; Severability. This Agreement (including all schedules and exhibits attached hereto and Placement Notices
issued pursuant hereto), by and between the Company and Ascendiant constitutes the entire agreement of the parties respecting the
subject matter hereof and thereof and supersedes all other prior and contemporaneous agreements and undertakings, both written
and oral, among the parties hereto with regard to the subject matter hereof and thereof. Neither this Agreement nor any term hereof
may be amended except pursuant to a written instrument executed by the Company and Ascendiant. In the event that any one or more
of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal, or unenforceable
as written by a court of competent jurisdiction, then such provision will be given full force and effect to the fullest possible
extent that it is valid, legal, and enforceable, and the remainder of the terms and provisions herein will be construed as if such
invalid, illegal, or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such
provision and the remainder of the terms and provisions hereof will be in accordance with the intent of the parties as reflected
in this Agreement.

 

18.           APPLICABLE
LAW; WAIVER OF JURY TRIAL. THIS AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. EACH PARTY HEREBY
IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

19.           CONSENT
TO JURISDICTION. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING
IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION
CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT
IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT
FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF
PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED
MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH
SERVICE WILL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN WILL BE DEEMED TO LIMIT
IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW.

 

    	 	25	 

    	 

    

 

20.           Use
of Information. Ascendiant may not use any information gained in connection with this Agreement and the transactions contemplated
by this Agreement, including due diligence, to advise any party respecting transactions not expressly approved by the Company.
Ascendiant acknowledges that any information gained in connection with this Agreement and the transactions contemplated by this
Agreement are subject to confidentiality and other restrictions pursuant to the Confidentiality Agreement and agrees to abide by
the terms of the Confidentiality Agreement.

 

21.           Counterparts.
This Agreement may be executed in two or more counterparts, each of which will be deemed an original, but all of which together
will constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile
transmission.

 

22.           Effect
of Headings. The section and exhibit headings herein are for convenience only and will not affect the construction hereof.

 

23.           Permitted
Free Writing Prospectuses. The Company represents, warrants, and agrees that, unless it obtains the prior consent of Ascendiant,
and Ascendiant represents, warrants and agrees that, unless it obtains the prior consent of the Company, it has not made and will
not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus, or that would otherwise
constitute a “free writing prospectus,” as defined in Rule 405, required to be filed with the SEC. Any such free
writing prospectus consented to by Ascendiant or by the Company, as the case may be, is hereinafter referred to as a “Permitted
Free Writing Prospectus.” The Company represents and warrants that it has treated and agrees that it will treat each Permitted
Free Writing Prospectus as an “issuer free writing prospectus,” as defined in Rule 433, and has complied and will
comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with
the SEC where required, legending, and recordkeeping. For the purposes of clarity, the parties hereto agree that all free writing
prospectuses, if any, listed in Exhibit B hereto are Permitted Free Writing Prospectuses.

 

24.           Absence
of Fiduciary Relationship. The Company acknowledges and agrees that:

 

(a)           Ascendiant
is acting solely as agent in connection with the public offering of the Placement Shares and in connection with each transaction
contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between
the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party,
on the one hand, and Ascendiant, on the other hand, has been or will be created in respect of any of the transactions contemplated
by this Agreement, irrespective of whether or not Ascendiant has advised or is advising the Company on other matters, and Ascendiant
has no obligation to the Company respecting the transactions contemplated by this Agreement except the obligations expressly set
forth in this Agreement;

 

(b)           it
is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated
by this Agreement;

 

(c)           Ascendiant
has not provided any legal, accounting, regulatory or tax advice respecting the transactions contemplated by this Agreement and
it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate;

 

(d)          it
is aware that Ascendiant and its affiliates are engaged in a broad range of transactions that may involve interests that differ
from those of the Company and Ascendiant has no obligation to disclose such interests and transactions to the Company by virtue
of any fiduciary, advisory or agency relationship or otherwise; provided that Ascendiant hereby agrees not to engage in any such
transaction that would cause its interests to be in direct conflict with the best interests of the Company; and

 

    	 	26	 

    	 

    

 

(e)           it
waives, to the fullest extent permitted by law, any claims it may have against Ascendiant for breach of fiduciary duty or alleged
breach of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees that Ascendiant will not
have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim
or to any Person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company,
other than in respect of Ascendiant’s obligations under this Agreement and to keep information provided by the Company to
Ascendiant and Ascendiant’s counsel confidential to the extent not otherwise publicly available.

 

25.           Definitions.
As used in this Agreement, the following terms have the respective meanings set forth below:

 

(a)           “Applicable
Time” means: (i) each Representation Date; and (ii) the time of each sale of any Placement Shares pursuant
to this Agreement.

 

(b)           “Issuer
Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433, relating
to the Placement Shares.

 

(c)           “Rule
164,” “Rule 172,” “Rule 405,” “Rule 415,” “Rule 424,”
“Rule 424(b),” “Rule 430A,” “Rule 430B,” and “Rule 433”
refer to such rules under the Securities Act Regulations.

 

(d)          All
references in this Agreement to financial statements and schedules and other information that is “contained,” “included,”
or “stated” in the Registration Statement or the Prospectus (and all other references of like import) will be deemed
to mean and include all such financial statements and schedules and other information that is incorporated by reference in the
Registration Statement or the Prospectus, as the case may be.

 

(e)           All
references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing
will be deemed to include the copy filed with the SEC pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing
Prospectus (other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with
the SEC) will be deemed to include the copy thereof filed with the SEC pursuant to EDGAR; and all references in this Agreement
to “supplements” to the Prospectus will include any supplements, “wrappers,” or similar materials prepared
in connection with any offering, sale, or private placement of any Placement Shares by Ascendiant outside of the United States.

 

[Signature Page Follows]

 

    	 	27	 

    	 

    

 

If the foregoing correctly sets forth the
understanding between the Company and Ascendiant, please so indicate in the space provided below for that purpose, whereupon this
letter will constitute a binding agreement between the Company and Ascendiant.

 

Very truly yours,

 

	 	AULT GLOBAL HOLDINGS, INC.
	 	 
	 	 
	 	By:	 
	 	Name:	Milton Ault, III
	 	Title: 	Executive Chairman

 

 

ACCEPTED as of the date
first-above written:

 

	 	ASCENDIANT CAPITAL MARKETS, LLC
	 	 
	 	 
	 	By: 	 
	 	Name:	Bradley J. Wilhite
	 	Title: 	Managing Partner

 

    	 	28	 

    	 

    

 

SCHEDULE 1

 

 

 

_________________________________

 

FORM OF PLACEMENT NOTICE

 

_________________________________

 

 

 

		From:	Ault Global Holdings, Inc.

 

		To:	Ascendiant Capital Markets, LLC

Attention: Bradley
J. Wilhite

 

		Subject:	At-The-Market Issuance--Placement Notice

 

Gentlemen:

 

Pursuant to the terms
and subject to the conditions contained in the At-The-Market Issuance Sales Agreement between Ault Global Holdings, Inc., a Delaware
corporation (the “Company”) and Ascendiant Capital Markets, LLC (“Ascendiant”), dated January
22, 2021, the Company hereby requests that Ascendiant sell up to ____________ shares of the Company’s Common Stock, par value
$0.001 per share, at a minimum market price of $_______ per share, during the period beginning [month, day, time] and ending [month,
day, time].

 

    	 	 	 

    	 

    

 

SCHEDULE 2

 

 

 

__________________________

 

Compensation

 

__________________________

 

The Company will pay
to Ascendiant in cash, upon each sale of Placement Shares pursuant to this Agreement, an amount equal to 3.25% of the gross proceeds
from each sale of Placement Shares.

 

    	 	 	 

    	 

    

 

SCHEDULE 3

 

__________________________

 

Notice Parties

 

__________________________

 

 

 

The Company:

 

Milton C.
Ault, IIITodd@aultglobal.com

William B.
HorneWill@ aultglobal.com

Henry C. W.
NisserHenry@ aultglobal.com

 

 

 

 

 

 

Ascendiant:

 

Bradley J.
Wilhitebwilhite@ascendiant.com

 

    	 	 	 

    	 

    

 

SCHEDULE 4

 

 

 

__________________________

 

Subsidiaries

 

__________________________

 

		1.	Coolisys Technologies, Inc., a Delaware corporation

 

		2.	Coolisys Technologies Corp., a Nevada corporation

 

		3.	Gresham Worldwide, Inc., a Delaware corporation

 

		4.	Ault Alliance, Inc., a Delaware corporation

 

		5.	Microphase Corporation, a Delaware corporation

 

		6.	FlexiSphere Acquisition Corp., a Delaware corporation

 

		7.	Digital Farms, Inc. (f/k/a Super Crypto Mining, Inc.), a Delaware corporation

 

		8.	Digital Power Corporation, a Delaware corporation

 

		9.	Digital Power Lending, LLC, a California limited liability company

 

		10.	Gresham Power Electronics Ltd. (f/k/a Digital Power Limited), a company organized under the laws
of England and Wales

 

		11.	It’sLikeFashion.com, a Delaware corporation

 

		12.	I.AM Inc., a Nevada corporation

 

		13.	Alliance Cloud Services, LLC, a Delaware limited liability company

 

		14.	Relec Electronics Ltd., a company organized under the laws of England and Wales

 

    	 	 	 

    	 

    

 

Exhibit A

 

Form of Representation
Date Certificate

 

This Officer’s
Certificate (this “Certificate”) is executed and delivered in connection with Section 7(l) of the At-The-Market
Issuance Sales Agreement (the “Agreement”), dated January 22, 2021, and entered into between Ault Global Holdings,
Inc. (the “Company”) and Ascendiant Capital Markets, LLC. All capitalized terms used but not defined herein
shall have the meanings given to such terms in the Agreement

 

The undersigned, a
duly appointed and authorized officer of the Company, having made all necessary inquiries to establish the accuracy of the statements
below and having been authorized by the Company to execute this certificate, hereby certifies as follows:

 

		1.	As of the date of this Certificate, (i) the Registration Statement does not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein not misleading and (ii) neither the Registration Statement nor the Prospectus contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light
of the circumstances under which they were made, not misleading and (iii) no event has occurred as a result of which it is necessary
to amend or supplement the Prospectus in order to make the statements therein not untrue or misleading.

 

		2.	Each of the representations and warranties of the Company contained in the Agreement were, when
originally made, and are, as of the date of this Certificate, true and correct in all material respects.

 

		3.	Each of the covenants required to be performed by the Company in the Agreement on or prior to the
date of the Agreement, this Representation Date, and each such other date as set forth in the Agreement, has been duly, timely
and fully performed in all material respects and each condition required to be complied with by the Company on or prior to the
date of the Agreement, this Representation Date, and each such other date as set forth in the Agreement has been duly, timely and
fully complied with in all material respects.

 

		4.	Subsequent to the date of the most recent financial statements in the Prospectus, there has been
no Material Adverse Effect.

 

		5.	No stop order suspending the effectiveness of the Registration Statement or of any part thereof
has been issued, and no proceedings for that purpose have been instituted or are pending or threatened by any securities or other
governmental authority (including, without limitation, the Commission).

 

		6.	Gresham Power Electronics Ltd., a private limited company formed and currently existing under the
laws of England and Wales and wholly owned subsidiary of the Company, does not engage in or conduct any trade or business within
the United States.

 

The undersigned has
executed this Officer’s Certificate as of the date first written above.

 

 

	 	
        AULT GLOBAL HOLDINGS, INC. 

	 	 
	 	 
	 	By:	 
	 	Name:	Milton C. Ault, III
	 	Title: 	Executive ChairmanExhibit 4.1

 

Free translation

 

 

 

Separation
and Other Covenants Agreement

 

entered
into between

 

on
one side,

 

Companhia
Brasileira de Distribuição

 

and,
on the other side,

 

Sendas
Distribuidora S.A.

 

December
14, 2020

 

 

 

     

     

    

 

Index

	Clause	 	Page
	 	 	 
	1.	Definitions and Interpretation	2
	 	 	 
	2.	Corporate Reorganization	10
	 	 	 
	3.	Representations and Warranties	12
	 	 	 
	4.	Reciprocal Settlement and Indemnity	18
	 	 	 
	5.	Acts of the Business Separation	25
	 	 	 
	6.	Distribution of Sendas’ Shares	41
	 	 	 
	7.	Other Covenants	43
	 	 	 
	8.	Resolutive Condition and Termination	47
	 	 	 
	9.	General Provisions	47

 

    i

     

    

 

		

Annexes

 

	Annex 2.1(i)	List of Transferred Real Estates
	 	 
	Annex 2.2(ii) 	List of Gas Stations
	 	 
	Annex 3.1.8(i) 	CBD’s Real Estates 
	 	 
	Annex 3.1.8(ii)	Licenses of CBD’s Real Estates
	 	 
	Annex 3.1.9 	Agreements to be assigned, amended, shared and/or reproduced on behalf of Sendas
	 	 
	Annex 3.1.12 	CBD’s or Subsidiaries’ Proxies to Sendas
	 	 
	Annex 3.2.10 	Sendas’ or Subsidiaries’ Proxies to CBD
	 	 
	Annex 5.2.1 	Shared Agreements 
	 	 
	Annex 5.3.2.1 	Guarantee Fee Flowchart
	 	 
	Annex 5.4	Existing Insurance
	 	 
	Annex 5.5.2(i) 	Incentive Plan Assumptions
	 	 
	Annex 5.5.2(iii) 	Employees’ Transfer Agreement
	 	 
	Annex 5.6.1 	Real Estates subject to sublease or assignment of the contractual position
	 	 
	Annex 5.6.1.1	Certain real estates subleased by CBD to Sendas
	 	 
	Annex 5.6.2 	Combo Stores
	 	 
	Annex 5.6.3 	Gallery Management Service Agreement
	 	 
	Annex 5.6.4.1 	Real Estate Regularizations
	 	 
	Annex 5.8 	Shared Active Claims
	 	 
	Annex 5.9.11 	Court Deposits
	 	 
	Annex 5.12 	Bellamar’s Shareholders’ Agreement
	 	 
	Annex 5.13 	Proxies maintained
	 	 
	Annex 7.3.4 	Personal Data Processing Agreement

 

    ii

     

    

 

The present Separation
and Other Covenants Agreement, dated December 14, 2020 (“Agreement”), is entered into between:

 

(1) Companhia
Brasileira de Distribuição, publicly-held company established in the Federative Republic of Brazil, headquartered
in the Municipality of São Paulo, State of São Paulo, at Avenida Brigadeiro Luiz Antônio, 3142, Jardim Paulista,
enrolled with CNPJ/ME under no 47.508.411/0001-56, represented herein by its legal representatives (“CBD”);
and

 

(2) Sendas
Distribuidora S.A., company established in the Federative Republic of Brazil, headquartered in the Municipality of Rio
de Janeiro, State of Rio de Janeiro, at Avenida Ayrton Senna, 0600, Jacarepaguá, enrolled with CNPJ/ME under no 06.057.223/0001-71,
represented herein by its legal representatives (“Sendas”).

 

CBD and Sendas hereinafter referred to as, collectively, the
“Parties” and, individually and indistinctly, the “Party”.

 

WHEREAS:

 

(A) CBD
is a publicly-held company, mainly engaged in the traditional retail market, including the multi retail market (as defined below)
with shares traded in B3 S.A. – Brasil, Bolsa, Balcão (“B3”) and American Depositary Receipts (“ADRs”),
representing the CBD’s shares, admitted for trading in the New York Stock Exchange (“NYSE”);

 

(B) Sendas
is a company mainly engaged in the wholesale and retail markets (cash and carry), which capital, as of the date hereof, amounts
to four billion, seven hundred and forty-nine million, two thousand, two hundred and four reais and ninety-three cents (R$4,749,002,204.93),
divided into two hundred and sixty-eight million, three hundred and fifty-one thousand, five hundred and sixty-seven (268,351,567)
registered common shares, with no par value, which total shares is held, as of the date hereof, by CBD;

 

(C) On
May 1, 2016 (“Multi Retail Business Spin-off Date”), CBD merged certain Sendas’ assets and liabilities
for purposes of allocation to the operations and activities of the Multi Retail Market conducted by CBD (“Multi Retail
Business Separation”);

 

(D) CBD
and Sendas intend to implement certain corporate and commercial transactions so that Sendas shall no longer be a company Controlled
by CBD and the Parties shall be able to operate on a fully independent basis (“Business Separation”);

 

(E) In
the context of the Business Separation, the Parties shall implement the corporate reorganization (“Corporate Reorganization”),
which shall comprise (i) the transfer of shares issued by Bellamar Empreendimentos e Participações S.A., company
enrolled with CNPJ/ME under no 06.950.710/0001-69 (“Bellamar”), and certain real estates owned by CBD to
Sendas, as well as cash contribution and capitalization of credits owned by CBD in Sendas, (ii) the transfer to CBD of the shares
issued by Almacenes Éxito S.A., publicly-held company established and existing under the Laws of Republic of Colombia, headquartered
at Carrera 48 no 32B Sur – 139, Envigado, Antioquia, Colombia (“Éxito”), and held by Sendas,
in conjunction with the assets relating to the gas stations, as identified below, owned by Sendas; and (iii) the CBD Partial Spin-off
(as defined below) whereby the shares issued by Sendas shall be merged into Sendas itself and delivered directly to the CBD’s
shareholders;

 

    1

     

    

 

(F) On
November 19, 2020, CBD obtained from the respective creditors all previous authorizations deemed necessary, related to the CBD’s
and Sendas’ debts, including the debts entered into in the capital market, according to the material facts disclosed by the
Parties on that date, in connection with the Business Separation;

 

(G) Upon
implementation of the Corporate Reorganization, the Sendas’ shares shall be traded in B3 and the ADRs, representing the Sendas’
shares, shall be admitted for trading in NYSE; and

 

(H) The
Parties intend to define the terms and conditions that shall govern the relationship between the Parties before, during and after
the Business Separation;

 

RESOLVED the Parties to enter into
this Agreement, which shall be governed by the terms and conditions jointly agreed below.

 

1.
Definitions and Interpretation

 

1.1.
Definitions. The terms, in capital letters, used in this Agreement shall have the meanings attributed to them in this Clause
1.1:

 

	Bellamar’s Shares	 	has the meaning set forth in Clause 2.1(ii) hereof.
	 	 	 
	Éxito’s Shares	 	has the meaning set forth in Clause 2.2(i) hereof.
	 	 	 
	FIC’s Shares	 	has the meaning set forth in Clause 3.1.7.3 hereof.
	 	 	 
	Sendas’ Shares	 	has the meaning set forth in Clause 2.1(iv) hereof.
	 	 	 
	Bellamar’s Shareholders’ Agreements	 	has the meaning set forth in Clause 5.12 hereof.
	 	 	 
	FIC’s Shareholders’ Agreement	 	has the meaning set forth in Clause 3.1.7.3 hereof.

 

    2

     

    

 

	Association Agreement	 	has the meaning set forth in Clause 3.1.7.3 hereof.
	 	 	 
	ADRS	 	has the meaning set forth in Whereas Clause (A) hereof.
	 	 	 
	Affiliate	 	means, in relation to any Person, however the case may be, (a) the companies that Control the Person directly or indirectly; (b) the companies Controlled, directly or indirectly, by the Person; (c) the companies Controlled, directly or indirectly, by any company that Controls the Person; or (d) any other company under common Control, directly or indirectly, of the Person. For the purposes of this Agreement, CBD shall not be deemed a Sendas’ Affiliate and Sendas shall not be deemed a CBD’s Affiliate.
	 	 	 
	Governmental Agent	 	means any person holding, although temporarily or without compensation, after election, appointment, designation, contracting or any other means to grant mandate, position, title or pubic employment in any Governmental Authority or political party.
	 	 	 
	Use of Tax Supervenience	 	has the meaning set forth in Clause 5.9.12 hereof.
	 	 	 
	CBD’s Assets	 	has the meaning set forth in Clause 2.1 hereof.
	 	 	 
	Sendas’ Assets	 	has the meaning set forth in Clause 2.2 hereof.
	 	 	 
	Transferred Assets	 	has the meaning set forth in Clause 2.2 hereof.
	 	 	 
	Governmental Authority	 	means the government of any country and any political subdivision, at federal, state or municipal level, or any executive, legislative, judiciary, regulatory, self-regulatory or administrative entity, authority or body, including, but not limited to, any authority, agency, department, board, commission, autarchy or organization, any court, tribunal or arbitrator, or any stock exchanges or organized over-the-counter markets, with permanent or temporary jurisdiction over any of the Parties and/or operations thereof and/or transactions in connection with this Agreement.
	 	 	 
	B3	 	has the meaning set forth in Whereas Clause (A) hereof.

 

    3

     

    

 

	Bellamar	 	has the meaning set forth in Whereas Clause (E) hereof.
	 	 	 
	Cash	 	has the meaning set forth in Clause 2.1(iii) hereof.
	 	 	 
	Arbitral Chamber	 	has the meaning set forth in Clause 9.11.3 hereof.
	 	 	 
	Mediation Chamber	 	has the meaning set forth in Clause 9.11.2 hereof.
	 	 	 
	CBD	 	has the meaning set forth in the Preamble hereof.
	 	 	 
	CBD’s Partial Spin-off	 	has the meaning set forth in Clause 2.3(iv) hereof.
	 	 	 
	Civil Code	 	
        means Law 10406, of January 10, 2002, as
        amended and in force.

         

	Code of Civil Procedure	 	means Law 13105, of March 16, 2015, as amended and in force.
	 	 	 
	Resolution Committee	 	has the meaning set forth in Clause 9.11.1 hereof.
	 	 	 
	Transition Committee	 	has the meaning set forth in Clause 5.1.1 hereof.
	 	 	 
	Compre Bem	 	has the meaning set forth in Clause 3.3.2 hereof.
	 	 	 
	Conflict Communication	 	has the meaning set forth in Clause 9.11 hereof.
	 	 	 
	Resolutive Condition	 	has the meaning set forth in Clause 8.1 hereof.
	 	 	 
	Conflict	 	has the meaning set forth in Clause 9.11 hereof.
	 	 	 
	Agreement	 	means this Separation Agreement and Other Covenants in conjunction with the attachments hereto.
	 	 	 
	Sharing Agreement	 	has the meaning set forth in Clause 5.2.3 hereof.

 

    4

     

    

 

	CBD’s Agreements	 	has the meaning set forth in Clause 3.1.9 hereof.
	 	 	 
	Shared Agreements	 	has the meaning set forth in Clause 5.2.1 hereof.
	 	 	 
	Control	 	
        means (including related terms, such as
        “Controller”, “Controlled by” and “under common Control”) the direct or
        indirect power (including representatives) to permanently ensure the majority of the votes in the resolutions of the general meeting
        (or equivalent body) and elect the majority of the directors and executive officers of a company, in addition to the effective
        exercise of this power to direct the corporate activities and the operation of the company’s bodies, as set forth in Article
        116 of Law 6404/76.

         

	Effective Spin-off Date	 	has the meaning set forth in Clause 2.4 hereof.
	 	 	 
	Effective Distribution Date	 	has the meaning set forth in Clause 6.1(i) hereof.
	 	 	 
	Multi Retail Business Spin-off Date	 	has the meaning set forth in Whereas Clause (C) hereof.
	 	 	 
	Defense	 	has the meaning set forth in Clause 4.5 hereof.
	 	 	 
	Active Claim	 	has the meaning set forth in Clause 5.8 hereof.
	 	 	 
	Shared Active Claim	 	has the meaning set forth in Clause 5.8 hereof.
	 	 	 
	Shared Claim	 	
        means any Shared Third-party Claim or Shared
        Active Claim.

         

	Third-party Claim	 	means any Claim filed by a Third-Party, including Governmental Authorities, which may result in a Loss.
	 	 	 
	Shared Third-party Claim	 	has the meaning set forth in Clause 5.7 hereof
	 	 	 
	Claims	 	means claims, requests, actions, communications, complaints, inquiries, summons, notices or proceedings, including arbitration proceedings, administrative proceedings, judicial and extrajudicial lawsuits or investigations of any kind.

 

    5

     

    

 

	Business Day(s)	 	means any day other than Saturday, Sunday or any day on which the commercial banks are obligated or authorized by the applicable Law in force to remain closed in the City of São Paulo, State of São Paulo.
	 	 	 
	Distribution	 	has the meaning set forth in Clause 6.1 hereof.
	 	 	 
	Mandatory Disclosure	 	has the meaning set forth in Clause 5.11.1 hereof.
	 	 	 
	Transaction Documents	 	means this Agreement in conjunction with the Sendas’ Partial Spin-off Agreement and the CBD’s Partial Spin-off Agreement of CBD.
	 	 	 
	Éxito	 	has the meaning set forth in Whereas Clause (E) hereof.
	 	 	 
	Fee	 	has the meaning set forth in Clause 5.3.2 hereof.
	 	 	 
	FIC	 	has the meaning set forth in Clause 2.1(ii) hereof.
	 	 	 
	Fronteira	 	has the meaning set forth in Clause 5.6.3 hereof.
	 	 	 
	Brazilian GAAP	 	means the accounting principles generally accepted in Brazil, in conformity with applicable Law in force.
	 	 	 
	Guarantee	 	has the meaning set forth in Clause 5.3 hereof.
	 	 	 
	Guarantor	 	has the meaning set forth in Clause 5.3 hereof.
	 	 	 
	CBD’s Real Estates	 	has the meaning set forth in Clause 3.1.8 hereof.
	 	 	 
	Dom Pedro Real Estate	 	means the real estate property located at Avenida Parque dos Resedás, 100, Anhumas, Municipality of Campinas, State of São Paulo, as described in public deed 18195, of the 1st Registry of Deeds and Documents of the City of Campinas, State of São Paulo.
	 	 	 
	Sendas’ Real Estate	 	has the meaning set forth in Clause 2.2(ii) hereof.

 

    6

     

    

 

	Transferred Real Estates	 	has the meaning set forth in Clause 2.1(i) hereof.
	 	 	 
	Law	 	means any law, decree, decree law, provisional measure, rule, regulation, instruction, resolution, order, decision, corrective measures, valid and effective lawsuit (including, but not limited to, any Order) or any other legal requisite or requisite submitted by any Governmental Authority.
	 	 	 
	LGPD	 	has the meaning set forth in Clause 7.3 hereof.
	 	 	 
	Multi Retail Market	 	means the businesses related to the retail food market, conducted by CBD, under the main brands Pão de Açúcar and Extra, including all forms and variations, in addition to other brands, such as Aliados, Compre Bem, among others.
	 	 	 
	NYSE	 	has the meaning set forth in Whereas Clause (A) hereof.
	 	 	 
	Burden	 	
        means any encumbrances, burdens, collaterals,
        pledges, mortgages, guarantees, disposals or fiduciary assignments, rights of first refusal, retention rights, charges, usufruct,
        seizures, options, preemptive rights or rights of first offer.

         

	Order	 	means any order, judgement, decision, dispatch, determination or sentence ruled by any Governmental Authority.
	 	 	 
	Standard Market Insurance Package	 	has the meaning set forth in Clause 5.4 hereof.
	 	 	 
	Secured Party	 	has the meaning set forth in Clause 5.3 hereof.
	 	 	 
	Indemnifying Party	 	has the meaning set forth in Clause 4.4 hereof.
	 	 	 
	Indemnified Party	 	has the meaning set forth in Clause 4.4 hereof.
	 	 	 
	Parte(s)	 	has the meaning set forth in the Preamble hereof.
	 	 	 
	Liability	 	means any liability, Claim, Loss, responsibility and obligation, pecuniary or not, contingent or not, overdue or not, arising from any applicable Law, agreement or any other instrument in force.

 

    7

     

    

 

	Loss(es)	 	means, as effectively incurred, any contingencies, losses, damages, fines, legal costs, inflation adjustments and reasonable attorneys’ fees, disbursements (including deposits, advances and financial guarantees) or losses of any nature or type, as well as any fine or pecuniary fine that may be imposed by Governmental Authorities, excluding indirect damages (such as loss of dividends, revenues or opportunities, moral damages or loss of profits). 
	 	 	 
	Exchange	 	has the meaning set forth in Clause 2.3(ii) hereof.
	 	 	 
	Person	 	means the Parties, any individual, corporation, limited-liability company, individual entrepreneur, trust, trade union, association, consortium, investment funds, Governmental Authority or any other legal entity or entity without legal personality. 
	 	 	 
	Gas Stations	 	has the meaning set forth in Clause 2.2(ii) hereof.
	 	 	 
	Service Providers	 	has the meaning set forth in Clause 3.3.3 hereof.
	 	 	 
	CBD’s Partial Spin-off Agreement	 	means the Partial Spin-off Agreement of Companhia Brasileira de Distribuição upon Merger of the Spun-off Portion into Sendas Distribuidora S.A., entered by and among the Parties on December 9, 2020.
	 	 	 
	Sendas’ Partial Spin-off Agreement	 	means the Partial Spin-off Agreement of Sendas Distribuidora S.A. upon Merger of the Spun-off Portion into Companhia Brasileira de Distribuição, entered by and among the Parties on December 9, 2020.
	 	 	 
	Chamber Regulation	 	has the meaning set forth in Clause 9.11.3 hereof.
	 	 	 
	Mediation Regulation	 	has the meaning set forth in Clause 9.11.2 hereof.
	 	 	 
	Corporate Reorganization	 	has the meaning set forth in Whereas Clause (E) hereof.
	 	 	 
	Existing Insurance	 	has the meaning set forth in Clause 5.4 hereof.

 

    8

     

    

 

	Sendas	 	has the meaning set forth in the Preamble hereof.
	 	 	 
	Business Separation	 	has the meaning set forth in Whereas Clause (D) hereof.
	 	 	 
	Multi Retail Business Separation	 	has the meaning set forth in Whereas Clause (C) hereof.
	 	 	 
	SOX	 	has the meaning set forth in Clause 7.5.1 hereof.
	 	 	 
	Disclosure Subcommittee	 	has the meaning set forth in Clause 5.11 hereof.
	 	 	 
	Tax Active Superveniences	 	has the meaning set forth in Clause 5.9.12 hereof.
	 	 	 
	Tribunal Arbitral	 	has the meaning set forth in Clause 9.11.4 hereof.
	 	 	 
	Taxes	 	means any fees, taxes, tariffs, contributions, charges, obligations or similar taxation (including interest, fines, penalties, inflation adjustments and additional amounts paid) registered by or payable to any Governmental Authority, including withholding income tax, taxes on consumption goods, ad valorem, taxes on value added, social contributions and taxes on payroll, financial taxes, taxes on fixed and current assets, taxes on transfer of licenses, sales, use, contracting of employees or services and other taxes of any type or nature, including the contributions to the Severance Pay Fund (FGTS).
	 	 	 
	Sendas’ Business Unit	 	has the meaning set forth in Clause 5.2.1 hereof.

 

1.2. Interpretation.
Except if expressly otherwise set forth in this Agreement: (i) the words (including the terms in capital letters defined in this
Agreement) in singular form shall include the respective plural form – and vice-versa – and words (including the terms
in capital letters defined in this Agreement) in any gender shall include the other gender, as required by the context; (ii) the
terms “herein” and “in this Agreement”, as well as other similar words, shall be construed in reference
to this Agreement as a whole (including the Appendices hereto) and not as a specific provision of this Agreement; (iii) the references
to Chapter, Clause and Appendix shall be construed as references to Chapter, Clause and Appendix of this Agreement; (iv) the word
“including” and similar words, when used in this Agreement, shall mean “including, but not limited to”;
(v) all references to any periods of days shall be deemed as references to the number of consecutive days, rather than Business
Days; (vi) the titles and subtitles of Chapters, Clauses and Appendices of this Agreement have been exclusively included for purposes
of convenience and reference, in the sense that such titles and subtitles shall not limit or impact the meaning and interpretation
of this Agreement; (vii) any reference to any document or instrument shall be deemed as including all respective changes, modifications,
replacements, restatements and amendments in effect on the date of the respective reference; (viii) all terms referred to herein
shall be counted in conformity with article 132 of the Civil Code, that is, excluding the initial day and including the maturity
date, and all terms ending on any day that is not a Business Day shall be automatically extended to the first subsequent Business
Day; (ix) the “Whereas Clauses” of this Agreement are an integral part hereof; and (x) the references to the provisions
or legal provisions shall be construed as references to the provisions or legal provisions, as respectively changed, extended,
consolidated, restated or revoked on the respective reference date. The Parties acknowledge that the terms and contents of this
Agreement resulted from the discussions between the Parties and, as such, there shall not be any assumption that eventual omissions
herein will be resolved unfavorably to any specific Party. Any conflicts with respect to the interpretation of this Agreement shall
be settled without events of authorship or negotiation.

 

    9

     

    

 

2.
Corporate Reorganization

 

2.1.
CBD’s Assets. The following assets shall be transferred from CBD to Sendas (“CBD’s Assets”)
in the context of the Corporate Reorganization:

 

		(i)	ownership rights held by CBD with respect to certain
real estates referred to in Appendix 2.1(i) (“Transferred Real Estates”);

 

		(ii)	sixty-nine million, four hundred and thirteen thousand,
seven hundred and ninety (69,413,790) registered shares, with no par value (“Bellamar’s Shares”), out
of which sixty-nine million, four hundred and thirteen thousand, seven hundred and eighty-nine (69,413,789) are common shares
and one (1) is preferred shares, representing 50% of the capital of Bellamar, which holds 35.76% of the capital of Financeira
Itaú CBD S.A. – Crédito, Financiamento e Investimento, a company enrolled with CNPJ/ME under no 06.881.898/0001-30
(“FIC”);

 

		(iii)	the amount equivalent to five hundred million reais
(R$500,000,000.00) (“Cash”); and

 

		(iv)	the total shares issued by Sendas and held by CBD
(“Sendas’ Shares”).

 

2.2.
Sendas’ Assets. The following assets shall be transferred from Sendas to CBD (“Sendas’ Assets”
and, in conjunction with the CBD’s Assets, the “Transferred Assets”) in the context of the Corporate
Reorganization:

 

		(i)	the total shares issued by Éxito and held by
Sendas (“Éxito’s Shares”); and

 

		(ii)	the assets relating to the gas stations identified
in Appendix 2.2(ii) (“Gas Stations”), including the real estate located in São Gonçalo,
registered under public deed no 28.274 with the 2nd Real Estate Registry Office of São Gonçalo/RJ (“Sendas’
Real Estate”).

 

    10

     

    

 

2.3.
The Corporate Reorganization shall be implemented through the acts described below, to be undertaken in the following order:

 

		(i)	approval by the Sendas’ shareholders, at the
Extraordinary Shareholders’ Meeting, of the Sendas’ capital increase, upon Cash contribution and two (2) Transferred
Real Estates, as well as credit capitalization, totaling approximately one hundred and forty million (R$140,000,000.00), held
by CBD against Sendas;

 

		(ii)	exchange of the Bellamar’s Shares and five (5)
of the Transferred Real Estates for thirty-nine million, two hundred and forty-six thousand and twelve (39,246,012) Éxito’s
Shares (“Exchange”);

 

		(iii)	approval by the Parties’ shareholders of the
Sendas’ partial spin-off, upon merger into CBD of the spun-off assets composed of (a) three hundred and ninety-three
million, ten thousand and six hundred and fifty-six (393,010,656) Éxito’s Shares; and (b) the assets relating
to the Gas Stations, including the Sendas’ Real Estate, in conformity with the Sendas’s Partial Spin-off Agreement;
and

 

		(iv)	approval by the Parties’ shareholders of the
CBD’s partial spin-off, upon merger into Sendas of the Sendas’ Shares, which shall be directly delivered to the CBD’s
shareholders, under the terms of Clause 6.3, in conformity with the CBD’s Partial Spin-off Agreement (“CBD
Partial Spin-off”).

 

 2.4. As from the date the CBD Partial Spin-off has been approved, at last, at the Extraordinary Shareholders’ Meeting of each of the Parties (“Effective Spin-off Date”), the Parties shall undertake reasonable commercial efforts to, in the shortest time possible, complete the transfer of the CBD’s Assets and the Sendas’ Assets, however the case may be, and perform the Business Separation, including the performance of all corporate acts and signature of all documents deemed necessary.

 

 2.5. Exchange. On the Effective Spin-off Date, the Parties agree to undertake any measures and enter into all and any instruments deemed necessary for the completion of the Exchange, including (i) the signature of the transfer term drafted in the book of transfer of Bellamar’s registered shares relating to the assignment of the Bellamar’s Shares from CBD to Sendas; and (ii) the signature of the necessary documents to complete the transfer of the Éxito’s Shares from Sendas to CBD.

 

    11

     

    

 

 3. Representations and Warranties

 

 3.1. CBD’s Representations and Guarantees. CBD hereby provides the following representations and guarantees to Sendas, which are true, correct and accurate as of the date hereof, and shall be true, correct and accurate on the Effective Spin-off Date, except for the representations and guarantees that refer to any specific date, which shall be true, correct and accurate on such specific date:

 

3.1.1. Good
Standing. CBD is a publicly-held company duly established and validly existing in accordance with the laws of the Federative
Republic of Brazil, with all necessary corporate powers and authority to enter into this Agreement and comply with the respective
obligations under the terms of this Agreement.

 

3.1.2. Validity
and Enforceability. This Agreement was duly entered into by CBD and represents a legal, valid and binding commitment, fully
enforceable against CBD under the terms and conditions set forth in this Agreement; there shall be no proceedings, Orders, investigations
or notices submitted by any Governmental Authorities against CBD that could prevent the execution and/or performance of the transactions
referred to in this Agreement.

 

3.1.3. Absence
of Violation. Neither the performance of this Agreement nor the compliance with the provisions shall violate: (a) any provision
of the CBD’s corporate documents, or any CBD’s relevant agreement; (b) any Law or regulation or decision ruled by the
Governmental Authority applicable to CBD; and/or (c) any other Orders applicable to CBD or agreements to which is bound.

 

3.1.4. Governmental
Consents and Approvals. Except as determined by the Brazilian Exchange and Securities Commission (CVM), the Securities Exchange
Commission (SEC), B3 and/or NYSE or, as set forth in this Agreement, the signature of, performance of and compliance with this
Agreement by CBD and the performance by CBD of the transactions referred to herein do not require and shall not require any consent,
approval, authorization or another order, action, representation, registry or notice to any Governmental Authority, by CBD.

 

3.1.5. Third-party’s
Consents and Approvals. CBD obtained, as of the date hereof, all necessary authorizations from third parties, including creditors,
for the execution, documentation and performance of this Agreement by CBD and the performance by CBD of the transactions referred
to herein.

 

    12

     

    

 

3.1.6. Sendas’
Shares. CBD is the holder of two hundred and sixty-eight million, three hundred and fifty-one thousand, five hundred and sixty-seven
(268,351,567) registered common shares, with no par value, representing one hundred percent (100%) of the Sendas’ capital,
which are, and shall be on the Effective Spin-off Date, free and clear of any Burden. There is no agreement, although not registered
with the Sendas’ head office, of any nature, which would directly or indirectly bind the Sendas’ Shares, or which would
limit the political and/or equity rights of the Sendas’ Shares. There are no options, rights, commitments or other covenants
of any nature, or other notes that could directly or indirectly require the sale or transfer of the Sendas’ Shares.

 

3.1.7. Bellamar.
Bellamar is a corporation duly established and validly existing under the laws of the Federative Republic of Brazil. As of the
date hereof, CBD is the lawful holder and owner of one hundred and thirty-eight million, eight hundred and twenty-seven thousand,
five hundred and eighty (138,827,580) registered shares, with no par value, out of which one hundred and thirty eight million,
eight hundred and twenty-seven thousand, five hundred and seventy-eight (138,827,578) are common shares and two (2) are preferred
shares of the same class, fully paid, representing 100% of Bellamar’s capital, free and clear of any Burden. Except for Bellamar’s
Shareholders’ Agreement, there is no agreement, registered or not with the Bellamar’s head office, of any nature, which
would directly or indirectly bind the Bellamar’s Shares, or which would limit the political and/or equity rights of the Bellamar’s
Shares; and there are no options, rights, commitments or other covenants of any nature, or other notes that could directly or indirectly
require the sale or transfer of the Bellamar’s Shares.

 

3.1.7.1. Compliance
with the Laws. To the CBD’s knowledge, Bellamar has complied with all applicable Laws in force, in all material respects,
and is not subject to any voluntary or involuntary proceedings or requests for settlement, judicial or extrajudicial reorganization
or bankruptcy of Bellamar.

 

3.1.7.2. Financial
Statements. To the CBD’s knowledge, the Bellamar’s financial statements as at September 30, 2020, included herein
in the form of Appendix 3.1.7.2, (i) are true, complete and correct in all material respects; (ii) have been prepared in
conformity with Bellamar’s accounting books and other financial records (except as referred to in the respective explanatory
notes), subject to reconciliation; (iii) truly represent, in all material respects, the financial condition, assets, obligations,
operational results and cash flow of Bellamar on the respective dates or for the covered periods; and (iv) have been prepared in
accordance with the applicable Law in force and the Brazilian GAAP, consistently applied in accordance with the Bellamar’s
past practices.

 

3.1.7.3. FIC.
Bellamar is the owner of three hundred and twenty-four million, five hundred and one thousand, one hundred and fourteen (324,501,114)
registered common shares, with no par value, representing 35.76% of the FIC’s capital (“FIC’s Shares”),
which are and shall be on the Effective Spin-off Date free and clear of any Burden, except for the Association Agreement entered
into on October 27, 2004 between CBD, FIC, Itaú Unibanco Holding S.A. and certain other parties, as amended and in force
(“Association Agreement”), as well as the Shareholders’ Agreement entered into on October 27, 2004, as
amended and in force (“FIC’s Shareholders’ Agreement”). Except for the Association Agreement and
FIC’s Shareholders’ Agreement, there is no agreement, registered or not with the FIC’s head office, of any nature,
which would directly or indirectly bind the FIC’s Shares, or which would limit the political and/or equity rights of the
FIC’s Shares; and there are no options, rights, commitments or other covenants of any nature, or other notes that could directly
or indirectly require the sale or transfer of the FIC’s Shares.

 

    13

     

    

 

3.1.8. CBD’s
Real Estates. CBD is the lawful owner or holder of all properties identified in Appendix 3.1.8(i) (“CBD’s Real
Estates”), as set forth in Clause 5.6.4. Except as set forth in Appendix 3.1.8(ii), each CBD’s Real Estate is
occupied under the terms of a valid and updated real estate permit (“habite-se”), operating license, technical inspection
report issued by the Fire Department (AVCB) and/or similar licenses, as determined by the applicable Law in force, and is duly
registered with the proper real estate offices, except as indicated in Appendix 3.1.8(i). The CBD’s Real Estates are
under good conditions and are adequate for the current use and purpose thereof, except for the normal wear and tear compatible
with the respective stage of useful life thereof. There are no (i) contractual or legal restrictions or Claims that would prevent
or limit or that could prevent or limit the use of the CBD’s Real Estates for the purposes according to which the CBD’s
Real Estates are currently being used; and/or (ii) to the CBD’s knowledge, decisions or domain lawsuits of any type pending
decision or threatened against the CBD’s Real Estates.

 

3.1.9. Agreements.
Appendix 3.1.9 includes a list of the agreements, to which CBD is a party and that, as deemed necessary by Sendas, shall
be assigned, amended, shared and/or reproduced on behalf of Sendas (“CBD’s Agreements”), under the terms
of Clause 5.2. None of the counterparties to the CBD’s Agreements has formally or informally informed to CBD the intention
to not renew or terminate the respective agreements in advance. Each of the CBD’s Agreements (i) is valid and binding in
relation to CBD and CBD’s counterparties, is enforceable against the respective counterparties, under the respective terms,
and is fully valid and effective; (ii) has been timely and fully performed by CBD in all material respects; and (iii) is not subject
to pending conflicts or, to the CBD’s knowledge, is imminent.

 

3.1.10. Intellectual
Property. The intellectual property rights exercised by CBD in the conduction of the respective activities are exclusively
owned by CBD or the exercise of such intellectual property rights have been duly authorized by the respective owners, in conformity
with the respective licenses, assignments, sublicenses and/or other agreements, including, but not limited to, the Shared Agreements,
however the case may be.

 

    14

     

    

 

3.1.11. Anticorruption.
CBD and, to the CBD’s knowledge, the directors, executive officers, employees, representatives and associates thereof have
not (a) performed any action that would result in violation, by such Persons, of any Law that would reduce or prohibit the corruption
or offer, payment, promise to pay or payment authorization of any amount or another type of property, gift, promise to offer or
authorization for donation of any item of value to any Governmental Agent or any political party or member of political party or
candidate of any public position; and (b) offered, promised, authorized or performed any payment or granted any other type of benefit
to any Governmental Agent with the intention or in order to: (i) influence any measure or decision ruled by such Governmental
Agent in the exercise of the respective duties; (ii) induce the Governmental Agent to undertake any act or omission that would
represent any violation of the exercise of the respective position; or (iii) induce the Governmental Agent to use his/her
influence to impact or influence any act or decision, in each case in order to contribute with CBD and/or its Affiliates to obtain
or retain businesses with any Person, or otherwise direct the businesses to any Person.

 

3.1.12. Proxies.
Appendix 3.1.12 includes a list of all proxies granted by CBD and/or its Subsidiaries to Sendas and/or its Subsidiaries
or respective employees and associates in effect on the signature date of this Agreement; and there are no other proxies in effect
that are not listed therein.

 

 3.2. Sendas’ Representations and Guarantees. Sendas hereby provides the following representations and guarantees to CDB, which are true, correct and accurate as of the date hereof, and shall be true, correct and accurate on the Effective Spin-off Date, except for the representations and guarantees that refer to any specific date, which shall be true, correct and accurate on such specific date:

 

3.2.1. Good
Standing. Sendas is a company duly established and validly existing in accordance with the laws of the Federative Republic
of Brazil, with all necessary corporate powers and authority to enter into this Agreement and comply with the respective obligations
under the terms of this Agreement.

 

3.2.2. Validity
and Enforceability. This Agreement was duly entered into by Sendas and represents a legal, valid and binding commitment, fully
enforceable against Sendas under the terms and conditions set forth in this Agreement; there shall be no proceedings, Orders, investigations
or notices submitted by any Governmental Authorities against CBD that could prevent the execution and/or performance of the transactions
referred to in this Agreement.

 

3.2.3. Absence
of Violation. Neither the performance of this Agreement nor the compliance with the provisions shall violate: (a) any provision
of the Sendas’ corporate documents, or any Sendas’ relevant agreement; (b) any Law or regulation or decision ruled
by the Governmental Authority applicable to Sendas; and/or (c) any other Orders applicable to Sendas or agreements to which is
bound.

 

    15

     

    

 

3.2.4. Governmental
Consents and Approvals. Except as determined by the Brazilian Exchange and Securities Commission (CVM), the Securities Exchange
Commission (SEC), B3 and/or NYSE or, as set forth in this Agreement, the signature of, performance of and compliance with this
Agreement by Sendas and the performance by Sendas of the transactions referred to herein do not require and shall not require any
consent, approval, authorization or another order, action, representation, registry or notice to any Governmental Authority, by
Sendas.

 

3.2.5. Third-party’s
Consents and Approvals. Sendas obtained, as of the date hereof, all necessary authorizations from third parties, including
creditors, for the execution, documentation and performance of this Agreement by Sendas and the performance by Sendas of the transactions
referred to herein

 

3.2.6. Éxito.
Éxito is a company duly established and validly existing under the laws of the Republic of Colombia. As of the date hereof,
Sendas is the holder of four hundred and thirty-two million, two hundred and fifty-six thousand, six hundred and sixty-eight (432,256,668)
Éxito’s Shares, fully paid, representing 96.57% of Éxito’s capital, fully free and clear of any Burden.
There is no agreement, registered or not with the Éxito’s head office, of any nature, which would directly or indirectly
bind the Éxito’s Shares, or which would limit the political and/or equity rights of the Éxito’s Shares.
There are no options, rights, commitments or other covenants of any nature, or other notes that could directly or indirectly require
the sale or transfer of the Éxito’s Shares.

 

3.2.7. Intellectual
Property. The intellectual property rights exercised by Sendas in the conduction of the respective activities are exclusively
owned by Sendas or the exercise of such intellectual property rights have been duly authorized by the respective owners, in conformity
with the respective licenses, assignments, sublicenses and/or other agreements, including, but not limited to, the Shared Agreements,
however the case may be.

 

3.2.8. Sendas’
Gas Stations and Real Estates. Appendix 2.2(ii) includes the Gas Stations, which assets are exclusively owned by Sendas, including
the Sendas’ Real Estate.

 

3.2.9. Anticorruption.
Sendas and, to the Sendas’ knowledge, the directors, executive officers, employees, representatives and associates thereof
have not (a) performed any action that would result in violation, by such Persons, of any Law that would reduce or prohibit the
corruption or offer, payment, promise to pay or payment authorization of any amount or another type of property, gift, promise
to offer or authorization for donation of any item of value to any Governmental Agent or any political party or member of political
party or candidate of any public position; and (b) offered, promised, authorized or performed any payment or granted any other
type of benefit to any Governmental Agent with the intention or in order to: (i) influence any measure or decision ruled by
such Governmental Agent in the exercise of the respective duties; (ii) induce the Governmental Agent to undertake any act
or omission that would represent any violation of the exercise of the respective position; or (iii) induce the Governmental
Agent to use his/her influence to impact or influence any act or decision, in each case in order to contribute with Sendas and/or
its Affiliates to obtain or retain businesses with any Person, or otherwise direct the businesses to any Person.

 

    16

     

    

 

3.2.10. Proxies.
Appendix 3.2.10 includes a list of all proxies granted by Sendas and/or its Subsidiaries to CBD and/or its Subsidiaries
or respective employees and associates in effect on the signature date of this Agreement; and there are no other proxies in effect
that are not listed therein.

 

 3.3. Mutual Representations and Guarantees. As set forth in Clause 4.8 below, the Parties hereby mutually provide the following representations and guarantees that, to the Parties’ knowledge, are true, correct and accurate as of the date hereof and shall be true, correct and accurate on the Effective Spin-off Date, except for the representations and guarantees that refer to any specific date, which shall be true, correct and accurate on such specific date:

 

3.3.1. Éxito.
Éxito is compliant with all applicable Laws in force, in all material respects; and there are no voluntary or involuntary
lawsuits or requests for settlement, judicial or extrajudicial recovery or bankruptcy of Éxito.

 

3.3.2. Compre
Bem. SCB Distribuição e Comércio Varejista de Alimentos Ltda., limited-liability company, enrolled with
CNPJ under no 30.197.161/0001-88, headquartered in the City of São Paulo, State of São Paulo, at Avenida Aricanduva,
5555, Edifício Shopping Interlar, Setor Âncora “E”, Conjunto 2, Vila Matilde, Zip Code 03527-000 (“Compre
Bem”), by itself and its representatives, is compliant with all applicable Laws in force, in all material respects; and
there are no voluntary or involuntary lawsuits or requests for settlement, judicial or extrajudicial recovery or bankruptcy of
Compre Bem. All engagements by Compre Bem were conducted in good faith and according to the interests of Compre Bem, in compliance
with applicable Law, bylaws and internal regulations in force.

 

3.3.3. Service
Providers. All service providers contracted by any of the Parties, which have provided or provide services to the other Party
(“Service Providers”), were engaged in good faith and according to the interests of the Parties, in compliance
with applicable Law, bylaws and internal regulations in force; and no verbal or written agreement entered into with such Service
Providers is subject to pending Claims or, to the Parties’ knowledge, imminent Claims, except as disclosed by one Party to
the other before the Effective Spin-off Date.

 

3.3.4. Accounting
Procedures. The accounting procedures and other books and records of each of the Parties were adopted in good faith and according
to the interests of the Parties, in compliance with applicable Law, bylaws and internal regulations in force.

 

    17

     

    

 

 4. Reciprocal Settlement and Indemnity

 

 4.1. Settlement. Except as otherwise set forth in this Agreement, the Parties, on their own behalf and on behalf of each of its Subsidiaries and respective executive officers, directors, employees, successors and assignees, shall grant each other full, general, irrevocable and unconditional settlement in relation to any Liabilities, currently existing or resulting from (i) any acts, facts or omissions that took place through or on the Effective Spin-off Date; and (ii) any acts, facts or omissions relating to the Business Separation, including the Corporate Reorganization. The Parties acknowledge that the activities performed and the acts undertaken by Parties’ directors and executive officers before the Effective Spin-off Date were performed in good faith and according to the interests of the Parties and its Affiliates, in the sense that each of the Parties waives, to the extension of applicable Law in force, any right to undertake any action against the other Party, its Subsidiaries and respective directors and executive officers based on any facts, acts or omissions covered by settlement under this Clause.

 

4.1.1. No
provision set forth in this Agreement shall (i) prevent or impact any right entitled to the Parties to request the compliance with
the agreements and accords entered into by the Parties, as well as with this Agreement and the other Transaction Documents and/or
any other acts deemed necessary or advisable for the Business Separation, which remain effective or shall be performed after the
Effective Spin-off Date; (ii) release any Person with respect to any terms set forth in employment or labor agreements, including,
but not limited to, obligations of confidentiality, non-contact and non-competition and/or payment of salary, compensation and
reimbursement, as well as payment of indemnities under insurance policies or indemnity agreements on behalf of any of the Parties,
and Affiliates and respective executive officers, directors, successors and assignees thereof, under the terms of the respective
policies or agreements; and/or (iii) prevent any Persons from the respective rights as shareholders of one of the Parties and/or
Affiliates thereof.

 

4.1.2. Each
of the Parties shall exercise the respective authority, to the extension permitted by the applicable Law in force, and undertake
commercially reasonable efforts to (i) avoid that the Subsidiaries and respective executive officers, directors, representatives,
successors and assignees thereof file any Claim against the other Party not in conformity with the settlement referred to in this
Clause 4.1; and (ii) ensure that the Subsidiaries and respective executive officers, directors, representatives, successors
and assignees thereof sign and deliver to the other Party the settlement term, as provided for in this Clause 4.1, as reasonably
requested by the other Party.

 

    18

     

    

 

 4.2. CBD’s Indemnity. Without prejudice to any other indemnity obligations defined in the Transaction Documents, as from the Effective Spin-off Date, CBD agrees to indemnify, reimburse and hold harmless Sendas, the Subsidiaries and respective executive officers, directors, employees, representatives, successors and assignees thereof, from any Losses arising from, related to or in connection with:

 

		(i)	any inaccuracy or violation of the representations
and guarantees provided by CBD in this Agreement and the other Transaction Documents, including, but not limited to, the representations
and guarantees referred to in Clause 3.1 above;

 

		(ii)	any partial or total violation of any of the CBD’s
obligations established in this Agreement and the other Transaction Documents;

 

		(iii)	any Claim filed by any Subsidiary, executive officer,
director, employee, successor or assignee of CBD and/or respective Subsidiaries against Sendas or Subsidiaries thereof and/or
respective executive officers, directors, employees, successors and assignees thereof, in violation of the settlement granted
by CBD, as set forth in Clause 4.1;

 

		(iv)	any act, fact or omission, passive supervenience or
active insufficiency relating to the Gas Stations and/or Sendas’ Real Estate, informed or not through the representations
and guarantees provided in connection with this Agreement, known or not by the Parties, which triggering event has taken place
through the Effective Spin-off Date (including), although the respective effects solely take place in the future.

 

		(v)	any
environmental Liabilities relating to the (a) CBD’s Real Estates, which triggering event has taken place through the Effective
Spin-off Date (including); and/or (b) Dom Pedro Real Estate, which triggering event has taken place through February 28, 2019
(including), informed or not through the representations and guarantees provided in the context of this Agreement, known or not
by the Parties, although the respective effects solely take place in the future;

 

		(vi)	any act, fact or omission, passive supervenience or
active insufficiency relating to Éxito, informed or not through the representations and guarantees provided in the context
of this Agreement, known or not by the Parties, which triggering event has taken place through the Effective Spin-off Date (including),
although the respective effects solely take place in the future; and

 

		(vii)	any act, fact or omission, passive supervenience or
active insufficiency relating to or arising from the Multi Retail Business Separation and/or CBD’s businesses, informed
or not through the representations and guarantees provided in the context of this Agreement, known or not by the Parties, which
triggering event has taken place through the Multi Retail Business Spin-off Date (including), although the respective effects
solely take place in the future.

 

    19

     

    

 

 4.3. Sendas’ Indemnity. Without prejudice to any other indemnity obligations defined in the Transaction Documents, as from the Effective Spin-off Date, Sendas agrees to indemnify, reimburse and hold harmless CBD, the Subsidiaries and respective executive officers, directors, employees, representatives, successors and assignees thereof, from any Losses arising from, related to or in connection with:

 

		(i)	any inaccuracy or violation of the representations
and guarantees provided by Sendas in this Agreement and the other Transaction Documents, including, but not limited to, the representations
and guarantees referred to in Clause 3.2 above;

 

		(ii)	any partial or total violation of any of the Sendas’
obligations established in this Agreement and the other Transaction Documents;

 

		(iii)	any Claim filed by any Subsidiary, executive officer,
director, employee, successor or assignee of Sendas and/or respective Subsidiaries against CBD or Subsidiaries thereof and/or
respective executive officers, directors, employees, successors and assignees thereof, in violation of the settlement granted
by Sendas, as set forth in Clause 4.1;

 

 4.4. Indemnity Procedures for Direct Claims. In the event any of the Parties incurs any indemnifiable Loss in accordance with Clause 4.2 or Clause 4.3 hereof (“Indemnified Party”), other than any Loss arising from a Third-party Claim, as referred to in Clause 4.5 below, such fact shall be informed to the other Party (“Indemnifying Party”), as provided for in Clause 9.1, including a description of the indemnity payable, the legal basis and the value of the respective Loss subject to indemnity, including receipts of final disbursements relating to the Loss.

 

4.4.1. Reimbursement.
Upon receipt of the notice, in the event the Indemnifying Party agrees with the terms of such notice or has not submitted any notice
to the contrary within ten (10) Business Days, the Indemnifying Party shall reimburse the Indemnified Party for the value of the
Loss informed during each quarter, within ten (10) Business Days counted as from the beginning of the quarter after notice, upon
transfer of immediately available funds to the bank account informed by the Indemnified Party. The Parties agree with the compensation
of credits and debts of each Party relating to the indemnities payable at the end of each quarter.

 

    20

     

    

 

4.4.2. In
the event the Indemnifying Party has not agreed with the indemnity notice submitted by the Indemnified Party, the Indemnifying
Party shall notify the Indemnified Party with respect to such disagreement within ten (10) Business Days as from the receipt of
such notice, and the Parties shall meet within fifteen (15) subsequent days to achieve an agreement in good faith in relation to
the matter under discussion. The failure of the Parties to achieve an amicable agreement with respect to the responsibility for
the payment of the eventual Loss shall be resolved under the terms of Clause 9.11 and subsequent clauses hereof, in which
case the award issued by the Arbitral Tribunal shall determine the final and indemnifiable Loss, as set forth in this Agreement.
The definition of the final Loss in connection with the arbitration award shall be reimbursed to the Indemnified Party within ten
(10) Business Days counted as from the award issued by the Arbitral Tribunal, except if otherwise decided by the Arbitral Tribunal.

 

4.4.3. The
non-payment of the indemnity within the term referred to in Clauses 4.4.1 or 4.4.2 above, however the case may be,
shall subject the Indemnifying Party to the payment of the indemnity value, adjusted based on the CDI rate between the payment
date and the effective payment date, plus interest in arrears of two percent (2%) per year, on a proportional basis.

 

 4.5. Third-Party Claim. Subject to the provisions of Clauses 4.5.4, 5.7 and 5.8 below, if there is a Third-Party Claim against any Indemnified Party, the Indemnified Party will notify, in writing, the Indemnifying Party regarding that Third-Party Claim, as provided for in Clause 9.1, within the term equivalent to 1/3 (one third) of the legal period for the presentation of the applicable defense or measure against said Third-Party Claim or within 10 (ten) Business Days, whichever is shorter (“Defense”), provided that, if the legal term for Defense is 5 (five) days or less, the notice referred to herein will be given until the half of the legal term for Defense. Such notice shall describe the Third-Party Claim in reasonable detail and contain, at a minimum, (i) the amount of the Third-Party Claim, if any, (ii) the facts and circumstances that resulted in the Third-Party Claim, and (iii) the full copy of the subpoena, notice, infraction report or summons related to the Third-Party Claim. In the event the Indemnified Party has failed to notify, on a timely basis, the Indemnifying Party, as set forth in this Clause, the Indemnified Party shall present the applicable Defense to the respective Third-party Claim, in the sense that, if the Indemnified Party has not presented the Defense on a timely basis or has not addressed all applicable preliminary issues and merits, the Indemnifying Party shall not be, under any circumstance, obligated to indemnify the Indemnified Party for any Losses arising from or related to the respective Third-party Claim.

 

    21

     

    

 

4.5.1. Conduction
of Third-Party Claim by Indemnifying Party. The Indemnifying Party will assume the Defense of the Third-Party Claim, through
attorneys of its choice, bearing all costs arising therefrom (including, but not limited to, attorney’s fees, court costs,
expertise fees, interest on arrears, fines, inflation adjustments, deposits, sureties and/or other judicial and extrajudicial guarantees).

 

4.5.1.1. The
Indemnified Party undertakes to (i) provide the Indemnifying Party with any and all information, documents, materials and/or access
to Persons, which are in its possession and/or under its control or authority, as reasonably requested, including, but not limited
to, the granting of mandates, in physical or electronic form, as well as (ii) make commercially reasonable efforts to meet the
other requests of the Indemnifying Party, in any event, to enable the conduct of the Defense of the Third-Party Claim, under the
terms of this Clause 4.5. Information, documents, materials and/or access to Persons, which are in possession and/or under
the control of the Indemnified Party and/or its Affiliates, shall be provided within the term equivalent to 1/3 (one third) of
the legal period for the submission of such information and/or document within the scope of a Third-Party Claim or within 10 (ten)
Business Days, whichever is shorter, provided that if the referred legal term is 5 (five) days or less, the provision shall occur
up to half of the applicable term. The Indemnified Party’s failure to provide such information, documents, materials and/or
access to Persons, including the prompt provision or at a later time, will not exempt the Indemnifying Party from the obligation
to indemnify provided for in this Agreement, except to the extent that the Indemnifying Party is impaired by such failure.

 

4.5.1.2. The
Indemnifying Party may, at any time, settle any Third-Party Claim for which it is responsible for indemnifying the Indemnified
Party hereunder, provided that the conclusion of any agreement, transaction or composition in such Third-Party Claim (i) is previously
communicated to the Indemnified Party with 10 (ten) days in advance or in the half of the legal term for its conclusion, whichever
is shorter; (ii) refers exclusively to payment in cash; and (iii) does not result in damage to the image or creates a material
adverse precedent for the Indemnified Party.

 

4.5.1.3. In
conducting the Defense of Third-Party Claims, the Indemnifying Party shall act in good faith with a view to preserving the interests
of the Parties and their Affiliates. In the event that the conduct of the Defense of Third-Party Claims may result in prejudice
to the activities of the Indemnified Party, the Indemnifying Party and the Indemnified Party shall negotiate in good faith the
best strategy to be adopted in the conduct of the Defense of the Third-Party Claim, including, but not limited to, the total or
partial settlement of the Claim.

 

4.5.1.4. The
Indemnifying Party undertakes to provide the Indemnified Party with the reports indicated in Clause 5.9.7 below in relation
to any and all Third-Party Claims that the Indemnifying Party is conducting, without prejudice to the use of the electronic system
referred to in such Clause. In addition, the Indemnified Party will have the right to appoint an attorney of its own choice to
accompany (but not control) the Defense of the Third-Party Claim, and this attorney’s fees and expenses will be borne entirely
by the Indemnified Party.

 

    22

     

    

 

4.5.1.5. Without
prejudice to the provisions set forth in Clause 4.5.1.1 above, if it is necessary to grant a guarantee or insurance within
the scope of a Third-Party Claim, the Indemnified Party, as a party of the Third-Party Claim, undertakes to obtain quotes for guarantees
and insurance offered by top-tier banks or insurance companies and to contract the guarantee or insurance at a lower price (provided
the necessary coverage is provided), providing the Indemnifying Party in a timely manner with all documents relating to such guarantee
or insurance to be submitted under the Third-Party Claim. For the avoidance of doubt, costs and expenses related to the contracting
of such a guarantee or insurance will be considered as indemnifiable losses by the Indemnifying Party to the Indemnified Party
under this Agreement.

 

4.5.2. Conduction
of Third-Party Claim by Indemnified Party. Should the Indemnifying Party (a) inform in writing, as provided in Clause 9.1
below, the Indemnified Party that it does not intend to conduct the Defense of the Third-Party Claim, or (b) reject the conduct
of the Third-Party Claim, expressly or tacitly, even if it does not recognize its obligation to indemnify, the Indemnified Party,
at its sole discretion, may assume the Defense, or the payment of the obligation purpose of the Third-Party Claim. In any event,
the Indemnifying Party shall ensure access by the Indemnified Party to information, documents or materials related to the Third-Party
Claim and its Defense, as reasonably requested by the Indemnified Party, applying, mutatis mutandi, the provisions of Clause
4.5.1.1.

 

4.5.3. Indemnification
Payment. Subject to the provisions of Clause 4.5.3.1 below, the indemnification for Losses arising from Third-Party
Claims, as provided for in this Clause 4.5, will only be due after a final and unappealable decision (not subject to appeal)
regarding the respective Third-Party Claim, and must be paid, by deposit or transfer of funds immediately available to the bank
account held by the Indemnified Party, within ten (10) Business Days as from the beginning of the quarter, following the date of
receipt of the notice sent by the Indemnified Party to the Indemnifying Party about such Losses, which shall contain the details
of the bank account of the Indemnified Party and the amount to be indemnified by the Indemnifying Party, accompanied by proof of
disbursement of the Loss (including payment slip and receipt, as applicable) and a copy of the respective final and unappealable
decision (not subject to appeal) that led to the Loss.

 

4.5.3.1. Although
pending a final and unappealable decision (not subject to appeal) in relation to a Third-Party Claim, any and all Losses actually
incurred by the Indemnified Party, including, but not limited to, costs and expenses related to the conduct of the Defense of such
Third-Party Claim, must be indemnified by the Indemnifying Party within ten (10) Business Days as from the beginning of the quarter
following the date of receipt of the notice sent by the Indemnified Party to the Indemnifying Party about such Losses, indicating
the details of its bank account and the amount to be indemnified by the Indemnifying Party, provided it is accompanied by proof
of disbursement referring to the Loss incurred (including payment slip and receipt, as applicable). Without prejudice to the term
referred to in this Clause and in Clause 4.5.3 above, the Indemnifying Party shall indemnify the Indemnified Party within
ten (10) Business Days as from the date that the indemnifiable Losses in connection with this Agreement are equivalent to an amount
equal to or above thirty million reais (R$30,000,000.00).

 

    23

     

    

 

4.5.3.2. Failure
to pay the indemnification within the period established in Clauses 4.5.3 and 4.5.3.1 above shall subject the Indemnifying
Party to the payment of the overdue amount, adjusted based on the CDI rate between the payment date and the effective payment date,
plus interest in arrears of two percent (2%), on a proportional basis.

 

4.5.3.3. The
Parties agree that the fees, costs and expenses of any advisors (including attorneys) contracted by the Parties in connection with
the conduct of the Defense of Third-Party Claim shall be billed directly to the Party which will be responsible for the payment
of such fees, costs and expenses, regardless of whether they consist of indemnifiable Losses under the Transaction Documents.

 

4.5.4. In
the event the Indemnifying Party does not agree, fully or partially, with the responsibility for any Losses in the context of any
Third-party Claim, including the value of the Losses, the Indemnifying Party shall notify the Indemnified Party with respect to
such disagreement within ten (10) Business Days as from the receipt of the notice submitted by the Indemnified Party, under the
terms of Clauses 4.5, 4.5.3 or 4.5.3.1, however the case may be, and the Parties shall meet within the next
subsequent fifteen (15) days to achieve an agreement in good faith involving the fact under discussion. The failure of the Parties
to amicably agree the responsibility for the payment of any possible Loss shall be resolved under the terms set forth in Clause
9.11 and following clauses hereof; and the award determined by the Arbitral Court shall have the power to determine the final
and indemnifiable Loss, under the terms set forth in this Agreement. The final Loss determined by the arbitration award shall be
reimbursed to the Indemnified Party, within ten (10) Business Days as from the arbitration decision determined by the Arbitral
Court, except of otherwise decided by the Arbitral Court.

 

 4.6. Cumulative Measures. The measures set out in this Clause 4 are cumulative and, subject to the provisions of Clause 4.1, shall not prevent the exercise by any Indemnified Party of other rights or measures against the Indemnifying Party.

 

    24

     

    

 

 4.7. Survival of the Indemnifications. Except for the indemnifications arising from any possible false representations provided under Clauses 3.1.1 to 3.1.5 by CBD or under Clauses 3.2.1 to 3.2.5 by Sendas, which are not subject to any limitation in terms of time, the rights and obligations of each of the Parties under Clauses 4.2 and 4.3 shall remain valid and effective for a period equivalent to the prescription period (excluding any extensions and interruptions), as set forth in applicable Law in force, of the respective Losses, and shall survive any sale or transfer, in part or in full, of the Assets Transferred to third parties, as well as any incorporation, spin-off, merger, asset dropdown or any other corporate or asset reorganization by any of the Parties.

 

 4.8. Exemption of Responsibility. Each of the Parties acknowledges and agrees that none of the Parties shall be entitled to any right to undertake any action or request any indemnification against the other Party in connection with this Agreement with respect to the mutual representations and guarantees referred to in Clauses 3.3.1, 3.3.2, 3.3.3 and 3.3.4, without prejudice to the CBD’s obligation to indemnify Sendas under Clause 4.2(vi).

 

 5. Acts of the Business Separation

 

 5.1. Business Separation. The Parties undertake to make commercially reasonable efforts for the Business Separation to be completed in the shortest possible period after the Effective Spin-off Date. Without prejudice to any other acts and measures necessary and/or convenient for Business Separation, the Parties undertake to implement all acts provided for in this Clause 5.

 

5.1.1. Transition
Committee. The Parties shall, within fifteen (15) days as of the Effective Spin-off Date, establish a Transition Committee,
composed of six (6) members, out of which three (3) members shall be appointed by CBD and three (3) members shall be appointed
by Sendas (“Transition Committee”). The Transition Committee will be responsible for coordinating any and all
activities related to Business Separation, with powers to make any and all decisions on behalf of the Parties, which do not depend
on the approval of their respective board of directors or shareholders’ meeting, except, however, that the Transition Committee
must not, under any circumstances, change the terms and conditions provided for in this Agreement.

 

5.1.1.1. Transition
Subcommittees. The Transition Committee may establish subcommittees to conduct activities related to any specific subject of
the Business Separation, which will be composed of an even number of members, with half of the members appointed by CBD and the
other half appointed by Sendas.

 

5.1.1.2. Committee’s
Meetings. The Transition Committee shall hold the first meeting within thirty (30) days from the Effective Spin-off Date to
approve the Transition Committee Regulation. The decisions of the Transition Committee (and/or any of its subcommittees) shall
be made by an absolute majority of its members.

 

    25

     

    

 

 5.2. Agreements. Without prejudice to the provisions set forth in Clause 5.2.1 below, the Parties agree to jointly negotiate and undertake commercially reasonable efforts to (i) amend, segregate and/or duplicate, as the case may be, the agreements to which CBD is a party on the Effective Spin-off Date, and that, as requested by Sendas, shall be amended, segregated and/or duplicated on behalf of Sendas, including, but not limited to, those listed in the Appendix 3.1.9, so that, after being amended, segregated and/or duplicated, such agreements bind, on the one hand, individually CBD or Sendas and, on the other hand, the respective counterpart, without interdependence between those agreements and the Parties; and (ii) assign the contractual position from CBD to Sendas or from Sendas to CBD, however the case may be, in relation to such agreements, in the sense that solely one of the Parties becomes a party to such agreements. Any and all costs and expenses directly arising from the amendment, segregation, duplication or assignment of such agreements, including the Shared Agreements, however the case may be, in relation to the Business Separation, shall be proportionally allocated to the benefit of the Parties subject to the respective agreement, except for (i) any indirect costs and expenses shall be assumed by the Party that incurred such costs and expenses; (ii) the Party responsible for the application of any fine and/or collection of any charges by the counterparty shall exclusively perform the payment of the respective amounts; and (iii) the Party responsible for the termination, or that intends to terminate, fully or partially, any agreement, shall be exclusively responsible for the payment of the costs, expenses and any amounts relating to the respective termination.

 

5.2.1. Shared
Agreements. Except as otherwise expressly provided in this or the other Transaction Documents, the agreements listed in Appendix
5.2.1 will be considered as “Shared Agreements”, as well as (i) any agreement or arrangement in which CBD
and/or its Subsidiaries and Sendas and/or its Subsidiaries are active or passive parties, jointly, as main parties, or otherwise,
or for which they may have any residual responsibility by agreement or formalized acknowledgment, and/or (ii) any agreement or
arrangement entered into by CBD prior to the Effective Spin-off Date, that is related to any Sendas’ business or business
unit (“Sendas Business Unit”), whose purpose and performance is not exclusively for the benefit of the Sendas
Business Unit; and/or (iii) any agreement or accord entered into by Sendas before the Effective Spin-off Date, which is related
to any Compre Bem’s business unit or business; provided that such agreement or accord under (i), (ii) or (iii) cannot be
separated and/or individualized on behalf of the Parties or the respective Subsidiaries thereof, or which segregation or individualization
could be significantly expensive, as set forth in Clause 5.2(iii).

 

5.2.1.1. The
rights and obligations under each Shared Agreement shall be allocated, by means of a written instrument between the Parties, in
the relevant party to CBD or Sendas, or to the respective Subsidiaries indicated by CBD or Sendas, without prejudice to any amendment
or addendum to the Shared Agreement itself during its term, so that each Party will be entitled to the rights and benefits, and
will assume the respective portion of any Liability, inherent to its respective business; provided that:

 

    26

     

    

 

		(A)	in no event will any Party be required to assign (or
amend) any Shared Agreement in its entirety or to assign a portion of any Shared Agreement that is not assignable (or which cannot
be changed) under its terms (including any terms that impose consents or conditions on an assignment, when such consents or conditions
cannot be obtained or fulfilled); and

 

		(B)	if any Shared Agreement cannot be partially assigned
by its terms or cannot be changed, if such an assignment or amendment unduly damages or encumbers the benefit that the Parties
derive from such Shared Agreement or if such Shared Agreement is listed or described in Appendix 5.2.1, then the Parties
shall, and shall cause their subsidiaries, to take other reasonable and legally effective actions and measures (including sending
notice to the other Party regarding any Claim or other relevant matters related to any Shared Agreement, in order to allow the
other Party to exercise any applicable rights under the law and the relevant Shared Agreement) to ensure that CBD or Sendas, as
the case may be, receives the rights and benefits of the Shared Agreement that relates to its respective business, as if such
Shared Agreement had been assigned (or changed), and bear the burden of the corresponding Liabilities, as if such Liabilities
had been assumed if the expected assignment or amendment had occurred due to Business Separation.

 

5.2.1.2. The
Parties shall comply, and the Transition Committee shall define and manage the action plan relating to the negotiation with third
parties to separate each one of the Shared Agreements.

 

5.2.1.3. CBD
and Sendas and the respective Subsidiaries thereof shall provide the same accounting and tax treatment to a Shared Agreement, in
accordance with applicable Laws and regulations, in line with the treatment previously adopted by the Parties, and undertake not
to report or take any tax position inconsistent with such treatment, except by legal imposition or change of interpretation of
the applicable Law, which shall be immediately communicated to the other Party.

 

5.2.2. Mitigation
of Adverse Effects. Each of the Parties undertakes to make commercially reasonable efforts to mitigate any and all adverse
effects on the other Party, its Affiliates and/or their respective businesses, as a result of negotiations for the conclusion or
renewal of agreements and arrangements with third parties within the scope of, or during, the Business Separation. Sendas undertakes
to make commercially reasonable efforts, and CBD undertakes to cooperate with Sendas, to negotiate new agreements for Sendas, either
with the counterparties of the Shared Agreements, or with other possible suppliers, if any, relating to services, products and/or
benefits under any Shared Agreement, so that the Parties terminate, in the shortest possible period, the existing relationships
between them under the Shared Agreements, as set forth in Clause 5.2.

 

    27

     

    

 

5.2.3. Sharing
Agreement. The material and human resources shared between the Parties, under the Private Instrument of Expenses Sharing Agreement,
signed between the Parties, Via Varejo S.A. and CNova Comércio Eletrônico S.A. on December 15, 2016, as amended and
in force (“Sharing Agreement”), shall be segregated and individualized within one (1) year, at most, as from the Effective
Spin-off Date, and the Transition Committee may create a specific subcommittee to conduct the activities necessary for the termination,
in the shortest possible period, of the relationship established between the Parties under said Sharing Agreement.

 

5.2.3.1. Back
Office. The Transition Committee shall coordinate, and the Parties shall practice, all necessary acts to segregate the teams,
processes and systems of human resources, personnel department and other administrative activities currently conducted together,
including, but not limited to, payroll processing management and service to subcontractors, provided that the accesses of the members
of each team shall be individualized within one (1) year as from the Effective Spin-off Date. Until the completion of the segregation
provided for in this Clause, Sendas shall reimburse CBD, and CBD shall reimburse Sendas, however the case may be, for any and all
costs and expenses related to the shared activities, maintaining the sharing rules currently practiced by the Parties.

 

5.2.3.2. The
Parties shall comply, and the Transition Committee shall define and manage the action plan, including estimated costs and work
schedule, for separation of the activities in connection with the Sharing Agreement.

 

5.2.4. Information
Technology and Systems. Without prejudice to the segregation of the relevant agreements, according to this Clause 5.2,
any and all software and computerized systems, as well as the databases of suppliers, employees and service providers, shared by
the Parties and/or the respective Subsidiaries thereof, shall be segregated as soon as possible and, in any event, within one (1)
year as from the Effective Spin-off Date. Sendas shall use its best efforts, and CBD commits to cooperate with Sendas, to carry
out in the shortest possible period any database migration between the Parties, as well as the creation or adaptation of any computerized
environment, systems or servers by Sendas, as set forth in Clause 5.2.

 

 5.3. Release of Guarantees. The Party that has any of its obligations or liabilities, or the obligations and liabilities of its Affiliates (“Secured Party”), guaranteed in any way (whether financial guarantees or otherwise) by the other Party and/or by any of its respective Affiliates (a “Guarantor”), undertakes, with the reasonable cooperation of the Guarantor, to make commercially reasonable efforts to release, replace and/or in any way remove the Guarantor from the position of guarantor, warrantor, joint obligor, joint or several debtor (“Guarantee”) in relation to any Liability of the Secured Party, including the removal of any Burden on any Guarantor’s goods and/or assets that may serve as the Guarantee of any Liability of the Secured Party, within six (6) months as from the Effective Spin-off Date, as set forth in Clause 5.3.2.

 

    28

     

    

 

5.3.1. To
the extent necessary to release a Guarantee, CBD or Sendas, as a Secured Party and/or Controlling Company of the Secured Party,
undertakes to enter into a guarantee covering the existing Guarantee, or otherwise acceptable to the Parties and creditors, whose
agreement shall include the removal of any Guarantee provided by the Guarantor and/or any Burden on a Guarantor’s asset that
may serve as a Guarantee for any Liability of the Secured Party, except and to the extent that such existing Guarantee contains
representations, agreements or other terms or provisions with which CBD or Sendas, as the case may be, would be unable to comply
or endure.

 

5.3.2. In
the event CBD or Sendas, justifiably, is not able to obtain, or ensure the obtaining of any removal or release of the Guarantee,
as set forth in Clauses 5.3 and 5.3.1, within the period defined in Clause 5.3, the Secured Party shall (i)
monthly pay to the Guarantor, as from the sixth (6th) month after the Effective Spin-off Date, on the 15th (fifteenth)
Business Day of each falling due month (the first payment falling due on the eighth (8th) month after the Effective Spin-off Date
relating to the immediately previous month), as compensation for the Guarantee, the amount equivalent to the lowest commercial
proposal received from, at least, three (3) first class banks and/or insurance companies, applied on a monthly basis to the outstanding
balance of the Guarantees not replaced or released (“Fee”) and, in the event the Guarantee remains in effect after
eighteen (18) months as from the Effective Spin-off Date, the Fee shall be increased by twenty percent (20%); (ii) indemnify, defend
and hold the Guarantor harmless against or from any Liability arising from or related to such Guarantee, and shall, as agent or
subcontractor of the Guarantor, fully comply with all Guarantor’s obligations or other Liabilities under the respective Guarantee;
and (iii) refrain from renewing or extending the term or scope of any Liabilities, of any nature, whether in the form of a loan,
guarantee, lease, agreement or other obligation, for which Guarantor is or may be responsible, unless that Guarantor is finally
and completely released from all its obligations as a result of and /or in connection with the respective Guarantee.

 

5.3.2.1. For
purposes of determination and calculation of the Fee, (a) the Parties shall agree within ten (10) days as from the beginning of
each month, the balance of the Guarantees, based on which the Fee payable shall be calculated, by comparing the values of the Guarantees
of one Party in relation to the other, in the sense that the Party holding the highest value of the secured obligations shall pay
the Fee to the other Party; (b) CBD shall be responsible for obtaining the quotations from three (3) first class banks and/or insurance
companies, for a guarantee of one (1) year, taking into account the subject matter of the Guarantees (e.g., real estate guarantee)
and the existing balance of the Guarantees; provided that the first quotations are obtained at the end of the period of six (6)
months as from the Effective Spin-off Date, subject to renewal each twelve (12) months, based on the existing Guarantees at the
end of the month before the obtaining of the quotations; (c) CBD shall submit to Sendas, within ten (10) Business Days as from
the beginning of each month, the calculation statement of the Fee; and (d) CBD shall submit to Sendas and, however the case may
be, copies of the quotations obtained. For clarification purposes, Appendix 5.3.2.1 includes a flowchart of the system referred
to in this Clause 5.3.2.

 

    29

     

    

 

5.3.3.
In the event that Guarantor is required to make any payment and/or disbursement as a result of a Guarantee, or, if a Guarantee
is executed, the Secured Party shall reimburse Guarantor for the Losses incurred in connection with the Guarantee provided by it,
within 48 (forty-eight) hours from the receipt of notice sent by Guarantor to the Secured Party (and to CBD or Sendas, as Controlling
Company of the Secured Party, pursuant to Clause 9.1 below), indicating the total amount of Losses, accompanied by proof
of payment and the assignment or endorsement of the securities and rights to which Guarantor has been subrogated.

 

 5.4. Insurance. CBD and Sendas shall jointly notify all insurance companies that have issued insurance policies whose coverage covers both Sendas and/or its assets, business and employees, and CBD and/or its other Affiliates and respective assets, business and employees, as listed in Appendix 5.4 (“Existing Insurance”), about the Business Separation, in order to provide insurance coverage in a market standard for Sendas and/or its assets, business and employees, including civil liability insurance for CBD officers who, as a result of the Business Separation, will take on management positions at Sendas, with coverage of events related to Business Separation (D&O runoff) (“Standard Market Insurance Package”). In the event the Existing Insurance is not extended or, for any reason, does not cover a Standard Market Insurance Package for Sendas, Sendas shall contract the necessary insurance so that, under any circumstance, the Standard Market Insurance Package is fully effective as from the Effective Spin-off Date to cover Sendas. CBD shall support Sendas with respect to the insurance coverage contracted by CBD and that are not applicable to Sendas; however, under no circumstance, CBD shall have any responsibility or obligation of any nature before Sendas in the event that any insurance policy is no longer contracted, loses effectiveness or is not paid, for any reason, after the Effective Spin-off Date; CBD’s cooperation for the renewal or extension of Existing Insurance does not represent any CBD’s commitment to ensure insurance coverage for Sendas, its assets, employees, managers, suppliers or business of any nature.

 

5.4.1. If
Existing Insurance, or a portion of them, is extended to Sendas, each Party shall be responsible, on a proportional basis, for
any costs and expenses relating to the Existing Insurance, including the extension premium.

 

    30

     

    

 

5.4.2. Except
to the extent that the Existing Insurance policies are extended or renewed according to Clause 5.4 above, as of the Effective
Spin-off Date, Sendas will have no rights under CBD or its Affiliates insurance policies. In the event the Existing Insurance policies
are extended, Sendas will appear as insured until the original policy term expires, and the new policies shall be contracted individually
without any link between CBD and Sendas.

 

5.4.3. As
of the Effective Spin-off Date, in relation to any Liabilities or Losses incurred by Sendas under the Existing Insurance, Sendas
shall undertake the necessary measures for submission, and CBD shall cooperate with Sendas in this regard, of claims that could
be covered by the Existing Insurance, in the sense that CBD shall transfer to Sendas eventual indemnities with respect to such
claims within fifteen (15) days after the receipt of the respective values; provided that such cooperation will be subject
to the terms and conditions of such insurance policies, including any limits of coverage or scope, any deductibles, and other fees
and expenses, and will be subject to the following additional conditions:

 

		(A)	Sendas shall indemnify, hold CDB harmless from and
refund CBD for any deductibles, fees, costs and expenses incurred by CBD in connection with any claims made by CBD under Existing
Insurance on behalf of Sendas, including any indemnification payments, agreements, judgments, legal fees and claim expenses; and

 

		(B)	Sendas shall bear exclusively (and CBD will have no
obligation to repay Sendas) and will be responsible for all uninsured, overdraft, unavailable or uncollectible amounts under the
respective policies.

 

5.4.4. All
payments and reimbursements by Sendas under this Clause 5.4 shall be made within fifteen (15) days after receipt by Sendas
of a notice from CBD on this subject. If CBD incurs costs to enforce Sendas’ obligations contained herein, Sendas agrees
to reimburse CBD for such execution costs, including attorney’s fees.

 

5.4.5. With
respect to Existing Insurance, CBD will retain the exclusive right to control its insurance policies and programs, including the
right to settle, release, repurchase or otherwise resolve disputes regarding any of its insurance policies and programs and to
change, modify or waive any right under such insurance policies and programs, regardless of whether such policies or programs apply
to any Sendas’ Liabilities or claims that Sendas has made or could make in the future, except for the fact that CBD shall
consult Sendas before the performance of any of these acts that could directly or indirectly impact Sendas. Each of the Parties
shall cooperate with each other and share such information, as reasonably deemed necessary, so that the other Party is able to
manage and conduct the insurance issues.

 

    31

     

    

 

5.4.6. Sendas
expressly acknowledges and agrees that CBD will have no obligation or responsibility towards Sendas as a result of insurance policies
and practices of CBD and its Affiliates in force at any moment, including as a result of any insurance coverage, the credit quality
of any insurance company, the terms and conditions of any policy or the suitability or timing of any notice to any insurance company
with respect to any claim or potential claim or otherwise.

 

 5.5. Labor Matters.

 

5.5.1. Unions
and Associations. Bearing in mind that the negotiation before employer and employee unions and associations of the Parties
is currently carried out by CBD, the Parties shall undertake commercially reasonable efforts to conduct individual negotiations
before such unions and associations, as applicable, so that Sendas is able to conduct such negotiations on Sendas’ own behalf
and independently from CBD within one (1) year, at most, as from the Effective Spin-off Date. Until Sendas is able to conduct such
negotiations on Sendas’ own behalf and independently, the negotiations of the labor collection agreement shall be conducted
by associates of both Parties, taking into consideration the maximum term of one (1) year as from the Effective Spin-off Date for
separation, and the Transition Committee shall establish a specific subcommittee to conduct activities related to the segregation
of the negotiation before employee unions, with the purpose of mitigating potential adverse effects resulting from this segregation
for the Parties.

 

5.5.2. Incentive
Plans. The Parties undertake, until the Effective Spin-off Date, to (i) amend the agreements (and applicable programs, as the
case may be) currently in effect, relating to the Share Call Option Plan and the CBD Shares Call Option Remuneration Plan, so that
the current beneficiaries of the respective programs, including beneficiaries who take and will take positions in Sendas after
CBD Partial Spin Off, will have right, within the scope of the respective agreements, to exercise the options and receive shares
issued by both Parties, according to the premises contained in Appendix 5.5.2(i); (ii) create and undertake the necessary
measures to approve Sendas’ new stock option plans and compensation under stock option plans, including respective programs,
under terms that are substantially similar to the terms and conditions of such CBD’s plans; and (iii) enter into the Employee’s
Transfer Agreement to govern, among other aspects, the allocation of costs and expenses relating to the performance of such share-based
compensation plans, in the form of the draft included in Appendix 5.5.2(iii).

 

 5.6. Real Estate Matters. Without prejudice to the corporate acts relating to the contribution of CBD’s Real Estate to Sendas, the Parties undertake to sign any and all documents, including public deeds, and to take any and all measures, including the rectification of corporate documents, which are necessary for the transfer from CBD’s Real Estate to Sendas, upon reasonable request from the other Party.

 

    32

     

    

 

5.6.1. Sublease
and Assignment. The real estate leased by any Party and/or its Affiliates, which include areas taken by the other Party, including
the real estates described in Appendix 5.6.1, shall be subject to contractual assignment or sublease, however the case may
be, by the tenant to the other Party and/or its Affiliates, with remuneration compatible with the rent amount due under the respective
lease agreement vis-à-vis the proportion of the area taken (or used, with common areas) by the Parties and their
respective Affiliates. In any event, lease agreements that benefit both Parties shall be considered Shared Agreements, being applicable,
mutatis mutandi, the provisions of Clause 5.2 above.

 

5.6.1.1 The real estate referred
in Appendix 5.6.1.1, which will be subject to own contracts to be signed by the Parties, will be governed solely by the rules established
in such contracts, not applying the provisions of this Agreement.

 

5.6.2. Combo
Stores. In relation to the stores identified in Appendix 5.6.2, the Parties agree to enter into, through September 30,
2021, instruments in writing to govern the shared use of these real estates.

 

5.6.3. Galleries.
Sendas and Fronteira Serviços Imobiliários Ltda., limited-liability company, Controlled by CBD and enrolled with
CNPJ under no 34.309.019/0001-36 (“Fronteira”), shall enter into, and CBD shall ensure Fronteira to enter
into, through the Effective Spin-off Date, a gallery management agreement, which shall govern the provision of real estate services
by Fronteira to Sendas, mainly in the form of the draft included in Appendix 5.6.3. CBD shall assign to Sendas its contractual
position in connection with any and all sublease agreements relating to real estates of which Sendas is the lessor, in which case
both Parties shall negotiate with the respective sublessees and undertake commercially reasonable efforts to perform such assignment
in the shortest time possible.

 

 

5.6.4. Real
Estate Regularization. The real estate regularization (such as, registry of ownership and obtaining of licenses, authorizations
and permits) and the implementation of eventually necessary refurbishments, including costs and expenses, in relation to the CBD’s
Real Estates and Dom Pedro Real Estate, shall be under Sendas’ exclusive responsibility, except for the environmental Liabilities
under CBD’s responsibility, as set forth in Clause 4.2(v). The Parties agree to undertake commercially reasonable
efforts and contribute between each other to obtain any regularization, licensing and refurbishment in real estates, as reasonably
requested, as set forth in this Clause.

 

5.6.4.1. The
Parties agree that the eventual real estate regularization or refurbishment deemed necessary to the operation of the Parties and
its Affiliates in the real estates identified in Appendix 5.6.4.1 shall be exclusively under the CBD’s responsibility,
provided that, however (i) the costs and expenses relating to the areas used by Sendas shall be assumed by Sendas, except as set
forth in the respective agreements that have been or shall be entered into between the Parties; and (ii) CBD shall present to Sendas
three (3) budgets for the contracting of advisors and/or performance of works, previously to the respective contracting or performance;
and Sendas shall be entitled to the right to select for contracting any of the budgets presented or, alternatively, present a fourth
(4th) budget covering the same scope of services.

 

    33

     

    

 

5.6.5. Dom
Pedro Real Estate. Sendas shall expressly assumes, and agrees to undertake any necessary measures to comply with all obligations
and responsibilities attributed to any of the Parties, including past events, in the context of Public Civil Action 0053712-05.2010.8.26.0114,
before the 1st Public Treasury of Campinas (Plaintiff: Public Prosecution Office of the State of São Paulo/Defendant: Companhia
Brasileira de Distribuição and Municipality of Campinas), as well as the agreements entered into or to be entered
into with any Governmental Authorities in relation to Dom Pedro Real Estate in connection with such Public Civil Action 0053712-05.2010.8.26.0114
(in relation to the agreements that may be entered into, Sendas shall agree with the respective terms set forth therein before
signature thereof), including, but not limited to, the Policy Adjustment Commitments (TACs) entered into with the Public Prosecution
Office of the State of São Paulo and the Municipality of Campinas. In addition, Sendas shall protect, to the extent permitted
by applicable Law in force, and hold CBD harmless from any responsibilities relating to Dom Pedro Real Estate, except for any environmental
Liabilities, which triggering event has taken place before February 28, 2019 (inclusive), under CBD’s exclusive responsibility.

 

5.6.6. Gas
Stations. The Parties agree that, on the Effective Spin-off Date, Sendas shall transfer the tangible and intangible assets
related to the Gas Stations, as set forth in Clauses 2.2(ii) and 2.3(iii), and shall discontinue the activities developed
in the Gas Stations, which may be conducted by CBD or any company Controlled by CBD, at CBD’s exclusive discretion, upon
obtaining of all licenses and authorizations deemed necessary to operate the Gas Stations, under CBD’s own brand or under
the brand of any CBD’s Subsidiary.

 

5.6.6.1. The
agreements that remain effective between the Parties after the Effective Spin-off Date, in relation to the operation of any gas
station (including the Gas Stations) under the “Assaí” brand or any other brands exclusively owned by Sendas,
shall be amended or terminated, however the case may be, to reflect the discontinued use by CBD of the “Assaí”
brand and any other brands exclusively owned by Sendas.

 

5.6.6.2. The
Parties agree that any and all gas stations operated by CBD, under the “Assaí” brand, shall operate, after six
(6) months counted from the Effective Spin-off Date, under independent brands owned by the fuel suppliers.

 

 5.7. Passive Claims. Subject to the provisions of Clause 5.9 below, at any moment after the Effective Spin-off Date, if a Party receives notice, subpoena or otherwise becomes aware of any preparatory act, injunctions or filing of a Third-Party Claim that may result in Losses for both Parties and/or respective Subsidiaries thereof, which are not fully indemnified by one Party to the other Party (“Shared Third-Party Claim”), such Party shall notify the other Party in writing within 1/3 (one third) of the legal period for presentation of Defense against said Shared Third-Party Claim or within 10 (ten) Business Days, whichever is shorter, and if the legal term for Defense is 5 (five) days or less, the notice referred herein will be given until the half of the legal term for Defense, and shall describe the Shared Third-Party Claim in reasonable detail, including, but not limited to (i) the amount of the Shared Third-Party Claim, if any, (ii) the facts and circumstances that resulted in the Shared Third-Party Claim, and (iii) the full copy of the subpoena, notification, notice or summons related to the Shared Third-Party Claim. Notwithstanding the foregoing, the failure of any Party to provide notice under this Clause will not prejudice the rights of such Party under this Agreement and/or under the Shared Third-Party Claim, except to the extent that the Party that should receive the communication and/or conduct of the Defense of the Shared Third-Party Claim has been impaired by the failure to provide notice under this Clause.

 

    34

     

    

 

 5.8. Active Claims. Each Party undertakes to cooperate with, and make commercially reasonable efforts to assist, the other Party in conducting any Claim filed by such Party and/or its Subsidiaries prior to the Effective Spin-off Date and/or in conducting any Claim based on facts, acts, agreements and/or legal relationships, prior to the Effective Spin-off Date, involving both Parties and/or their Affiliates, in any event, against any third parties, including, but not limited to, Governmental Authorities, but provided that they are not related parties of one of the Parties (“Active Claim”). If the Parties and/or their Affiliates have common interests in an Active Claim (“Shared Active Claim”), the Parties shall comply with the provisions set forth in Clause 5.9 below, including the Shared Active Claims referred to in Appendix 5.8.

 

5.9. Conduction
of Shared Claims.

 

5.9.1. Control
of Shared Claim.  The Parties shall establish which Party has the greatest financial interest in the Shared Claim
and such Party shall be responsible for controlling the Active Claim or Defense strategy of the Shared Third-Party Claim, as the
case may be. If the Parties define that the shared conduct is in the best interest of the Parties, the strategies will be equally
shared, and in the event of disagreement, the strategy of the Party that has the largest monetary amount at risk in the Shared
Third-Party Claim or the largest potential pecuniary benefit arising from the Active Claim shall prevail.

 

5.9.2. Defense
Costs Allocation.  The Party responsible for conducting the Shared Claim will be solely responsible for all costs and
expenses incurred in connection with such Shared Claim and will only be entitled to reimbursement from the other Party for the
costs and expenses that are incurred during the Shared Claim course in proportion to the Losses or economic benefits, as the case
may be, attributable to that other Party. If there is a decision to share the conduction of the Shared Claim, each Party will be
solely responsible for the costs of its own attorneys.

 

    35

     

    

 

5.9.3. Right
to Monitor and Participate. A Party that does not conduct any Shared Claim (or does not control the Defense, if
applicable) will be entitled to appoint an attorney of its own choice to monitor (but not to control) such Shared Claim, and attorney’s
fees and expenses will be borne by such Party, who shall make commercially reasonable efforts to cooperate with the Party that
conducts the Shared Claim, including, but not limited to, making available to that Party all the witnesses, information and materials
in its possession, except if there are real or potential conflicts of interest between the Parties that render joint representation
inadequate.

 

5.9.4. Impossibility
of Transacting Rights. The Party that conducts the Shared Claim shall not transact or compromise rights without
the prior and express consent of the other Party, unless the respective agreement (i) is communicated to the other Party 10 (ten)
days in advance or half of the legal term for its execution, whichever is shorter; (ii) refers exclusively to payment in cash;
(iii) does not result in damage to the image or create a material adverse precedent to the other Party; and (iv) in the case of
Shared Third-Party Claim, provides for full discharge with the total, unconditional and irrevocable release of the other Party
from all responsibility in connection with the respective Shared Third-Party Claim, or, in the case of an Active Claim, ensures
to the other Party, at least, the economic benefit intended by it with the respective Active Claim.

 

5.9.5. Provision
of Information and Documents. Each Party undertakes to (i) provide the other Party and its Affiliates with any and all
information, documents, materials and/or access to Persons, which are in its possession and/or under its control or authority,
as reasonably requested, including, but not limited to, the granting of mandates, in physical or electronic form, as well as (ii)
make commercially reasonable efforts to meet the other requests of the other Party, in any event, to enable the conduction of any
Shared Claim, according to this Clause 5.9. Information, documents, materials and/or access to Persons, which are in possession
and/or under the control of one of the Parties and/or its Affiliates, shall be provided within the term equivalent to 1/3 (one
third) of the legal period for submission of such information and/or document within the scope of a Shared Claim or within 10 (ten)
Business Days, whichever is shorter, provided that, if the referred term is 5 (five) days or less, the provision shall occur up
to half of the applicable term. The failure of one of the Parties to provide such information, documents, materials and/or access
to Persons, including untimely provision or at a later time, will not in any way prejudice that Party’s rights in relation
to such Shared Claim, except to the extent that such failure impairs the conduction of the Shared Claim and/or results in Losses
for the other Party.

 

    36

     

    

 

5.9.6. Legal
Guarantees. Without prejudice to the provisions set forth in Clause 5.9.5 above, if it is necessary to present a guarantee
or insurance under a Shared Claim, the Party (or its Subsidiary) that appears as a party of the Shared Claim must obtain quotes
for guarantees and insurance offered by top-tier banks or insurance companies and contract the lowest price guarantee or insurance
(provided the necessary coverage is provided), providing the Party conducting such Shared Claim, as the case may be, in a timely
manner, with all documents relating to such guarantee or insurance to be presented under the Shared Claim.

 

5.9.7. Reports. The
Party conducting a Shared Claim shall provide the other Party (i) with a quarterly report, in writing, to be delivered by the last
day of each quarter (i.e., March 31, June 30, September 30 and December 31 each year), detailing the Shared Claims, including,
but not limited to, the progress and other information reasonably required by the Parties; (ii) a monthly report, to be delivered
on the 1st(first) Business Day of each month, with the indication of the amounts involved in each Shared Claim whose
risk assessment requires the establishment of an accounting provision; and (iii) a monthly report, to be delivered by the 4th
(fourth) Business Day of each month, with the indication of the amounts involved in each Shared Claim that does not require the
establishment of an accounting provision. In addition, through the Transition Committee (or a subcommittee created by the Transition
Committee) a reasonably acceptable procedure will be established for automatic submission of reports and electronic notices to
feed a dispute management system when any Shared Claim is filed, procedurally evolves or is terminated.

 

5.9.8. Payment
of Reimbursements or Indemnifications. The Party that has borne Losses resulting from Shared Claims that should
be, totally or partially, under any Transaction Document or applicable Law, supported by the other Party and/or its Subsidiaries,
shall send notice to this other Party, indicating the details of its bank account and the amount to be reimbursed or indemnified,
accompanied by proof of the effective disbursement of the Loss (including payment slip and receipt, as applicable) and copy of
the respective final and unappealable decision (not subject to appeal) that gave rise to the Loss, if applicable, and the other
Party shall make the payment of the reimbursement or indemnification, by depositing or transferring funds immediately available
to the bank account indicated in the notice, (i) within ten (10) Business Days as from the beginning of the quarter after the receipt
date of the respective notice or (ii) within ten (10) Business Days as from the date such Losses are equivalent to or above thirty
million reais (R$30,000,000.00), whichever takes place firstly.

 

5.9.9. Onlending
of Economic Benefits. The Party that receives any amounts or obtains any economic benefits (including, but not
limited to, the recovery of Losses already indemnified or reimbursed by the other Party, under this Agreement, and the Use of Tax
Supervenience) that, totally or partially, are attributable or should be paid to the other Party and/or its Subsidiaries, shall
transfer to the other Party the due amount, as well as provide to the other Party all and any calculations and assumptions relating
to the transferred amounts, (i) within ten (10) Business Days as from the beginning of the quarter after the receipt date of the
respective amounts or (ii) within ten (10) Business Days as from the date such amounts are equivalent to or above thirty million
reais (R$30,000,000.00), whichever takes place firstly.

 

    37

     

    

 

5.9.10. Advisors
Fees. The Parties agree that the fees, costs and expenses of any advisors (including attorneys) contracted by the Parties in
connection with the conduction of the Shared Claims shall be billed directly to the Party that will be responsible for the payment
of such fees, costs and expenses, regardless of whether they consist of Indemnifiable Losses under the Transaction Documents.

 

5.9.11. Court
Deposits. The Parties agree that all and any amounts relating to the court deposits referred to in Appendix 5.9.11 shall
be exclusively allocated to CBD, although such court deposits have been performed on behalf of Sendas, provided that (i) in the
event such deposits are provided, at any time, Sendas shall transfer such amounts to CBD in conformity with the provisions set
forth in Clause 5.9.9, or (ii) in the event such deposits are, fully or partially, used in the settlement of any Losses
in connection with any Claim, the amounts relating to such deposits shall be (a) used to pay the indemnification payable by CBD
to Sendas in connection with this Agreement, however the case may be, in relation to the Losses in connection with such Claim;
and/or (b) reimbursed to CBD by Sendas, in accordance with the amount allocated to the Claim, in the event the Losses in connection
with such Claim are not indemnified by CBD to Sendas, as set forth in Clause 5.9.9.

 

5.9.12. Tax
Credits. In the event that any of the Parties conducts a Claim for ratification of credits against tax Governmental Authorities
(“Tax Active Superveniences”), including due to the overpayment of Taxes or statement of rights that implies
the return of financial amounts to the Parties, for the benefit, totally or partially, of the other Party and/or its Affiliates,
such Party shall conduct the Claim in good faith and in the best interest of both Parties, proceeding to offset or refund the amount
administratively ratified, according to the chronology order of the Tax Active Superveniences (i.e., first offsetting the oldest
Tax Active Superveniences) (“Use of Tax Supervenience”) in the shortest possible period. Once the economic benefit
of the Tax Active Supervenience has been obtained through the Use of the Tax Supervenience, the Party directly benefited shall
pass on the amount of the economic benefit attributable to the other Party within ten (10) Business Days as from the beginning
of the quarter after the Use of Tax Supervenience, as set forth in Clause 5.9.9.

 

5.9.12.1. If
the Use of Tax Supervenience is subsequently rejected by the competent tax Governmental Authority, the Parties shall make commercially
reasonable efforts to defend the maintenance of such Use of Tax Supervenience, and the Party with the greatest economic benefit
involved in this Use of Tax Supervenience being entitled to conduct the respective defense, subject, as applicable, to the provisions
of Clause 5.9.1. If there is a final and unappealable decision confirming the rejection of the Use of Tax Supervenience,
the Parties will be responsible for the payment of the debt and other costs, expenses, penalties, arrears and other monetary amounts
that may be charged by the tax Governmental Authority as a result of such tax rejection, in proportion to the economic benefit
enjoyed by each Party in connection with the respective Use of the Tax Supervenience. In the event that the refusal of the Use
of Tax Supervenience arises from the exclusive fault of one of the Parties, this Party will be the sole and exclusive responsible
for the payment of the debt and other charges resulting from such refusal, even though both Parties have benefited from the Use
of the Tax Supervenience.

 

    38

     

    

 

5.9.12.2. The
Parties expressly agree that any Tax Active Superveniences relating to all Multi Retail activities, which triggering event is dated
before the Multi Retail Business Spin-off Date (including), shall belong exclusively to CBD and, in the event of Use of the Tax
Supervenience by Sendas in relation to such Tax Active Superveniences, Sendas shall fully transfer to CBD the respective economic
benefit arising from such Use of the Tax Supervenience, in conformity with the provisions set forth in Clauses 5.9.12 and
5.9.12.1.

 

5.9.12.3. The
Parties agree to undertake reasonably commercial efforts so that the Use of the Tax Supervenience takes place in the shortest period
and in conformity with the chronological order of the Tax Active Superveniences, although to the exclusive benefit of the other
Party and/or its Subsidiaries. The Party responsible for the Claim relating to any Tax Active Supervenience, which may partially
or fully benefit the other Party and/or its Subsidiaries, shall provide to such other Party, whenever reasonably requested in advance,
a report on the progress and current position of the Claim.

 

 5.10. Related-party Transactions. Without prejudice to the other provisions set forth in this Agreement, the Parties shall undertake commercially reasonable efforts to jointly review, negotiate, amend, terminate and/or promote the novation in good faith of all accords and agreements that remain effective between the Parties (and/or its respective Subsidiaries) after the Effective Spin-off Date, in order to align the existing relationship between the Parties with the respective related-party transaction policies and other rules in connection with these transactions, in the shortest time possible.

 

5.10.1. The
Parties agree to, within six (6) months as from the Effective Spin-off Date, contract the guarantees under market terms and conditions
with first class insurance companies, with respect to any real estate leased or subleased by any Party and/or respective Subsidiaries
to the other Party and/or respective Subsidiaries, with a coverage term of twelve (12) months, renewable for equal periods, over
the respective agreement. The delay or lack of fulfilling of the obligation of contracting guarantees, in accordance with this
Clause, shall create an obligation for the defaulting Party to pay a penalty to the other Party in the equivalent of three (3)
months rental which is due under the relevant lease or sublease agreement, whichever the case may be; the monthly rental will be
based in the previous month rental, which shall be multiplied by the number of months delayed, having the non-defaulting Party
the right to terminate the relevant lease or sublease agreement and/or be indemnified for all losses and damages which may have
occurred due to the lack of fulfillment of such obligation.

 

    39

     

    

 

 5.11. Financial Statements. In order to comply with the obligations before CVM, SEC, B3 and NYSE, the Parties shall cooperate with the exchange of information for purposes of preparation and disclosure of the financial statements. The Transition Committee shall implement a supporting committee (“Disclosure Subcommittee”), which shall be responsible for the review and approval of information, representations, statements, declarations, instruments and other accounting and/or financial statements and documents, including reports and forms, which shall be disclosed by the Parties or registered or filed with CVM or SEC, which contents shall reflect, although partially, the Business Separation and/or the business, transactions and accounting of the other Party, in the sense that the Disclosure Subcommittee shall ensure the consistency of such information or documents with similar information and documents previously disclosed by the Parties. All disclosures to be performed by any of the Parties under this Clause shall be submitted to the Disclosure Subcommittee within reasonable advance to ensure the proper review of the respective information or documents by the Disclosure Subcommittee. Except if determined by the applicable Law in force, none of the Parties shall disclose any accounting or financial information that may conflict, totally or partially, with any information or document previously disclosed by the other Party, except if such disclosure has been previously approved by the Disclosure Subcommittee.

 

5.11.1. The
Parties shall fully cooperate and undertake commercially reasonable efforts to ensure that the Parties’ auditors cooperate,
as necessary, with the preparation of any and all statements and financial and/or accounting statements, including reports and
forms, under the applicable Law in force, including those that shall be filed with CVM, SEC, B3 or NYSE (“Mandatory Disclosure”).
Without prejudice to the provisions set forth in Clause 7.3 below, each of the Parties shall provide to the other Party
any information that has been reasonably requested in connection with the Mandatory Disclosure, on a timely basis, in order to
ensure that the other Party shall be able to prepare and disclose any Mandatory Disclosure within the term set forth in the applicable
Law in force.

 

 5.12. Bellamar’s Shareholders’ Agreement. As of the date hereof, the Parties entered into the Bellamar’s shareholders’ agreement, as set forth in Appendix 5.12, in order to govern the relationship between the Parties as the Bellamar’s shareholders (“Bellamar’s Shareholders’ Agreement”).

 

    40

     

    

 

5.13. Proxies.
The proxies granted by one Party or its Subsidiaries to the other Party and/or its Subsidiaries or respective employees, associates
and service providers thereof shall be deemed automatically revoked on the Effective Spin-off Date, regardless of notice, except
for the proxies referred to in Appendix 5.13, which shall solely be revoked upon notice to the respective signatories on
a timely basis to avoid any negative impact in the management of the Parties’ and its Subsidiaries’ businesses.

 

 6. Distribution of Sendas’ Shares

 

 6.1. Shares Prior to Distribution. Before the distribution of the Sendas’ shares to the CBD’s shareholders (“Distribution”) and in conformity with the terms and conditions set forth in this Agreement, the Parties shall undertake, or shall ensure the undertaking of the following actions with respect to the Distribution:

 

		(i)	Notice to the Shareholders. CBD and Sendas
shall agree with B3 the Distribution date (“Effective Date of Distribution”).

 

		(ii)	Sendas’ Registry as a Publicly-held Company
and Listing with B3. Through the Effective Date of Distribution, Sendas shall have been registered as the issuer, under
category A, before CVM, in the sense that Sendas’ shares shall have been admitted for trading in B3.

 

		(iii)	Admission for Trading of the ADRs in NYSE.
Through the Effective Date of Distribution, Sendas shall have ADRs representing the shares admitted for trading in NYSE.

 

		(iv)	ADRs Deposit Agreement. The deposit agreement
shall have been entered into to indicate a depositary to the ADRs representing the Sendas’ shares;

 

		(v)	Sendas’ Managers. Through the Effective
Date of Distribution, CBD and Sendas shall undertake all necessary measures so that (a) the Sendas’ managers have been duly
indicated and taken office; and (b) the composition of Sendas’ management has been disclosed to the market;

 

		(vi)	Securities Laws. Sendas shall file any
documents, amendments or supplements, as deemed necessary or advisable, in order to ensure that the registry forms become and
remain in effect as determined by CVM and SEC or the applicable Laws in force. CBD and Sendas shall cooperate with the preparation
and filing with CVM and SEC of the documents and information deemed necessary to reflect the transactions contemplated by this
Agreement and the other Transaction Documents, including any documentation and commitment letters to undertake or not any acts
deemed necessary or advisable to perform the Distribution as soon as possible. CBD and Sendas shall undertake all necessary or
adequate measures set forth in the applicable Laws in force in connection with the Distribution.

 

    41

     

    

 

		(vii)	Information Availability Statement. CBD
shall submit the necessary information on the Distribution to the holders of ADRs and shares issued by CBD, as set forth in the
applicable Law in force.

 

 6.2. Distribution Conditions. The completion of the Distribution shall be subject to the performance of the following conditions:

 

		(i)	SEC shall have declared the effectiveness of the Form
20-F and no order suspending the effectiveness of the Form 20-F shall be in effect or being analyzed by SEC;

 

		(ii)	the information shall have been submitted to the holders
of the CBD’s shares and ADRs, subject to the proper disclosure by the means defined by the applicable Laws in force;

 

		(iii)	the Corporate Reorganization shall have been validly
implemented;

 

		(iv)	all approvals or notices by any Governmental Authorities
deemed necessary for the performance of the Distribution shall have been obtained;

 

		(v)	no Order shall have been issued and no other legal
restriction or prohibition that prevents the completion of the Business Separation, the Distribution or any transaction set forth
in this Agreement or the other Transaction Documents shall be in force; and

 

		(vi)	no other event or fact shall exist or shall have taken
place that, based on the opinion and exclusive discretion of the CBD’s Board of Directors, would make the Business Separation,
the Distribution or any transaction set forth in this Agreement or the other Transaction Documents not advisable.

 

6.2.1. The
abovementioned conditions are exclusively to the CBD’s benefit and shall not originate or create any obligation by CBD or
the CBD’s Board of Directors to waive or not waive any such condition, or otherwise limit the CBD’s right to terminate
this Agreement. Any resolution undertaken by the CBD’s Board of Directors, before the Distribution, with respect to
the performance or waiver of any or all conditions set forth in this Clause 6.2 shall be final and shall bind the Parties.
In the event CBD waives any material condition, CBD shall immediately disclose the material fact to the market with respect to
such decision.

 

    42

     

    

 

 6.3. Delivery of Sendas’ Shares. The Distribution shall take place on the Effective Distribution Date, upon delivery to the CBD’s shareholders of the Sendas’ Shares, at the ratio of one share issued by Sendas for one share issued by CBD, as set forth in the CBD’s Partial Spin-off Agreement, provided that (i) the shareholders whose shares are deposited in B3’s Central Depositary shall receive the Sendas’ Shares through the respective custody agent; (ii) the shareholders holding the book-entry shares, not deposited in B3’s Central Depositary may receive the Sendas’ Shares directly from the bookkeeper contracted by Sendas; and (iii) the holders of the ADRs representing the CBD’s shares shall receive the ADRs representing the Sendas’ Shares duly admitted for trading in NYSE.

 

 7. Other Covenants

 

 7.1. Expenses. The costs and expenses incurred with legal costs and attorneys’ fees, accountants, financial consultants and other external professionals, and financial institutions relating to the Business Separation, this Agreement and all other transactions related thereof, shall be equally shared between the Parties.

 

7.1.1. Rendering
of Accounts. Within sixty (60) days as from the Effective Distribution Date, each of the Parties shall render accounts to the
other Party with respect to all and any costs and expenses to be apportioned between the Parties; and the Party that has assumed
the lowest value of these costs and expenses shall reimburse the other Party in order to comply with the cost apportionment set
forth in Clause 7.1. The costs and expenses referred to in this Clause shall be reimbursed within ten (10) Business Days
as from the beginning of the quarter immediately after the conclusion of such rendering of accounts, in conformity with the provisions
set forth in Clause 7.7

 

 7.2. Confidentiality. The Parties agree to maintain the confidentiality and not disclose to the public the terms and conditions set forth in this Agreement and other confidential information provided by one Party to the other in the context of the Business Separation, within five (5) years as from the Effective Spin-off Date, without the previous consent of the other Party, except for the conditions set forth in Clause 7.2.1 below. In addition, each of the Parties and the respective officers, directors and employees thereof agree to handle as strictly confidential and do not disclose to any third parties any confidential information related to the other Party and respective Affiliates thereof, except for any information that (i) is or may be disclose to the public; (ii) had already been known by the receiving Party on the date of such disclosure by the other Party; or (iii) has been lawfully received, by any of the Parties, from third parties that are not subject to any confidentiality obligation before the other Party.

 

    43

     

    

 

7.2.1. The
confidentiality obligation set forth in this Agreement shall not prevent the Parties to disclose the information under the terms
and strict limits determined by the applicable Law in force, inclusive for purposes of registry before CVM, B3, SEC and NYSE. In
the event any of the Parties and/or respective Affiliates are obligated, as set forth in the applicable Law in force or by any
proper Governmental Authority, to disclose, in the whole or in part, any confidential information referred to in this Clause
7.2, such Party may disclose such information without being subject to indemnifications or charges, and shall notify the other
Party with respect to such disclosure obligation (if possible, before the respective disclosure).

 

7.2.2. Marketing.
The Parties shall agree with respect to the disclosure of any notes, press releases or other public statements relating to the
Business Separation, including the Corporate Reorganization and the Distribution, or any other transaction in connection with the
Transaction Documents.

 

 7.3. Sharing of Information. Without prejudice to any other provisions set forth in the Transaction Documents and except for any request relating to any pending or threatened Claim, by one Party and/or respective Affiliates thereof against the other Party and/or respective Affiliates thereof, each of the Parties shall provide to the other Party and/or respective Affiliates thereof, as requested, with reasonable advance, at any time before or after the Effective Spin-off Date, in the shortest possible period, any information and/or document under the control or owned by the respective Party and/or Affiliate thereof, including the access to Person under the authority thereof, for purposes of (i) performance of the obligations by the requesting Party and/or respective Affiliates thereof in conformity with any applicable Law in force, including, but not limited to, by virtue of Orders; (ii) use by the requesting Party and/or the respective Affiliates thereof in lawsuits and/or administrative and arbitration proceedings; and/or (iii) performance of the obligations assumed by the requesting Party and/or respective Affiliates thereof in connection with this Agreement or the other Transaction Documents, or, in addition, in connection with any other agreements, accords or commercial arrangements in force before the Effective Spin-off Date. The requesting Party shall use the respective information and/or document exclusively for the purposes provided for in this Clause and in strict compliance with the applicable Law in force, including, but not limited to, Law 13709, of August 14, 2018, as amended and in force (“LGPD”).

 

7.3.1. The
provision of information and/or documents as set forth in this Clause 7.3 shall comply with the rules applicable to the
personal data sharing set forth in LGPD, however the case may be and, except as set forth in Clause 7.3.3, shall not grant
any property or license right to the requesting Party with respect to the information and/or documents provided thereto.

 

7.3.2. Except
if otherwise set forth in the Transaction Documents, the requesting Party shall reimburse the disclosing Party for any costs and
expenses, if any, effectively incurred with the obtaining, preparation and/or provision of the respective information, document
or access to Persons, as applicable.

 

    44

     

    

 

7.3.3. After
the Effective Spin-off Date, (a) Sendas shall deliver to CBD all and any information and/or documents controlled or owned by Sendas,
as well as ensure the reasonable access to Persons under Sendas’ responsibility, which hold information relating to Compre
Bem and/or Gas Stations; and (b) CBD shall deliver to Sendas any and all information and/or documents controlled or owned by CBD,
as well as ensure the reasonable access to Persons under CBD’s responsibility, which hold information relating to CBD’s
Real Estates and Sendas (in relation to Sendas, provided that such information and/or documents are exclusively related to Sendas).

  

7.3.4. Data
Protection Agreement. The Parties shall enter into a Personal Data Handling Agreement, in the form of the draft included in
Appendix 7.3.4, which shall govern the obligations attributed to the Parties in relation to the exchange of information
and provision of personal data, as well as the responsibility and indemnity of the Parties by virtue of possible violations of
the LGPD.

 

7.3.5. Documents
Forwarding. In the event any of the Parties and/or Affiliates thereof receive communications, summons and/or notices relating
to Third-Party Claims eventually addressed to the other Party and/or any Affiliates thereof, the Party that has received such communication,
summon and/or notice agrees to inform and submit such documents to the other Party within the period equivalent to one third (1/3)
of the legal period for presentation of the Defense against such Third-Party Claim or within five (5) Business Days, whichever
is the shortest period, provided that, in the event the legal term for Defense is five (5) days, such documents shall be delivered
within up to a half of the term for the Defense. The other communications received by one Party and/or Affiliates eventually addressed
to the other Party and/or any of the Affiliates thereof shall be submitted to the proper recipient within five (5) Business Days.

 

7.3.6. Transfer
of Amounts. Without prejudice to any other provisions set forth in this Agreement, the Party that has received any amounts
that should have been allocated to the other Party (and/or Affiliates thereof) shall transfer such amounts to the other Party within
five (5) Business Days from the respective receipt date, subject to the provisions set forth in Clause 7.7.

 

 7.4. Non-Solicitation. Except as otherwise agreed between the Parties, over the period of twelve (12) months as from the Effective Spin-off Date, the Parties and any of the respective Affiliates shall not, directly or indirectly, (i) persuade any person holding any management or executive position, statutory or not in the other Party and/or respective Affiliates thereof to resign or terminate the employment relationship with such Party; and (ii) engage such persons as employees or service providers.

 

    45

     

    

 

 7.5. Other Documents and Approvals. Each of the Parties agrees to enter into any documents and adopt any measures that may be deemed necessary or advisable, from time to time, to comply with this Agreement and perform the Business Separation. In this regard, the Parties agree to cooperate and undertake commercially reasonable efforts to obtain all and any approvals, consents, permits, authorizations, certificates, registries, filings and other documents and/or third-party acts in the shortest possible period.

 

7.5.1.
Compliance Certificates. The CBD’s compliance and internal control policies and procedures are, as of the date
hereof, applicable to Sendas as the CBD’s Affiliate. In order to ensure the presentation by the Sendas’ officers of
the certificates referred to in Section 302 of the Sarbanes-Oxley Act of 2002 (“SOX”), CBD shall, in relation
to any periods before the Effective Spin-off Date (inclusive), provide to Sendas one or more certificates (in the format agreed
between the Parties in good faith) relating to such compliance and internal control procedures and respective effectiveness thereof,
for purposes of such Section 302 of the SOX, within thirty (30) days as from the end of any quarter in which Sendas’ financial
information has been disclosed.

 

7.5.1.1. Each
Party agrees to comply with the regulatory requirements of the other Party, as requested by auditors or other Governmental Authorities,
relating to periods before the Effective Spin-off Date. The Party requesting such procedures shall be responsible for possible
costs and expenses and maintain such procedures to the shortest extent possible.

 

7.5.2. Tax
Compliance. In addition to the sharing of information referred to in Clause 7.3 above, each of the Parties agrees to
undertake, at the Parties’ own expenses, all measures deemed necessary for the regularization of any acts, events and/or
facts under the responsibility of each Party that may prevent the issuance of Tax Compliance certificates (debt clearance certificates
and/or debt clearance certificates with negative effects) on behalf of the other Party, including, but not limited to, the obtaining
of Orders for suspension of the obligation or the right that the non-performance would not prevent the issuance of the certificate
on behalf of the other Party, or the performance of the Liability that has prevented the issuance of such certificate, within ten
(10) days as from the notice in this regard submitted by the other Party.

 

 7.6. Offset. The Parties agree to offset, although partially, any and all net debts, overdue and existing between the Parties in connection with the Transaction Documents, in conformity with articles 368 and following articles of the Civil Code.

 

 7.7. Delayed Payment. In the event one of the Parties fails to perform, on a timely basis, the payment or reimbursement or transfer of any amounts set forth herein, such Party shall be subject to the payment or transfer of the overdue amount, adjusted based on the CDI rate between the maturity date and the effective payment date, plus interest of arrears of two percent (2%) per year, on a proportional basis.

 

    46

     

    

 

 7.8. Data Room Copy. CBD agrees to deliver to Sendas, within thirty (30) days as from the Effective Distribution Date, a media certified by Intralinks including a copy of the contents of the virtual data room relating to the Business Separation.

 

 8. Resolutive Condition and Termination

 

 8.1. Resolutive Condition. The Parties acknowledge that this Agreement shall be entered into under the resolutive condition, as set forth in articles 127 and 128 of the Civil Code, in the sense that such Agreement may be immediately terminated in the event the CBD’s Partial Spin-off has not been approved by the shareholders of the Parties, and/or the Corporate Reorganization or Distribution has not been implemented through June 30, 2021 (“Resolutive Condition”).

 

8.1.1. Effects
of Resolutive Condition Verification. Upon verification of the Resolutive Condition, this Agreement may be terminated by any
of the Parties, in which case the acts undertaken for purposes of Business Separation shall be reversed as if such acts have not
been undertaken, and the Parties shall return to the respective status quo ante.

 

 8.2. Termination. This Agreement may be terminated by CBD, at any time, before the Effective Spin-off Date, regardless of any motive or reason, upon notice submitted to Sendas, pursuant to Clause 9.1.

 

 9. General Provisions

 

 9.1. Notices. The notices, claims, requests, consents, approvals, statements, deliveries or other communications, under the terms of this Agreement, shall be deemed valid and effective if prepared in writing and delivered (a) in person (by means of protocol or confirmation of delivery); (b) by certified letter or courier service (upon confirmation of receipt and post service); or (c) by e-mail upon confirmation of delivery, to the following physical and electronic addresses:

 

Companhia
Brasileira de Distribuição

C/O: CEO, with a copy to the Legal Chief
Officer

Avenida Brigadeiro Luiz Antônio,
3142, Jardim Paulista, São Paulo/SP, Zip Code 01402-001

E-mail:

 

Sendas
Distribuidora S.A.

C/O: CEO, with a copy to the Financial
Chief Officer

Avenida Aricanduva, 5555
- Âncora "E", Central Administrativa Assaí (Shopping Interlar - Aricanduva), Vila Aricanduva, São
Paulo/SP, Zip Code 03527-000

E-mail:

 

    47

     

    

 

9.1.1. The
delivery of any notice required under this Agreement may be waived by the Party to whom it is addressed. Any Party may change the
address to which the communication shall be submitted, upon notice in writing to the other Party in accordance with Clause 9.1,
provided that, in relation to this provision, the notice shall be deemed received solely upon recognition of such receipt by the
receiving Party.

 

 9.2. Specific Performance. The commitments and obligations assumed hereunder by each of the Parties are subject to specific performance, according to the Code of Civil Procedure, it being agreed that the establishment of damages will not constitute adequate and sufficient reparation. For this purpose, the Parties acknowledge that this Agreement, duly signed by two (2) witnesses, constitutes an extrajudicial enforcement instrument for all purposes of article part II, of the Code of Civil Procedure.

 

 9.3. Entire Agreement. This Agreement and the other Transaction Documents comprise all understandings between the Parties in relation to the matters in connection with the Transaction Documents and shall prevail over all other express or implicit agreements, understandings, representations, statements and guarantees, orally or in writing, entered into between the Parties and the respective Affiliates, representatives and agents thereof with respect to the matters in connection with the Transaction Documents.

 

 9.4. Waiver; Amendment. No waiver or termination of this Agreement or any of the terms or provisions hereof shall be binding on any of the Parties, unless confirmed in writing. No waiver by any of the Parties of any term or provision set forth in this Agreement or any default related to this instrument shall impact the rights of such Party, as from such date, to execute such term or provision or exercise any right or remedy in relation to any other default, whether similar or not. This Agreement may not be changed or amended except in writing and executed by all Parties.

 

 9.5. Severability. In the event that one or more provisions of this Agreement are considered void, voidable, invalid or ineffective, the validity, legality and enforceability of the other provisions contained in this Agreement shall in no way be affected and/or impaired by such event, remaining in full force and effect, as if such void, voidable, invalid or ineffective provision was not present.

 

 9.6. Successors and Assignors. This Agreement will bind the Parties and their respective successors and permitted assignors. None of the Parties may assign this Agreement or any of its rights and obligations hereunder, without the prior and express written consent of the other Parties.

 

    48

     

    

 

 9.7. Binding Effect. This Agreement is entered into in an irreversible and irrevocable basis, and constitutes legal, valid and binding obligations, to be enforceable and to inure to the benefit of the Parties and their respective successors and permitted assignors.

 

 9.8. Assignment. The Parties shall not assign or transfer this Agreement, totally or partially, on any account, directly or indirectly, to any Third Party, without the previous consent in writing of the other Party.

 

 9.9. Performance of the Agreement. Each of the Parties shall comply, and ensure the compliance by the respective Affiliates, associated companies, officers, directors, employees, representatives and agents, with all respective obligations, covenants and accords in connection with this Agreement and the other Transaction Documents, which shall be complied by such Affiliates, associated companies, officers, directors, employees, representatives and agents. For the purposes of this Clause, the Parties agree to timely inform the obligations, covenants and accords relating to the respective Affiliates, associated companies, officers, directors, employees, representatives and agents thereof.

 

 9.10. Applicable Law. This Agreement shall be governed by and construed in accordance with the Laws of the Federative Republic of Brazil.

 

 9.11. Dispute Resolution. In the event of any disputes, conflicts, issues or divergences of any nature (“Conflict”) in connection with this Agreement, which, after the Effective Spin-off Date, have not been resolved by the Transition Committee, the Parties shall undertake commercially reasonable efforts to resolve the Conflict. In order to do so, any of the Parties may notify the other Party of its desire to initiate the procedure set forth in this Clause from which the Parties shall initiate negotiations to resolve the Conflict amicably and in good faith (“Conflict Communication”). In the event the Parties are not able to achieve any resolution within thirty (30) consecutive days as from the delivery of the Conflict Communication by one Party to the other, the Conflict may be submitted to the Resolution Committee and/or mediation and/or directly to arbitration.

 

9.11.1. Resolution
Committee. The Parties shall implement the Resolution Committee composed of six (6) members (“Resolution Committee”),
out of which three (3) members indicated by each Party, including the CEO of each Party. No member of the Resolution Committee
shall indicate an attorney-in-fact or substitute to attend to and/or vote for such member at the Resolution Committee’s meetings.
The Resolution Committee shall meet whenever a Conflict is submitted, which frequency shall be defined by the Resolution Committee.
The decisions undertaken by the Resolution Committee shall be subject to the approval of, at least, four (4) members, to which
the Parties and respective Affiliates thereof shall be bound for all purposes and effects. In the event the resolution of any Conflict
has not been approved by the Resolution Committee within forty-five (45) days as from the date the Conflict has been submitted
to the Resolution Committee, the Parties may submit the Conflict to mediation or directly to arbitration in accordance with Clauses
9.11.2 and 9.11.3 below.

 

    49

     

    

 

9.11.2. Non-Binding
Mediation. Any Conflict not resolved in accordance with Clauses 9.11 or 9.11.1 above may be submitted to mediation,
provided that jointly requested by the Parties before the Arbitration and Mediation Center of the Brazil-Canada Chamber of Commerce
– CAM-CCBC (“Mediation Chamber”), in accordance with the Mediation Regulation of the Mediation Chamber
(“Mediation Regulation”), except for the modifications agreed between the Parties in this Clause. The mediation
shall be conducted in the municipality of São Paulo, State of São Paulo, except if otherwise agreed by the Parties.
The Parties shall, within twenty (20) days, jointly appoint a mediator. In the event the Parties are not able to achieve an agreement
with respect to the mediator within such period, the mediator shall be appointed in conformity with the Mediation Regulation. The
mediation set forth in this Clause shall be confidential, in the sense that none of the Parties shall disclose or authorize the
disclosure of any information, evidence or document prepared by the other Party in the course of the mediation, as well as the
existence, contents or decisions in connection with the mediation, without the previous consent in writing of the other Party,
except for the exact extension required by the applicable Law in force, taking into account that, before any disclosure under the
applicable Law in force, the disclosing Party shall, to the extent permitted by the applicable Law in force, notify the other Party
with respect to such disclosure so that the respective Party is able to protect the related rights and interests. In the event
the mediation has been conducted and the Conflict has not been resolved within sixty (60) days as from the request of the mediation
before the Mediation Chamber, or within another term agreed by the Parties under the terms of the mediation, the Conflict may be
submitted to arbitration, pursuant to Clause 9.11.3 below.

 

9.11.3. Arbitration.
The arbitration shall be conducted in the City of São Paulo, State of São Paulo, before the Arbitration and Mediation
Center of the Brazil-Canada Chamber of Commerce – CAM-CCBC (“Arbitral Chamber”), in conformity with the
rules established by the Arbitral Chamber and effective on the arbitration date (“Regulation of the Chamber”),
taking into account eventual amendments to these rules, as jointly agreed between the Parties.

 

9.11.4. The
arbitration shall be conducted by three arbitrators (“Arbitral Tribunal”). The claimant shall appoint an arbitrator
and the respondent shall appoint an arbitrator in accordance with the Regulation of the Chamber. In the event there is more than
one claimant, they should appoint only one arbitrator, jointly and by mutual agreement. In the event there is more than one defendant,
they should appoint only one arbitrator, jointly and by mutual agreement. The two appointed arbitrators shall choose the third
arbitrator, jointly and by mutual agreement. The third arbitrator shall chair the arbitration court.

 

    50

     

    

 

9.11.5. Any
omission, refusal, conflict, doubt or disagreement with respect to the appointment or selection of the arbitrators shall be resolved
by the Arbitral Chamber.

 

9.11.6. 11.14.5.
The language of the arbitration shall be Portuguese.

 

9.11.7. The
Parties acknowledge that any one of them may need the granting of a preliminary injunction or of a provisional remedy by the Judiciary
Branch before the constitution of the Arbitral Tribunal. Therefore, the advanced relief or preliminary injunction filed before
the Judiciary Branch shall not be deemed incompatible with or represent a waiver of the provisions set forth in this Clause. Subsequently
to the implementation of the Arbitral Tribunal, any preliminary injunction or advanced relief shall be exclusively filed before
the Arbitral Tribunal.

 

9.11.8. The
Parties elect the court of the City of São Paulo, State of São Paulo, to the exclusion of any other, however privileged
it may be, exclusively for the purposes of (i) concession of preliminary injunctions or advanced reliefs, before the implementation
of the Arbitral Tribunal; (ii) execution of the decisions ruled by the Arbitral Tribunal; (iii) execution of the arbitration; and
(iv) other lawsuits expressly accepted by Law 9307, of September 23, 1996, as amended and in force.

 

9.11.9. The
arbitration award shall be in writing, to which the Parties shall be ultimately bound, enforceable in conformity with the respective
terms thereof, not subject to any decision by equity. The Parties acknowledge and agree that the award shall be considered a final
resolution of the Conflict, and that they shall accept the award as the actual expression of their own decisions regarding such
Conflict. The Arbitral Tribunal may grant any available and appropriate remedy in accordance with the Law governing this Agreement,
including specific performance. The arbitration award shall consider the distribution of expenses, including reasonable attorney’s
fees and expenses, based on the principles of defeated party’s fees, in the sense that each Party shall be responsible for
the respective expenses incurred during the progress of the arbitration proceeding or, in the event the expenses cannot be attributed
to a specific Party, such expenses shall be equally shared between the Parties.

 

[the remainder of the page was intentionally
left in blank]

 

    51

     

    

 

[page of signatures of the Separation
and Other Covenants Agreement]

 

São Paulo, December
14, 2020.

 

	 	/s/ Christophe José Hidalgo	 	/s/ Jorge Faiçal Filho	 
	 	Christophe José Hidalgo	 	Jorge Faiçal Filho	 
	 	Interim CEO, CFO and 

Investor Relations Officer	 	Chief Retail Officer	 

	 	 	 
	

Companhia
Brasileira de DistribuiÇÃo

 

	 	/s/ Daniela Sabbag	 	/s/ Belmiro de Figueiredo Gomes	 
	 	Daniela Sabbag	 	Belmiro de Figueiredo Gomes	 
	 	CFO and Investor Relations Officer	 	CEO	 

	 	 	 
	Sendas Distribuidora S.A.

 

Witnesses:

 

	1. 	/s/ Geovani Diogo Jardim de Sousa	 	2.	Vanessa Borges Rezende	 
	 	Name: Geovani Diogo Jardim de Sousa	 	 	Name: Vanessa Borges Rezende	 
	 	ID: 49.433.380-7	 	 	ID: 34.864.975-7	 
	 	CPF: 435.826.438-75	 	 	CPF: 305.858.878-02	 

 

 

 

52

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]